Lincoln University Digital Thesis Copyright Statement The digital copy of this thesis is protected by the Copyright Act 1994 (New Zealand). This thesis may be consulted by you, provided you comply with the provisions of the Act and the following conditions of use: you will use the copy only for the purposes of research or private study you will recognise the author's right to be identified as the author of the thesis and due acknowledgement will be made to the author where appropriate you will obtain the author's permission before publishing any material from the thesis. A comparative study of immunomodulatory activity of deer and cow milk proteins A thesis Submitted in partial fulfilment of the requirements for the Degree of PhD of Food Science at Lincoln University by Nelum Lawanya Opatha Vithana Lincoln University 2012 i Declaration Parts of this thesis are submitted or accepted for publication and/or presented in advance of submission of the thesis: Publications N. L. Opatha Vithana, S. L. Mason, A. E. A. Bekhit, J. D. Morton (2012). Immunomodulatory activity of fresh and fermented red deer and cow milk. Food and Bioprocess Technology Journal (submitted). N. L. Opatha Vithana, S. L. Mason, A. E. A. Bekhit, J. D. Morton (2012). In vitro digestion of red deer (Cervus elaphus) and cow (Bos taurus) milk. International Food Research Journal. 19: 409-416. N. L. Opatha Vithana, S. L. Mason, A. E. A. Bekhit, J. D. Morton (2011). The release of peptides by in vitro digestion of fermented red deer (Cervus elaphus) and cow (Bos taurus) milk. Proceedings of the Nutrition Society of New Zealand. Volume 35. (Full paper accepted) N. L. Opatha Vithana, S. L. Mason, A. E. A. Bekhit, J. D. Morton (2011). The release of peptides by in vitro digestion of fermented red deer (Cervus elaphus) and cow (Bos taurus) milk. Proceedings of the Nutrition Society of Australia.35: 66. (Abstract) N. L. Opatha Vithana, S. L. Mason, A. E. A. Bekhit, J. D. Morton (2010) Immunomodulatory bioactives from red deer milk. Proceedings of the IDF International Dairy conference. http://www.wds2010.com/delegates/posters/DST-Opatha%20Vithana.Pdf (Abstract) Presentations and Posters N. L. Opatha Vithana, S. L. Mason, A. E. A. Bekhit, J. D. Morton. The composition and immunomodulatory properties of milk from red deer and cows. Annual Conference of the Nutrition Society of New Zealand. 22nd November – 23rd December 2012. Auckland, New Zealand. ii N. L. Opatha Vithana, S. L. Mason, A. E. A. Bekhit, J. D. Morton. The release of peptides by in vitro digestion of fermented red deer (Cervus elaphus) and cow (Bos taurus) milk. Joint Annual Conference of the Nutrition Society of New Zealand and the Nutrition Society of Australia. 29th November – 2nd December 2011. Queenstown, New Zealand. N. L. Opatha Vithana, S. L. Mason, A. E. A. Bekhit, J. D. Morton. Immunomodulatory bioactives from red deer milk. Lincoln University Postgraduate Conference. 2nd – 3rd September 2010. Lincoln University, New Zealand. N. L. Opatha Vithana, S. L. Mason, A. E. A. Bekhit, J. D. Morton. Immunomodulatory bioactives from red deer milk. IDF International Dairy conference. 4th – 11th November 2010. Auckland, New Zealand. N. L. Opatha Vithana, S. L. Mason, A. E. A. Bekhit, J. D. Morton. Immunomodulatory bioactives from red deer milk. New Zealand Society for Biochemistry and Molecular Biology: Canterbury Branch Regional Meeting. 21st September 2009. Lincoln University, New Zealand. iii Abstract of a thesis submitted in partial fulfilment of the requirements for the Degree of PhD of Food Science. Abstract A comparative study of immunomodulatory activity of deer and cow milk proteins by Nelum Lawanya Opatha Vithana The aim of this study was to compare the immunomodulatory activity of peptides derived from deer and cow milk using in vitro lymphocyte proliferation assays and cytokine (IL-2 and INFγ) production by human peripheral blood mononuclear cells (PBMC). Bioactive peptides were produced using in vitro digestion and lactic acid bacteria (LAB) fermentation. Deer and cow milk were fermented using Lactobacillus delbrueckiisubspbulgaricus, Streptococcus salivarius subsp thermophilus and Lactobacillus casei strain Shirota at 37oC for 24 hours. Unfermented and fermented milk proteins were digested in two steps; imitating both the human stomach (Pepsin, pH 2.5, 30 min) and the duodenum (Corolase PP, pH 7.5, 30 min) digestion. The production of peptides was quantified using the O-phthaldialdehyde assay and the degradation patterns of the milk proteins were analysed by SDS-PAGE. Immunomodulatory activity of each hydrolysate was carried out for 0.125, 0.25 and 0.5 mg/ml protein concentrations. All unfermented and fermented deer and cow milk digestions were fractionated using Fast Protein Liquid Chromatography (FPLC) in order to separate and identify the most active fractions. Identification of peptides present in these immunostimulating fractions were carried out using Liquid Chromatography–Mass Spectrometry (LC-MS/MS) and database searching. Deer milk contained 8.8 ± 0.13% protein which was twice the level found in cow milk (4.1 ± 0.02%). Peptide production was significantly higher in unfermented deer milk than unfermented cow milk (P< 0.05). The commercial proteolytic enzymes degraded milk proteins from deer more rapidly than those from cow. Deer milk fermentation gave higher peptide production than cow milk fermentation. Following in vitro digestion peptide production was significantly greater in deer milk ferment than cow milk ferment (P≤ 0.05). iv Lymphocyte proliferation, interleukin-2 (IL-2) and interferon-γ (INFγ) production were significantly greater in deer milk digestions than cow milk digestions (P ˂ 0.001)at the same concentration. LAB fermentation of both deer and cow milk prior to in vitro digestion increased (P < 0.001) lymphocyte proliferation. Fermentation with lactobacillus strains increased lymphocyte proliferation and cytokine IL-2 and IFNγ production (P < 0.05) more than with streptococcus. The immunostimulating effect was significantly greater (P ˂ 0.001) at 0.125 mg/ml protein concentration than at higher protein concentrations. The deer milk digests were more effective at increasing lymphocyte proliferation than the cow milk digests (P < 0.001) at the same protein concentration. Proliferation was higher (P < 0.001) at 0.125 mg/mL protein than at higher protein concentrations. FPLC fractions (11, 22 and 30) with high immunostimulatory activity from deer digests (unfermented and fermented) showed higher lymphocyte proliferation and higher cytokine IL-2 and IFNγ production than the correspondening fractions of cow digests when measured in vitro with human PBMC. Mixtures of different peptides with different protein origin have been identified in the above FPLC fractions in both deer and cow milk digests which could be responsible for theimmunostimulating effect. The main protein source was β casein for both deer and cow fractions. Some differences in amino acid composition of β casein, α1 and α2 casein were identified between deer milk than cow milk. Few previously identified immunostimulating peptide sequences were found in tested FPLC fractions in cow digests. Some different peptides were detected in deer fractions compared to corresponding cow fractions. No previously identified immunostimulating peptides were detected in deer digests. Further studies are required to further purify and identify unknown immunostimulating peptides. The activity could be confirmed with synthesised peptides. Keywords: deer milk, cow milk, milk proteins, peptides, in vitro digestion, fermentation, immunomodulatory activity, human PBMC, lymphocyte proliferation, cytokine production, FPLC, LC-MS/MS, database searching v Acknowledgements I would like to thank my main supervisor Dr. Sue Mason for her patience, time, guidance,knowledge and advice. I would also like to thank my associate supervisors Dr. Aladin Bekhitand Prof. Jim Morton for their expertise, time and advice throughout the project. Having access to such individuals with their specialized knowledge allowed the project to flow smoothly. I also would like to acknowledge Dr. Richard Sedcole for helping me with statistical analysis and for his expertise knowledge. I acknowledge the support and cooperation of Martin Ridgway and Martin Wellby, Lincoln University deer farm and Mr. Keith Neylon (Blue River Dairy) for the donation of sheep milk.Additional acknowledgements go to Dr. Stefan Clerens from AgResearch who helped with the mass spectrometric analysis.Also I would like to thank Karl, Omega, Nadia and all other technical staff at Wine, Food and Molecular Biosciences Department that helped in completing this project. I would like to thank my loving husband Hashan, daughter Linara, parents and brothers for their support and guidance throughout the doctoral programme. Additional acknowledgements include fellow lab mates, postgraduate students and friends for their help in surviving the undertaking of the doctoral programme. I would not have been able to complete my doctorate successfully without help of all mentioned above. This research could not have been conducted without the financial support of Lincoln University. Also part of this project was funded by the Primary Partnership fund from Otago University. I acknowledge their partnership in the project and would like to thank them for their contribution. vi Table of Contents Declaration……………………………………………………………………………………ii Abstract ............................................................................................................................... iv Acknowledgements............................................................................................................. ivi Tabel of Content................................................................................................................. vii List of Tables ........................................................................................................................ x List of Figures...................................................................................................................... xi Chapter 1 Introduction ........................................................................................................ 1 Chapter 2 Literature Review............................................................................................... 5 2.1 Milk.............................................................................................................................. 5 2.2 Milk Bioactives............................................................................................................. 5 2.3 Bioactive Peptides from Milk........................................................................................ 6 2.3.1 Immunomodulatory Bioactive Peptides from Milk............................................. 8 2.3.2 Immunomodulatory Bioactive Peptides from Fermented Milk ........................... 8 2.4 Overview of the Immune System ................................................................................ 13 2.5 Deer milk,Usage and Potential of Immunomodulating Bioactives ............................... 23 Chapter 3In vitroDigestion of Red Deer (Cervus elaphus) and Cow (Bos taurus) milk .. 26 3.1Introduction..................................................................................................................... 26 3.2Materials & Methods....................................................................................................... 27 3.2.1 Materials ........................................................................................................... 27 3.2.2 Preparation of Milk Samples ............................................................................. 27 3.2.3 Protein Content ................................................................................................. 28 3.2.4 Dry Matter Content ............................................................................................ 28 3.2.5 In vitro Digestion .............................................................................................. 28 3.2.6 Proteolysis Assesment Using OPA Assay.......................................................... 29 3.2.7 SDS-PAGE ....................................................................................................... 29 3.2.8 Quantification of Protein Bands......................................................................... 29 3.2.9 Statistical Analysis ............................................................................................ 30 3.3Results & Discussion....................................................................................................... 30 3.4Conclusion ...................................................................................................................... 38 Chapter 4 Fermentation of Deer and Cow Milk ............................................................... 39 4.1Introduction..................................................................................................................... 39 4.2 Materials & Methods...................................................................................................... 40 4.2.1 Materials ........................................................................................................... 40 4.2.2 Milk Fermentation............................................................................................. 40 4.2.3 In vitro Digestion .............................................................................................. 40 4.2.4 Proteolysis Assesment Using OPA Assay.......................................................... 41 4.2.5 SDS-PAGE ........................................................................................................ 41 4.2.6 Statistical Analysis ............................................................................................ 41 4.3 Results ........................................................................................................................ 41 4.4 Discussion...................................................................................................................... 50 4.5 Conclusion…………………………………………………………………………….....54 vii Chapter 5 Immunomodulatory Activity of Deer and Cow Milks..................................... 55 5.1Introduction..................................................................................................................... 55 5.2Material & Methods ........................................................................................................ 55 5.2.1 Materials................................................................................................ 56 5.2.2 Collection &Preparation of Milk Samples .............................................. 56 5.2.3 Fermentation.......................................................................................... 56 5.2.4 In vitro Digestion ................................................................................... 57 5.2.5 BCA Protein Assay ................................................................................ 57 5.2.6 Isolation of human PBMC...................................................................... 57 5.2.7 In vitro Lymphocyte Proliferation Assay ............................................... 57 5.2.8 Cell Viability Test.................................................................................. 58 5.2.9 Cytokine Production…………………………………………………... 58 5.2.10 Statistical analysis…………………………………………………… 59 5.3Results & Discussion....................................................................................................... 59 5.4Conclusion ...................................................................................................................... 71 Chapter 6 Comparative Study of Deer Milk with Three other mammallian Milks ........ 73 6.1 Introduction................................................................................................................... 73 6.2 Materials & Methods..................................................................................................... 73 6.2.1 Materials................................................................................................ 73 6.2.2 Compositional analysis .......................................................................... 74 6.2.3 Determination of BC of Deer, Cow, Goat & Sheep Milk ........................ 75 6.2.4 In vitro Digestion of Deer, Cow, Goat & Sheep Milk ............................ 75 6.2.5 SDS-PAGE of Deer, Cow, Goat & Sheep Milk ...................................... 76 6.2.6 Immunomodulation Activity……………………………………………..........76 6.2.6.1 In vitro Lymphocyte Proliferation Assay............................................. 76 6.2.6.2 Cytokine Production............................................................................ 76 6.2.7 Statistical Analysis…………………………………………………………….76 6.3 Results ........................................................................................................................ 77 6.4 Discussion...................................................................................................................... 87 6.5 Conclusion…………..…………………………………………………………………...95 Chapter 7Fractionation of Immunomodulatory Bioactive Peptides of deer and Cow Milk Ferments and Digests ................................................................................................ 96 7.1 Introduction................................................................................................................... 96 7.2 Materials & Methods..................................................................................................... 97 7.2.1 Materials................................................................................................ 97 7.2.2 Fractionation of Peptide by FPLC .......................................................... 97 7.2.3 In vitro Lymphocyte Proliferation Assay................................................ 98 7.2.4 Cytokine Production ............................................................................... 98 7.2.5 BCA Protein Assay ................................................................................ 98 7.2.6 Statistical Analysis…………………………………………………….....98 7.3 Results ........................................................................................................................ 99 7.4 Discussion.................................................................................................................... 109 7.5 Conclusion……………………………………………………………………………..113 viii Chapter 8Identification of Peptides from Immunostimulating Fractions of Deer and Cow Milk Digestions ........................................................................................................ 114 8.1 Introduction................................................................................................................. 114 8.2 Materials & Methods................................................................................................... 114 8.2.1 Materials.............................................................................................. 114 8.2.2 Liquid Chromotography-Mass Spectrometry........................................ 115 8.2.3Data Base Searching……………………………………………………115 8.3 Results & Discussion.................................................................................................... 115 8.4 Conclusion ................................................................................................................... 123 Chapter 9 General Discussion , Conclusion & Future Work ......................................... 124 References......................................................................................................................... 128 Appendix A The release of peptides by in vitro digestion of fermented red deer (Cervuselphus) and cow (Bos taurus) milk. ........................................................................ 150 Appendix BIL-2 production by human peripheral blood mononuclear cells (PBMC) stimulated by Con A with FPLC fraction 13 and 36 of unfermented and fermented deer and cow milk in vitrodigests ..................................................................................................... 155 Appendix CDeer and cow milk digests FPLC fractions absorbance at 280 nm .................. 156 ix List of Tables Table 2.1 Table 2.2 Table 2.3 Table 2.4 Table 2.5 Table 3.1 Table 3.2 Table 4.1 Table 5.1 Table 5.2 Table 6.1 Table 6.2 Table 6.3 Table 6.4 Table 6.5 Table 7.1 Table 8.1 Table 8.2 Table 8.3 Immunomodulatory peptides derived from milk proteins ..................................... 9 Immunomodulatory peptides derived from fermented milk ................................ 11 Cytokine families............................................................................................... 20 Traditional products and uses of Reindeer milk. ................................................. 24 Gross composition (%) of milk of human & some domesticated mammals......... 25 Dry matter & protein content of red deer and cow milk. ..................................... 30 Protein content (%) remaining in raw milk before digestion (start), after stage 1 digested with pepsin at pH 2.5 for 30 min / 37 °C and after stage 2 digested with CPP at pH 7.5 for 30 min / 37 °C.. ............................................................. 37 Remaining protein content (%) in digest of milk, Lactobacillus delbrueckii subsp bulgaricus, Streptococcus salivarius subs thermophilus and Lactobacillus casei strain Shirota fermented milk before and after in vitro digested.............................................................................................................. 49 ANOVA Table for percent change in lymphocyte proliferation for deer and cow unfermented and fermented. ....................................................................... 65 Proportion of viable cells compares to control sample after up to three days incubation with different protein concentrations................................................. 67 Mean of proximate composition for deer, cow, sheep and goat milks and concentration of milk proteins............................................................................ 78 Major and minor mineral contents of deer, cow, sheep and goat milk. ................ 79 Mineral composition of red deer early, middle and late milking. ........................ 80 Canonical variate analysis for the red deer minerals. .......................................... 82 ANOVA Table for % change in lymphocyte proliferation. ................................. 84 ANOVA Table for % change of lymphocyte proliferation for FPLC fractions 13, 24 and 36 of unfermented and fermented deer and cow milk digests at 0.125 mg/ml protein concentration................................................................... 107 Total number of identified peptides contained and source of protein in FPLC fraction 11, 22 and 30 from unfermented and Lactobacillus delbrueckii subsp bulgaricus fermented cow and deer in vitro digestions...................................... 116 Comparison of amino acid residues in milk protein of deer with cows giving its specific position base on results of peptides found in FPLC fractions. ......... 118 Sequences and corresponding milk protein fragment of peptides contained in FPLC fractions................................................................................................. 120 x List of Figures Figure 1.1 Structure of chapters and research experiments of the thesis................................. 4 Figure 2.1 Summarizing scheme of the possible mechanisms by which bioactive peptides can be released from the precursor proteins by microbial fermentation and/or gastrointestinal digestion...................................................................................... 7 Figure 2.2 Different biological activites of peptides. ............................................................. 7 Figure 2.3 Integrated human immune system. ..................................................................... 14 Figure 2.4 Recognition by the immune system.................................................................... 16 Figure 2.5 Immune response. .............................................................................................. 17 Figure 2.6 Distribution of lymphocytes to the different organs............................................ 18 Figure 2.7 Regulation of adaptive immunity by cytokines................................................... 20 Figure 3.1 pH during in vitro digestion of deer andcow milk............................................... 31 Figure 3.2 Peptide production during in vitrodigestion of deer and cow milk simulated stomach and then simulated duodenum. ............................................................. 33 Figure 3.3 SDS-PAGE of defatted Deer Milk & Deer Milk digested with pepsin and CPP.. 34 Figure 3.4 SDS-PAGE of skimmed CowMilk & CowMilk digested with pepsin and CPP. . 35 Figure 3.5 In vitro digestion of casein (a), α-lactalbumin (b), immunoglobulin (c) in raw milk from deer and cow by pepsin at pH 2.5 / 37 °C and CPP at pH 7.5 / 37 °C. ..................................................................................................................... 36 Figure 4.1 Growth of Lactobacillus delbrueckiisubsp bulgaricus, Streptococcus salivarius subsp thermophilus in deer and cow milk at 37°C for 24 hr............................... 42 Figure 4.2 Growth of Lactobacillus casei strain Shirota in deer and cow milk at 37°C for 72hr. .................................................................................................................. 42 Figure 4.3 pH drop during fermentation of deer and cow milk at 37°C..………………...... .44 Figure 4.4 Peptide production measured by OPA assay during fermentation of deer and cow milk at 37°C. .............................................................................................. 45 Figure 4.5 Peptide production during in vitro digestion of 24hr fermented deer and cow milk. .................................................................................................................. 46 Figure 4.6 Peptide production after in vitro digestion of raw milk, 24hr fermented milk and fermented digests for deer and cow milk...................................................... 47 Figure 4.7 SDS-PAGE of cow and deer milk following fermentation.................................. 48 Figure 5.1 Percent change of lymphocyte proliferation at a) 0.125mg/mL, b) 0.25mg/mL and c) 0.5mg/mL protein level for in vitro digestions of deer and cow milk and fermented milk................................................................................................... 60 Figure 5.2 Percent change of lymphocyte proliferation of digest deer andcow milk at 0.125, 0.25 and 0.5 mg/mL protein concentrations. ............................................ 62 Figure 5.3 Percent change of lymphocyte proliferation with ConA and without ConA for different protein concentrations of digested a) Deer and b) Cow......................... 63 Figure 5.4 Percent change of lymphocyte proliferation with ConA) and without ConA for different protein concentrations of digests of Lactobacillus delbrueckiisubsp bulgaricus ferments of a) Deer and b) Cow. ....................................................... 64 Figure 5.5 Interleukin-2 production by human peripheral blood mononuclear cells at different protein concentrations of deer) and cow milk digesions and fermented milk digestions. ................................................................................. 68 Figure 5.6 IFNγ production by human peripheral blood mononuclear cells at different protein concentration of deer and cow milk digest and fermented milk digests. .. 69 Figure 6.1 Canonical analysis for 15 minerals at four milking times.................................... 81 Figure 6.2 Buffering index of cow, sheep and goat milks compared with deer milk............. 83 xi Figure 6.3 SDS- PAGE of Deer, Cow, Sheep and Goat milk before and after digestion ...... 84 Figure 6.4 Percentage change of lymphocyte proliferation at 0.125mg/ml,0.25mg/ml and 0.5mg/ml protein concentration for deer, cow, sheep and goat milk digestions. .. 85 Figure 6.5 Interleukin-2 production by Con A stimulated human peripheral blood mononuclear cells. ............................................................................................. 86 Figure 6.6 IFNγ production by Con A stimulated human peripheral blood mononuclear cells. .................................................................................................................. 86 Figure 7.1 RP-FPLC chromatograms of the unfermented and fermented deer and cow milk after in vitro digest. .................................................................................. 101 Figure 7.2 Percentage change in lymphocyte proliferation of FPLC fraction 11, 22 and 30 of unfermented and fermented deer and cow milk in vitro digests. ................... 102 Figure 7.3 Interleukin-2 production by human peripheral blood mononuclear cells stimulated by Con A treated with FPLC fraction 11, 22 and 30 of unfermented and fermented deer and cow milk in vitro digests. ............................................ 104 Figure 7.4 IFNγ production by human peripheral blood mononuclear cells stimulated by Con A treated with FPLC fraction 11, 22 and 30 of unfermented and fermented deer and cow milk in vitro digests .............................................. 105 Figure 7.5 Percentagechange of lymphocyte proliferation with ConA and without ConA for different protein concentrations of deer milk digests FPLC fraction 30. ...... 106 Figure 7.6 IL-2 and IFNγ production by human peripheral blood mononuclear cells stimulated by Con A with FPLC fraction 24 of unfermented and fermented deer and cow milk in vitro digests. ................................................................... 108 Figure 8.1 Localization of identified peptides in FPLC fraction 30 of unfermented cow and deer milk digests and digests of Lactobacillus delbrueckiisubsp bulgaricus ferment of cow and deer on cow β casein. ........................................................ 122 xii Chapter 1 Introduction Milk has been described as nature’s most complete food (Park, 2009). It provides essential nutrients during neonatal development and plays an important protective role in development of the immune system of new-born mammals (Inglingstad et al., 2010; Korhonen and Pihlanto, 2006). Ruminant milk and milk products have also formed an integral part of human diets since the earliest domestication of livestock (Cross &Gill, 2000). The nutritional benefits of milk derived protein, vitamins and minerals have been promoted extensively by commercial dairy enterprises, and the vast range of milk based products now available are partly the result of the continued image held by consumers of milk as a ‘healthy’ product. Research has identified milk as a product with benefits beyond its nutritional value (Cross &Gill, 2000). The concept of milk as a functional food with bioactive peptides and one which has direct and measurable influence on the health of its recipient, has increasingly gained scientific creditability (Meisel, 1997; Mclntosh et al., 1998; Meance et al., 2003; Korhonen, 2009). Bioactive peptides have been defined as specific protein fragments that have an impact on body functions or conditions and may ultimately influence health (Kitts & Weiler, 2003). Bioactive peptides exhibit opiate-like, mineral binding, immunomodulatory, antimicrobial, antioxidant, antithrombotic, hypocholesterolemic, and antihypertensive actions (Erdmann et al, 2008) and most contain 2–20 amino acid residues per molecule, although some are larger than 20 amino acids (Erdmann et al., 2008). Such peptides are inactive within the sequence of the parent protein and can be released by digestive enzymes during gastrointestinal transit or by fermentation or ripening during food processing (Korhonen & Pihlanto, 2003). Immunomodulatory peptides have been identified from milk and milk products (Fabienne Parher, 1984; Laffineur et al., 1996; LeBlanc et al., 2002; Silva et al., 2005; Erdmann et al., 2008; Korhonen, 2009; Nagpal et al., 2011; Perez Espitia et al., 2012). Currently milk proteins are the most important commercial source of bioactive peptides (Korhonen, 2009) and widely studied but information on peptides from milk of species other than cow is very limited. The proteins in milk from different species vary in concentration and amino acid composition. Cow milk has a protein content of approximately 3.3% (Park & Haenlein, 1 2006), whereas red deer milk contains more protein, approximately 7.6% (Arman et al., 1974). This suggests deer milk might produce more bioactive peptides than cow milk after fermentation and digestion. Along the borders between Russia, Mongolia, and China there is historical use of deer milk to cure digestive problems; heal wounds, frostbite and other injuries (Park &Haenlein, 2006), which suggest immunomodulating bioactive properties of deer milk. Extracts of deer velvet have been shown to induce proliferation of a variety of cell lines and trials to develop novel anti-cancer products and products to treat specific gastrointestinal conditions are underway (Gosh & Playford, 2003; Yang et al., 2009). In 2010, Liu et al. reported that hydrolysed red deer plasma was rich in bioactives with AEC inhibitory activity (Angiotensin I-Converting Enzyme Inhibitors). There is an interest in bioactive peptides from deer products (velvet, antler) and deer milk which could be a good source of bioactive peptides and is not utilized presently. New Zealand has 1.2 million farmed deer which is half of the world’s farmed deer population.They are used to producemeat and velvet. Therefore, there is a large potential for isolation of immunomodulatory peptides from deer milk for pharmaceutical or nutraceutical purposes. Hypotheses • Deer milk proteins are a better source of immunomodulating bioactive peptides than cow milk proteins. • Lactic acid bacteria (LAB) fermentation of milk prior to digestion with commercial enzymes will improve the formation of bioactive peptides. Project Aims There are a number of studies and reviews on cow milk bioactives (Minervini et al., 2003; Gobbetti, 2007; Korhonen, 2009; Picariello et al., 2010) and a few on bioactives from other species such as sheep and goat (Silva et al., 2006; Papadimitriou et al., 2007; HernandezLedesma et al., 2011), camel (El-Agamy, 2009), buffalo (Pandya and Haenlein, 2009) and yak (Mao et al., 2005). To the author’s knowledge there are no reported studies on red deer milk bioactives. This PhD thesis aimed at investigating immunomodulatory bioactive peptides from red deer milk and comparedthem to cow milk bioactivity. 2 The first objective of this study was to investigate the in vitro digestion of deer and cow milk by commercial gastric and duodenal enzymes with the major focus being on comparison of the degradation of protein to evaluate the differences in digestibility and peptide production. Secondly deer and cow milks were fermented using three LAB cultures to compare peptide production before and after in vitro digestion and to compare deer and cow milk proteins digestibility. The LAB fermentation and in vitro digestion of both deer and cow milks were tested for immunomodulatory activity. Lymphocyte proliferation and cytokine production (IL-2 and IFNγ) were determined using human peripheral blood mononuclear cells (PBMC). The immunomodulatory activity of deer milk in vitro digests was compared with that of milk digests from three species (cow, sheep and goat). Finally immunomodulatory peptides of deer milk were fractionated by FPLC and their sequences were determined by mass spectrometry and compared with those of cow milk. Thesis Structure Including this introduction, this thesis contains nine chapters. Chapter 2 is the literature review which gives background information on which this project is based. Chapters 3 to 8 are experimental chapters prepared as journal papers. Chapter 9 provides the overall conclusions from the project, future work and is followed by a complete list of references. Figure 1.1 details how the experimental chapters are related and data that contribute to more than one chapter. 3 Chapter 1: Introduction (Importance, aims and structure of the project) Chapter 2: Literature review (Background information necessary for project) Chapter 3 Peptide production & digestibility of deer and cow milk protein by in vitro digestion Chapter 4 Peptide production after LAB Fermentation&in vitro digestion of deer and cow milk protein Chapter 5 Immunomodulatory activity of unfermented & fermented deer and cow milk protein Chapter 6 Immunomodulatory activity of deer milk comparedwith three other milk species (cow, sheep and goat) Chapter 7 Fractionated immunomodulatory peptides from deer and cow milk digests (unfermented and fermented) by FPLC Chapter 8 Identification ofpeptides in immune active fractions by LC-MS/MS and sequencing Chapter 9: General discussion, conclusion and future work Figure 1.1: Structure of chapters and research experiments of the thesis.Chapters shown in boxes are experimental chapters. 4 Chapter 2 Literature Review 2.1 Milk Milk is the substance that is produced to feed the mammalian infant. All mammals, from mice to whales, produce milk for this purpose. Milk has been described as the most perfect food in nature and it is balanced for most nutrients and often has a high caloric value (Park, &Haenlein, 2006). It contains lactose, protein, lipid and minerals which all are required for optimal health and growth. The components of milk provide critical nutritive elements, immunological protection, and biologically active substances to both neonates and adults (Shah, 2000). Milk and milk products are consumed everywhere and in 2010 the world total milk production was 713.6 million tonnes (FAO, http://www.fao.org/docrep/012/ak341e/ak341e10.htm). Cowshave been the major source of milk and dairy products in developed countries, especially in the Western world (Haenlein, 2001) but milks from other mammals such as goat, sheep, reindeer, buffalo, camel and yak are also consumed (Park, 2009). 2.2 Milk Bioactives Research over the last twenty years has identified milk as a product that has a commercial value beyond its traditional nutritional value (Cross & Gill, 2000). In their native form, milk proteins exert an appreciable range of physiological activities. The major role of milk proteins is to supply amino acids and nitrogen to young mammals and constitute an important part of dietary proteins for the adult. Intact milk proteins also have specific functions such as micelle formation (Nagpal et al., 2011). Specific immunoglobulins in milk provide the first line of defence to suckling neonates through passively acquired immunity. Also milk is good source of several hormones and growth factors (Grosvenor et al., 1993). Other non-specific antimicrobial milk factors including the iron-binding protein, lactoferrin, and several enzymes such as lactoperoxidase and lysozyme prevent microbial proliferation (Florisa et al., 2003). 5 Although the protein fraction of milk has been the most widely studied in terms of bioactive compounds, there are other compounds that have shown physiological significance in milk such as some milk sugars (lactose, oligosaccharides), calcium and lipid-based bioactive compounds (Shah, 2000). Lactose has been reported to enhance calcium absorption and lactulose which is a product of lactose, is used as a promoter of probiotic bacteria and its use is now widespread in infant formula (Shah, 2000). Calcium plays a role in the regulation of blood pressure and calcium phosphate binds bile salts in order to prevent their toxic effect, thereby reducing the risk of colon cancer (Der Meer et al., 1991). The lipid-based bioactive compounds in milk include fatty acids and the role of conjugated linoleic acid for inhibition of cancer and atherosclerosis has been studied (Pariza et al., 2001). 2.3 Bioactive Peptides from Milk In recent years, intense research interest has been focused on identifying biologically active components in cow milk and characterising the mode by which mammalian physiological functionsare modulated by these compounds (Fait et al., 1993; Korhonen, 2009). At present, milk proteins are considered the most important source of bioactive peptides (Korhonen, 2009). Bioactive peptides have been defined as specific protein fragments that have a positive impact on body functions or conditions and may ultimately influence health (Kitts & Weiler, 2003). They usually contain 2–20 amino acid residues per molecule, but in some cases they may consist of more than 20 amino acids (Erdmann et al., 2008). Such peptides are inactive within the sequence of the parent protein and become active only when they are released from the precursor protein (Fig. 2.1.). Different mechanisms can release the encrypted bioactive peptides from the precursor proteins (Korhonen & Pihlanto, 2003): a.) In vivo, during gastrointestinal digestion through the action of digestive enzymes or of microbial enzymes of the intestinal flora; b.) During milk processing (e.g. milk fermentation, cheese production) through the action of microbial enzymes expressed by the microorganisms used as starter; c.) During milk processing through the action of a single purified enzyme or a combination of selected enzymes; 6 In many studies, combinations of (a) and (b) or (a) and (c), have proven to be effective in generation of short functional peptides (Korhonen & Pihlanto, 2003). Removed due to copy right Moller, S. A., Danielsson, L. D., & Borrebaek, C. A. (1986). Concanavalin A-induced B-cell proliferation mediated by allogeneically derived helper factors. Immunobiology, 57(3), 387393. Fig 2.1. Summarizing scheme of the possible mechanisms by which bioactive peptides can be released from the precursor proteins by microbial fermentation and/or gastrointestinal digestion, from Möller at al.(2008). The production and properties of milk protein-derived bioactive peptides have been reviewed in many articles (Samacchi & Goggetti, 2000; Silva & Malcata, 2005; Korhonen & Pihlanto, 2006; Korhonen, 2009). Depending on the sequence of amino acids, these peptides can exhibit diverse activities, including opiate-like, mineral binding, immunomodulatory, antimicrobial, antioxidant, antithrombotic, hypocholesterolemic, and antihypertensive actions (Erdmann et al., 2008). Many bioactive peptides are multifunctional and can exert more than one of the effects (Fig. 2.2) mentioned (Korhonen, 2009; Pihlanto et al. 2011). Removed due to copy right Pihlanto, A., & John, W. F. (2011). Milk protein products | bioactive peptides. In Encyclopedia of Dairy Sciences (Second Edition) (pp. 879-886). San Diego: Academic Press. Retrieved from http://www.sciencedirect.com/science/article/pii/B9780123744074003514 Fig 2.2. Different biological activities of peptides from Pihlanto & John (2011). 7 2.3.1 Immunomodulatory Bioactive Peptides from Milk Cow milk contains a number of potent peptides that affect the immune system via cellular functions including cell proliferation and downstream immunological responses (Werner et al., 1986; Coste & Tome, 1991; Fiat et al., 1993; Kayser & Meisel, 1996; Gill et al., 2000; Cross &Gill, 2000; Phelan et al., 2009). A large number of studies have demonstrated that hydrolysis of cow milk protein by digestive enzymes can produce biologically active peptides including immunomodulatory peptides (Gill et al., 2000; Korhonen and Pihlanto, 2009) and some of these are summarised in Table 2.1. Immunomodulation can be defined as adjustment of the immune response to a desired level, as in immunopotentiation, immunosuppression, or induction of immunologic tolerance. Pepsin, trypsin and chymotrypsin have been shown to release a number of immunomodulatory peptides both from caseins (α-, β-, and κ- casein) and whey proteins, e.g. α- lactalbumin, β-lactoglobulin and glycomacropeptide (Gauthier et al., 2003; Gobbetti et al., 2004; Phelan et al., 2009). 2.3.2 Immunomodulatory Bioactive Peptides from Fermented Milk A number of reports (Table 2.2) have demonstrated up- and down-regulation of the immune system by milk-derived immunomodulatory peptides from fermented milk products (Korhonen & Pihlanto, 2006). Growing evidence drawn from epidemiological studies, scientific reports and clinical data indicate that consumption of fermented dairy products reduces the risk of certain types of cancer; including tumours of breast, colon, lung and subcutaneously implanted fibrosarcomas (Matar et al., 2001; Matsuzaki et al., 1996; Biff et al., 1997). The peptidic profile of milk proteins is significantly different after microbial fermentation, suggesting that modification exerted by microbial proteolysis can be a potential source of bioactive peptides (Matar et al., 1996). It is now well established that physiologically active peptides are produced from milk protein during fermentation of milk with lactic acid bacteria (Korhonen & Pihlanto, 2006). Lactic acid bacteria (LAB) utilize milk proteins as their source of essential and growth-stimulating amino acids (Juillard et al., 1998). These bacteria possess cell-envelope-located proteinases which degrade caseins into oligopeptides, peptide transport systems, which internalize the released oligopeptides; and intracellular peptidases, which hydrolyse the oligopeptides into smaller peptides or into amino acids, which can then be used by the cell (Juillard et al., 1998). 8 Table 2.1. Immunomodulatory peptides derived from milk proteins Peptide Val-Glu-Pro-IlePro-Tyr Source Human β casein Hydrolysis Trypsin Immune effect No effect on antibody formation ↑ Phagocytosis ↓ Klebsiella pneumoniae infection Reference Parker et al., 1984 Gly-Leu-Phe Human casein Trypsin ↑ Phagocytosis ↓ Klebsiella pneumoniae infection Berthou et al., 1987 Leu-Leu-Tyr Cow casein Trypsin ↑ Phagocytosis No effect on Klebsiella pneumoniae infection ↓ Antibody formation Berthou et al., 1987 Tyr-Gly Cow κ - casein ↑ Human lymphocyte proliferation Kayser & Meisel, 1996 Casein hydrolysates Casocidin-I Cow casein ↑ IL-2 production Phelan et at., 2009 Cow α2 - casein synthetic peptides corresponding to bioactive sequences Commercial enzyme hydrolysis Acid hydrolysis Zucht et al., 1995 Goat α2 – Casein fraction Casein hydrolysates Beta-casomorphin Goat casein No hydrolysis ↓ growth of E. coli&Staphylococcus carnosus ↑ Antibody formation (indirect ELISA) Cow casein Human gastric and duodenal ↓ Human lymphocyte proliferation or commercial enzymes Trypsin ↑ lymphocytes proliferation, NK activity and neutrophil locomotion Chymosin Stimulation of phagocytosis and immune responses against bacterial infections Casecidin αs1casein f(1-23) Cow β-casein Cow αs1-casein Haza et al., 1995 Eriksen et al., 2008 Migliore-Samour et al., 1989 Lahow and Regelson, 1996 9 Isracidin Cow αs1-casein Chymosin Cow κ casein f(106-169) Cow whey protein hydrolysates Lactoferrin hydrolysates Cow κ casein Rennin Cow whey proteins Trypsin/ Chymotrypsin Cow Lactoferrin Pepsin Cow & goat milk whey protein hydrolysates Tyr-Gly-Gly Cow & goat whey protein Human Gastric juice & Human duodenal juice Cow α-lactalbumin synthetic peptides corresponding to bioactive sequences Trypsin, Chymotrypsing & Lactobacillus paracasei NCC2461 Peptidases Unsequenced Cow β - Lactoglobulin acidic immunomodulatory peptides of less than 1000kDa in size Stimulation of phagocytosis and immune responses against bacterial infections Depression of mice lymphocytes proliferation ↑ mice lymphocyte proliferation at lower concentration (0.5 - 500µg/ml) Stimulation of proliferation and antibody production in murine splenocytes and ↓ Human lymphocyte proliferation Lahow and Regelson, 1996 Eriksen et al., 2008 ↑ Human lymphocyte proliferation Kayser & Meisel, 1996 ↑ IL-10 production ↓lymphocyte proliferation Prioult et al, 2004 Otani et al., 1992 Mercier et al., 2004 Miyauchi et al., 1997 10 Table 2.2. Immunomodulatory peptides derived from fermented milk Fermentative strain Lactobacillus helveticus R389 Lactobacillus helveticus R389 Lactobacillus helveticus L89 (In vitro digestion) Lactobacillus helveticus 5089 Lactobacillus helveticus R389 Lactobacillus helveticus R389 Lactobacillus acidophilus DPC6026 Lactic acid bacteria (LAB) Peptide Fraction Immune effect Reference Size-exclusion HPLC Fraction п Response following Escherichia coli O157:H7 infection ↑Intestinal IgA+ B cells ↑ Intestinal IgA secretion ↑ total serum IgA secretion ↑ Cytokine production (IL-4 & IFN-γ ) LeBlanc et al., 2004 Size-exclusion HPLC Fractions ↑Intestinal IgA+ B cells ↓ Fibrosarcoma Tumor _ LeBlanc et al., 2004 ↑ IFN-γ production ↓ IL-2 production ↑ lymphocyte proliferation Laffineur et al., 1996 ↑ IL-6 production ↑ IgA production ↑ IgA production -↑ Phagocytosis Vinderola et al., 2006 IKHQGLPQE, VLNENLLR, SDIPNPIGSENSEK -Antibacterial against Enterobacter sakazakii ATCC 12868 &Escherichia coli DPC5063 Hayes et al., 2006 Isolate from goat cheese Antibacterial against the Gram-positive bacteria Bacillus cereus, Clostridium sporogenes and Staphylococcus aureus; and against the Enterobacteriaceae, Shigella sonnei and Klebsiella pneumoniae. Hernandez et al., 2005 Reverse-phase HPLC - low molecular mass peptides - YPVEPF - HPHPHLSFM β Casein ferment Non-bacterial fraction Fermented milk Matar et al., 1996 Martha et al., 2001 11 Lactobacillus helveticus PR4 Human β casein f184-210 Lactobacillus casei strain Shirota Dairy products Lactobacillus helveticus Lactobacillus casei strain Shirota Fermented milk Fermented drink Antibacterial against Gram-positive and -negative bacteria, including species of potential clinical interest, such as Enterococcus faecium, Bacillus megaterium, Escherichia coli, Listeria innocua, Salmonella spp., Yersinia enterocolitica, and Staphylococcus aureus. ↑ IFN-γ production ↑ IL-1β ↑ TNF-α ↓ Tumour growth in rodents ↓ Bladder cancer in human ↓ Mammary tumour growth in mice ↓ IL-6 production ↓ natural killer (NK) activity Minervini et al., 2003 Matsuzaki, 1998 Richid et al., 2006 Takeda & Okumura, 2007 12 The transport system of LAB enables them to internalize oligopeptides up to 18 amino acids in length, although rarely above 10 amino acids (LeBlanc et al., 2002). This allows the longer oligopeptides to be a source of bioactive peptides when further degraded by gastrointestinal enzymes or by intracellular peptidases of LAB. Lactobacillus helveticus fermented milk has demonstrated an immunomodulating effect on lymphocyte proliferation in vitro (Laffineur et al., 1996). This strain is known to have high proteolytic activity, causing the release of oligopeptides from milk proteins. Matar et al. (2001) identified immunostimulatory peptides generated through fermentation of milk protein using LAB, specifically Lactobacillus helveticus commonly used in the manufacture of Swiss-type cheese and other fermented milk products. The immunostimulatory and antitumor properties of peptidic fractions issued from milk fermented with Lactobacillus helveticus R389 were also reported by LeBlanc et al. (2002). 2.4 Overview of the Immune System Although the immunomodulation mechanism of bioactive peptides remains uncertain, it was confirmed that immunomodulatory activity was related to lymphocyte proliferation, cytokine and antibody synthesis (Gauthier et al., 2006; Yang et al., 2009; Hou et al., 2012). Therefore, it is important to have an overview of the human immune system in order to gain a better understanding of the potential immunomodulation mechanisms of bioactive peptides. Immune system The mammalian immune system has evolved to provide protection against infectious agents called pathogens (Wood, 2006). Pathogens include infectious organisms, such as bacteria, viruses and eukaryotic parasites, and foreign inanimate materials, for example toxins. The immune system has historically been divided into innate and adaptive (specific) systems (Turvey et al., 2010). The human immune system can be simplistically viewed as consisting of three levels: (1) anatomical and physiological barriers; (2) innate immunity; and (3) adaptive immunity (Fig 2.3). Failure in any of these systems will greatly increase susceptibility to infection (Turvey et al., 2010). 13 Removed due to copy right Turvey, S. E., & Broide, D. H. (2010). Innate immunity. Journal of Allergy and Clinical Immunology, 125(2, Supplement 2), S24-S32. Fig 2.3. Integrated human immune system from Turvey et al. (2010). The human defence system can be simplistically viewed as consisting of 3 levels: (1) anatomical and physiological barriers; (2) innate immunity; and (3) adaptive immunity. In common with many classification systems, some elements are difficult to categorize. For example, natural killer (NK), T cells and dendritic cells could be classified as being on the cusp of innate and adaptive immunity rather than being firmly in one camp. Innate immune system The innate immune system includes: • Cells (e.g. macrophages, neutrophils, mast cells) • Soluble factors (e.g. the complement proteins, acute-phase proteins). The innate immune system used to be regarded as a primitive defence system of limited effectiveness, found in vertebrates and invertebrates. Cells and proteins of the innate immune system can recognize certain molecules on the surface of pathogens (pathogen-associated molecular patterns – PAMPs) as foreign. PAMPs are large molecules with a significant nonprotein component and examples include lipopolysaccharides, peptido-glycans, lipotechoic acids and mannans. They are found only on microbes and are essential for microbial survival; therefore they cannot stop manufacturing them as a way of avoiding recognition by the innate immune system. The cell receptors that recognize PAMPs are called pattern-recognition receptors and include toll-like receptors and lectins such as the mannose receptor. Soluble 14 factors recognizing PAMPs include mannose-binding lectin and C-reactive protein (Fig. 2.4) (Wood, 2006). There is a limit to the number of receptors that can evolve to recognize foreign PAMPs and, given the quicker replication of pathogens compared with mammals, some pathogens will evolve ways of escaping recognition by the innate immune system. For example, avirulent streptococci are recognized and eliminated by the innate immune system and therefore do not cause disease. However, virulent streptococci synthesize a waxy carbohydrate outer coat that is not recognized by the innate immune system and therefore to eliminate them a specific immune response is required(Wood, 2006). Adaptive immune systems The cellular components of the adaptive immune system are the lymphocytes (mainly T and B lymphocytes). Lymphocyte precursors originate from the bone marrow and some differentiate in the thymus into T lymphocytes which are responsible for cellular immunity. They have receptors for antigen on their surface (Fig. 2.4). Other lymphocyte precursors differentiate into B lymphocytes in the fetal liver and after birth in the bone marrow. B lymphocytes are responsible for humoral immunity (immunity that is mediated by secreted antibodies). They have antibody molecules on their surface (Fig. 2.4). After differentiation, the lymphocytes migrate to the lymph nodes and other lymphoid tissue. Although morphologically indistinguishable, the three types of lymphocyte perform different functions. One of the main features distinguishing specificor adaptive immunity from innate immunity is that specific immunity is not present before infection. Following initial infection with a pathogen it takes about 4 days to produce antibodies against it. The specific immune system is found only in vertebrates and was thought to be the main defence mechanism. It is now known that the innate immune system does more than provide the first line of defence and plays an important role in determining the type of specific immune response that is mounted against infectious agents (Wood, 2006). 15 Removed due to copy right Wood, P. J. (2006). The immune system: recognition of infectious agents. Anaesthesia & Intensive Care Medicine, 7(6), 179-180. Fig 2.4. Recognition by the immune system from Wood, (2006) The simplified working procedure of our immune system is illustrated in Fig. 2.5. Specialized antigen presenting cells (APCs) called macrophages circulate throughout the body and if they encounter an antigen, they ingest and fragment them into antigenic peptides (I). The pieces of these peptides are displayed on the cell surface by major histocompatibility complex (MHC) molecules existing in the digesting APC. The presented MHC–peptide combination on the cell surface is recognised by the T-cells causing them to be activated (II). Activated T-cells secrete some chemicals as alert signals to other units in response to this recognition (III). Bcells, one of the units that respond to these signals, become activated with the recognition of antigen by their antibodies occurring at the same time (IV). When activated, B-cells turn into plasma cells that secrete antibodies which are bound on their surfaces (V). Secreted antibodies bind the existing antigens and neutralize them signalling other components of immune system to destroy the antigen–antibody complex (VI) (Polat et al., 2006). 16 Removed due to copy right Perelson, A. S., & Oster, G. F. (1979). Theoretical studies of clonal selection: Minimal antibody repertoire size and reliability of self-non-self discrimination. Journal of Theoretical Biology, 81(4), 645-670. Fig 2.5. Immune response from Perelson & Oster (1979). Lymphocytes The three major types of lymphocytes are T lymphocytes (or T cells), B lymphocytes (or B cells) and natural killer cells (NK cells). T and B lymphocytes are the main self-defence weapons of the adaptive immune system (Turvey et al., 2010). The T cells coordinate the entire immune response and eliminate viruses hiding in infected cells and contribute to the immune defences in a cell-mediated way and can be sub-grouped as follow. T helper cells (Th cells) assist other white blood cells in immunologic processes, including maturation of B cells into plasma cells and activation of cytotoxic T cells and macrophages, among other functions. Cytotoxic T cells (TC cells, or CTLs) destroy virally infected cells and tumour cells, and are also implicated in transplant rejection. After the infection has resolved, another subset of antigen-specific T cells persist and they are called Memory T cells. They quickly expand to large numbers of effector T cells upon re-exposure to their cognate antigen, thus providing the immune system with "memory" against past infections. Memory T cells comprise two subtypes: central memory T cells (TCM cells) and effector memory T cells (TEM cells). Finally, regulatory T cells (Treg cells), formerly known as suppressor T cells, are crucial for the maintenance of immunological tolerance. Their major role is to shut down 17 T cell-mediated immunity toward the end of an immune reaction and to suppress autoreactive T cells that escaped the process of negative selection in the thymus (Wood, 2006). Natural killer cells (NK cells) are a type of cytotoxic lymphocyte. NK cells play a major role in the rejection of tumours and cells infected by viruses. The cells kill by releasing the proteins called perforin and granzyme that cause the target cell to die by apoptosis. Most of the production of lymphocytes occurs during fetal and neonatal life, but there is a slow continuous production of new lymphocytes from stem cells in adults (Turvey et al., 2010). Lymphocytes reside in different organs of the human body. They circulate through the primary lymphoid organs (thymus and bone marrow), the secondary lymphoid organs (spleen, lymph nodes (LN), tonsils and Peyers patches (PP)) as well as non-lymphoid organs such as blood, lung and liver (Fig. 2.6.). Especially in lymphoid organs, lymphocyte subsets migrate and home to different compartments (Blum & Pabst, 2007). Removed due to copy right Blum, K. S., & Pabst, R. (2007). Lymphocyte numbers and subsets in the human blood: Do they mirror the situation in all organs? Immunology Letters, 108(1), 45-51. Fig. 2.6. Distribution of lymphocytes to the different organs from Blum and Pabst, (2007) 18 Cytokines The components of the immune system act cooperatively to eliminate the infection. The “communication” between the different parts is mediated by specialized chemical mediators, called cytokines (Belardelli & Ferrantini, 2002). Cytokines are diverse and potent chemical messengers secreted by the cells of the immune system. Over 80 cytokines have been described and they play an important role in coordinating embryonic development, cell growth and maturation, new blood vessel formation, wound repair and healing, the immune response including acute phase reactions and septic shock, and destroying targeted cells including cancer cells (Dunlop et al., 2000). Expression of cytokines and their receptors after stimulation is an important indicator of mononuclear cell activation (Garibay-Escobar et al., 2003) Lymphocytes, including both T cells and B cells, secrete cytokines called lymphokines, while the cytokines of monocytes and macrophages are called monokines. Many of these cytokines are also known as interleukins because they serve as a messenger between leukocytes. Binding to specific receptors on target cells, cytokines recruit many different subsets of the immune system. Moreover, it is common for different cell types to secrete the same cytokine or for a single cytokine to act on several cell types. Cytokines are redundant in their activity, meaning that the same function can be stimulated by different cytokines. Cytokines include several categories such as interleukins (IL-1, IL-2, IL-6, IL-10), interferons (IFNα, IFNβ, IFNγ), tumor necrosis factor (TNFα), colony-stimulating factors (CSF), growth factors and others (Dunlop et al., 2000). They may be grouped into various sub-families (Table 2.3), although the nomenclature is somewhat arbitrary, having arisen in different branches of biology. 19 Table 2.3. Cytokine families Removed due to copy right Hopkins, S. J. (2003). The pathophysiological role of cytokines. Legal Medicine, 5, Supplement(0), S45-S57. Reference: Hopkins, (2003) A complex network of cytokines, simplistically outlined in Fig. 2.7, critically affects the nature of the lymphocyte response. Removed due to copy right Hopkins, S. J. (2003). The pathophysiological role of cytokines. Legal Medicine, 5, Supplement(0), S45-S57. Fig. 2.7.Regulation of adaptive immunity by cytokines from Hopkins, (2003). Cytokine production (solid arrows) regulates adaptive immunity at the level of antigen presentation (1), clonal expansion (2), differentiation along alternate T-cell regulatory pathways (3), regulation of B cell differentiation (4) and effector actions of T cells at the tissue level (5). 20 In particular, two important cytokines involved in the proliferation and activation of lymphocytes are IL-2 and INFγ (Belardelli and Ferrantini, 2002). IL-2 is a T cell growth factor produced by T helper 1 (Th1) and NK cells. As an autocrine and paracrine growth factor, IL-2 induces proliferation and differentiation of T and B cells (Belardelli and Ferrantini, 2002). IL-2 is responsible for stimulation of B cells for antibody synthesis. IL-2 stimulates the growth of NK cells and enhances the cytolytic function of these cells, producing lymphokine-activated killer cells. IL-2 can also induce interferon INFγ secretion by NK cells (Smyth et al., 2001).IL-2 is a major autocrine and/or paracrine T-cell growth factor, produced primarily by CD4+ T cells and used for the treatment of some human malignancies and priming of immune activity (Belardelli & Ferrantini, 2002). IFN-γ has marked effects on cells of innate immunity, including macrophages, the activation state of which is regulated mainly by INF-γ (Belardelli, 1995). The fact that IFN-γ is produced typically during a Th1 immune response has led this cytokine to be considered as characteristic of adaptive immunity. However, recent studies have reported IFN-γ production by cells of the innate immune system, such as macrophages (Gessani & Belardelli, 1998) and T cells (Frucht et al., 2001), suggesting that IFN-γ plays a role in bridging the innate and adaptive branches of the immune response. IFN-γ is important in host defense against intracellular pathogens, viruses, natural surveillance against cancer and IFN-γ can induce marked antitumor effects in mouse models (Belardelli & Ferrantini, 2002). In vitro lymphocyte proliferation assay as an immunomodulatory parameter After activation by encounter with an antigen (or foreign protein), B and T lymphocytes start to proliferate and rapidly expand their numbers, so that there are many lymphocytes available which can recognize and fight the invading antigens (Zilman et al., 2010). Measurement of lymphocyte proliferation is frequently used in clinical and experimental immunology as a means of assessing lymphocyte activation and response to a variety of stimuli including nonspecific mitogens, specific antigen, cytokines, and allergenic stimulation in mixed lymphocyte reactions (De Fries & Mitsuhashi, 1995). The lymphocyte proliferation assay measures the ability of lymphocytes placed in short-term tissue culture to undergo a clonal proliferation when stimulated in vitro by a foreign molecule, antigen or mitogen (Zhi-Jun et al., 1997; Wanger et al., 1999; Zilman et al., 2010). 21 Proliferation of lymphocytes in response to various stimuli has been assessed by several means. Traditionally the most commonly used method assessed the incorporation of radiolabeled nucleotides (3H-thymidine) into cells during cell division (Khan et al., 1986; Fries & Mitsuhashi, 1995; Metcalf & Wiadrowski, 1966 and Eriksen et al., 2008). The primary drawbacks of the 3H-thymidine incorporation assay are that it requires specialized equipment, as well as the use of radioisotopes which present a hazard in the laboratory and which pose increasing difficulties in their disposal (Fries & Mitsuhashi, 1995). A number of alternative methodologies for measurement of lymphocyte proliferation have been reported. Assays which measure total cell number by detecting reduction of tetrazolium compounds, such as MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) by microbial enzymes, have been evaluated (Weichert et al., 1991). Methods which measure incorporation of fluorescent dye into cellular DNA (Blaheta et al., 1991) and incorporation of BrdU (5-bromodeoxyuridine) and subsequent detection by ELISA assay (Houng et al., 1991) have also been reported. The Alamar Blue assay was developed by Alamar Bioscience Inc (Fries and Mitsuhashi, 1995), as a reliable and sensitive alternative assay for determining lymphocyte proliferation which is convenient, simple to perform and does not require the use of radioactive materials (Ansar Ahmad et al., 1994; Zhi-Jun et al., 1997; Al-Nasiry et al., 2007; Jacquot et al., 2010). An oxidized form of the Alamar Blue reagent is added to cells and this is reduced by mitochondrial enzyme activity of the cells being tested. Reduction causes a change in colour as well as a shift in fluorescence profile which can be quantitatively detected colorimetrically or fluorimetrically (Zhi-Jun et al., 1997). Fries and Mitsuhashi, (1995) have demonstrated the reliability of Alamar Blue assay in measuring human peripheral blood mononuclear cell (PBMC) proliferation. Cytokine production as immunomodulatory parameter It has been well established that cytokine levels correlate with the severity of diseases and/or clinical outcomes (Kurzrock et al., 1993; Tartour et al., 1994). Commercially available ELISA kits (based on a sandwich technique using antibodies) make it convenient to measure cytokines in biological samples and cell culture supernatants (Leduret al., 1995). The same ELISA procedure has been used to test immunomoduatory activity of milk proteins previously with human lymphocytes (Laffineur et al., 1996; Phelan et al., 2009) and murine splenocytes (Saint-Sauveur et al., 2007). 22 2.5. Deer milk, usage and potential of immunomodulating bioactives Most of the studies and reviews on bioactive peptides are on cow milk (Minervini et al., 2003; Gobbetti, 2007; Korhonen, 2009; Picariello et al., 2010) while only a few on milk from different species such as sheep and goat (Silva et al., 2006; Papadimitriou et al., 2007; Hernandez-Ledesma et al., 2011) are found In the mass production of bioactive peptides cow milk is used as an ingredient for the manufacture of functional foods by chromatographic purification (Choi et al., 2012). There is no reported study on deer milk bioactives which may have this potential. Knowledge of milk and milk bioactives of ruminants is mainly related to studies on bovids. These are often taken to be typical of the sub-order as a whole, but it is interesting to extend our knowledge to the milks of other families to see their value. Of these families, the cervids are the largest and appear to have evolved earlier than the bovids. The cervids, especially the reindeer (Rangifer tarandus L.) are herded but their milk and milk proteins have not been studied in any detail (McDougall & Stewart, 1975). Reindeer pastoralism, where milking was an integrated part of the farming activity, evolved at least two thousand years ago in the Taiga region of eastern Siberia around Lake Baikal and spread to nearby ethnic groups (Fondahl, 1989). The most intensive milking regime was developed along the borders between Russia, Mongolia and China. The animal provided milk both for immediate fresh consumption and processing. The milk was dried and processed into cheese, butter, and sour cream, (Table 2.4.) as well as used medicinally. The milk was curdled and often mixed with herbs such as Oxyria spp. and Angelica spp. (Park & Haenlein, 2006). Reindeer milk and its products were highly priced and also used as a medical remedy to cure digestive problems (the milk has antidiarrheic properties) and to heal wounds (Park & Haenlein, 2006). Fat exuded by heat from reindeer cheese was also used to cure nursing pains, frostbites, and other injuries. In addition, colostrum was used for children’s ailments (Fondahl, 1989). 23 Table2.4. Traditional Products and Uses of Reindeer milk (Park & Haenlein, 2006) Removed due to copy right Park, Y. W., & Haenlein, G. F. W. (Eds.). (2006). Handbook of Milk of Non-Bovine Mammals. Iowa: Blackwell Publishing. Red deer (Cervus elaphus L.) has become an experimental animal and increasing attention is being given to methods of farming it (Gómez et al., 2002). Intensive farmed red deer production for meat increased in France following the success of Scotland and New Zealand where the first commercial flocks were created 20 years ago and deer hinds produce 120 to 200kg milk in 100 days depending on pasture quality and the milk contains on average 10 % fat and 8 % protein which is twice the levels found in cow milk (Theriez, 1988). Milk composition of Red deer and some domesticated mammals and human milk are shown in Table 2.5. 24 Table 2.5. Gross Composition (%) of milk of human & some domesticated mammals Species Fat Protein Total solids Human 4.1 1.3 12.3 Cow 3.6 3.3 12.3 Goat 3.8 3.5 12.2 Sheep 5.3 5.5 16.3 Deer (Red Deer) 10.3 7.8 23.9 Data from Emmett & Rogers, (1997) and Park & Haenlein, (2006) Since milk protein is the precursor of several bioactive peptides, this may indicate that deer milk might be rich in bioactives compared to bovine milk. So far there are no studies on deer milk bioactives. Furthermore, the evidence of historical use of deer milk as a medical remedy suggests there is potential to capture immunomodulatory bioactive peptides in deer milk and utilize them more efficiently for certain age groups that require support for the immune system. 25 Chapter 3 (Paper published in International Food Research Journal 2012,19 (4): 409-416 In vitro Digestion of Red Deer (Cervus elaphus) and Cow (Bos taurus)milk 3.1. Introduction The proteins in milk from different species vary in concentration and amino acid composition. The protein content in milk from bovine species is approximately 3.3%, whereas reindeer milk contains more protein, approximately 7.8% (Park & Haenlein, 2006). Casein is the main protein component of bovine milk constituting about 80% of the total milk proteins (Shah, 2000). The casein fraction consists of αs1-, αs2-, β- and κ-casein. The main proteins in the whey fraction are β-lactoglobulin (β-lg), α-lactalbumin (α-la), serum albumin (SA), immunoglobulins (Igs), lactoferrin (LF) and lysozyme (LZ) (Inglingstad et al., 2010). The amino acid composition of casein and whey protein fractions varies in different species and will affect their digestibility (Almaas et al., 2006). Protein digestion starts in the stomach by the action of acid and pepsin and is followed by intestinal digestion by trypsin, chymotrypsin and various carboxypeptidases and aminopeptidases. Milk protein represents an important dietary source for humans, providing that they are digested suitably.The high digestibility of milk protein (~ 95%), combined with a superior amino acid composition for human requirements, makes milk a “high quality protein” source (Bos et al., 1999). In vivo results of Dangin et al. (2002, 2003) led to the concept of “slow” digested caseins and “fast” digested whey protein. In vivo studies with either milk or purified milk proteins in healthy human showed that whey proteins were taken up more rapidly in the upper jejunum than the casein (Mahe et al., 1995, 1996). However, studies by Almaas et al., (2006) using human gastric and duodenal juices for the in vitro digestion of cow and caprine milk proteins revealed that the whey proteins, α-lactalbumin 26 and β-lactoglobulin were very resistant to hydrolysis and that the caseins were degraded faster. This study investigates the in vitro digestion of deer and cow milk by commercial gastric and duodenal enzymes with the major focus being on comparison of the degradation of protein to evaluate the differences in digestibility and peptide production. No information on the digestion of red deer milk, which is unique from other species in its composition (LandeteCastillejoset al., 2000), is available and only basic composition of red deer milk has been reported. This information could potentially be useful in understanding functional roles in animal nutrition and evaluating its potential for human use. 3.2. Materials & Methods 3.2.1. Materials Oxytocin was purchased from Pharm Distributors (Auckland, New Zealand). Pepsin (66 units / mg solid) from porcine stomach mucosa, OPA (O-phthaldialdehyde), Leucine and TCA (trichloroacetic acid) were purchased from Sigma (St. Louis, MO, USA) and Corolase PP (CPP) (350 proteolyticU/mg) from pig pancreas was from AB Enzymes (Darmstadt, Germany). Corolase PP is a mixture of trypsin, chymotrypsin and several amino and carboxypeptidases. NuPAGE 4-12% Bis-Trisprecast gels were purchased from Invitrogen USA. Bio-Rad Precision Plus Protein TM standard was used as a high molecular weight marker. 3.2.2. Preparation of Milk Samples Pooled deer milk was obtained from the Lincoln University deer farm at Lincoln (New Zealand). Calves were weaned from twenty hinds which were then milked twice-daily. Immediately prior to milking, each hind received an injection of 1 ml oxytocin (10 IU/ml) to enable the ‘let down’ of milk. The hinds were milked in a side-loading crush, using a commercial machine designed for milking sheep and goats. Approval for this work was given by Lincoln University Animal Ethics Committee (# 377).Pooled cow milk was obtained from Lincoln University Dairy Farm. Fat was removed by centrifugation at 4000 ×g for 30 min at 4°C. Defatted milk was freeze dried and stored at room temperature in airtight containers until analysis. 27 3.2.3. Protein content Total nitrogen (TN), non-protein N (NPN) and non-casein nitrogen (NCN) were measured using the Kjeldahl method (Barbano et al., 1991). NPN was estimated after precipitation of protein with 24% trichloracetic acid followed by centrifugation at 27,000 x g for 60 min. The supernatant was filtered using Whatman No 1 filter paper and the filtrate was used for Kjeldahl analysis. NCN was measured after precipitation of casein by adjusting the milk to pH 4.6 with slow addition of 1M HCL while stirring and centrifugation at 10,000 ×g for 15 min at 200C. The supernatant was filtered and protein content was determined using the Kjeldahl method. Total protein [(TN-NPN) x 6.38], casein protein [(TN-NCN) x 6.38] and whey protein [(NCN-NPN) x 6.38] concentrations were calculated. 3.2.4. Dry matter content Weights of deer and cow milk were taken before and after freeze drying of milk. Dried weight was calculated as percentage of total milk weight. 3.2.5. In vitro Digestion Defatted deer and cow milk samples (20 ml) were prepared in triplicate by rehydrating freeze dried defatted milk in 26% and 12% rehydration ratio respectively. In vitro protein digestion was performed using pepsin and CPP according to Eriksen et al. (2008). The procedure mimics “normal digestion” in the human gastro-intestinal tract. The first incubation, which mimics digestion in the stomach, was adjusted to pH 2.5 with 1M HCl, and used pepsin (4mg/g milk protein) at 37°C for 30 min. The second incubation used CPP (4 mg/g milk protein) at 37°C for 60 min after the pH was adjusted to 7.5 with 1M NaOH. Continuous shaking (150 rpm) was maintained during digestion. The digestion of milk protein was monitored by measuring pH, the production of amino-terminals by O-phthaldialdehyde (OPA) assay andsodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE). Small samples were drawn for OPA assay (250 µl) and SDS-PAGE (1 ml) every 10 min of digestion. 28 3.2.6. ProteolysisAssessment using OPA assay The OPA assay followed the method of Church et al. (1983). The OPA reagent contained 2.5 ml of 20% (w/v) SDS, 25 ml of 100 mM sodium tetraborate, 40 mg OPA (previously dissolved in 1 ml methanol), 100 µl of 2-mercaptoethanol and distilled water up to 50 ml. Samples were incubated with 0.75 M TCA at a sample:TCA ratio of 1:3 (250 µl: 750 µl) at 4°C for 30 min and then centrifuged (4000 ×g for 10 min)to eliminate any interference of the undigested protein fractions as suggested by Church et al. (1983). A 10 µl aliquot of the supernatant was diluted by adding 140 µl H2O, 1 ml of OPA reagent was added and then the tube was incubated at room temperature for 2 min. Absorbance at 340 nm was measured using UNICAM 8625 UV/VISspectrophotometer. Leucine (Leu) was used for the construction of a standard curve and the proteolytic activity was expressed as mM Leu equivalent. 3.2.7. SDS -polyacrylamide gel electrophoresis (SDS-PAGE) Electrophoresis was used to analyse the protein samples taken at different hydrolysis times during digestion. SDS-PAGE was performed according to a standard protocol (Laemmli, 1970) using NuPAGE 4-12% Bis-Trisgels. Bio-Rad Precision Plus Protein TM standard was used as a molecular weight marker. Samples were diluted to 2 mg /ml protein with 6x sample buffer (30 µl) containing 0.35 M Tris-HCl, 10.28% SDS, 30% glycerol, 0.012% bromophenol blue and 5% mercaptoethanol. The volume was adjusted to 180 µl with water and the sample was heated at 95°C for 4min. Samples (15 µl) and 10 µl of protein marker were loaded into the wells. Electrophoresis was performed at a constant voltage of 200V for 40 min. Gels were fixed in 50% methanol and 7% acetic acid for 15 min with rocking and then washed 3 times for 15 min with water. Gels were stained with Coomassie Brilliant Blue (Gel Code Blue) and destained with continuous shaking in water overnight. 3.2.8. Quantification of protein bands The intensities of protein bands in the gels were quantified (Inglingstad et al., 2010) by ImageJ software (version 1.42 http://rsbweb.nih.gov/ij/). Gels were scanned using Coral Photo Paint 12. Image rectangle was applied for background subtraction, and rolling ball radius was fixed to 30 pixels. Bands of interest were marked in each lane to be able to investigate the degradation pattern of the different proteins. In order to measure degradation, the amount of intact protein remaining in the digested samples was calculated as a percentage 29 of its undigested counterpart. Three gels from each sample were quantified, and the results are given as a mean value. 3.2.9.Statistical analysis All experiments were carried out in triplicate and values are mean ± standard deviation. The data were subjected to one way analysis of variance (ANOVA), followed by Tukey’s test to determine the significant differences between samples at P < 0.05 level using Minitab statistical software(version 16, Minitab Inc., USA). 3.3. Results and Discussion Milk composition The dry matter content and protein composition of deer and cow milk are shown in Table 3.1. Dry matter content of deer milk was 25.7% while cow milk has 12.1% dry matter. Hence deer milk had more than twice the dry matter of cow milk. Similarly total protein content in deer milk is 8.8% which is more than twice that of cow milk (4.1%). In accordance with this finding Arman et al.,(1973) showed total protein content of red deer has between 7.1 to 8.6 %.Total protein is the combination of casein and whey proteins. Deer milk has 8.7% casein while cow milk has only 4.0% casein. Both deer and cow milk have very low amounts of whey proteins which are 0.64% and 0.57% respectively. Therefore both milks have high casein to whey protein ratio. The difference between total proteins detected and sum of casein and whey proteinmay be due to experiment error. Table 3.1. Dry matter & protein content of red deer and cow milk Milk Type Dry matter (%) Total Protein (%) Casein (%) Whey protein (%) Deer Milk 25.7 ± 0.76b 8.8 ± 0.13b 8.7 ± 0.13b 0.64 ± 0.002 Cow Milk 12.1 ± 0.01a 4.1 ± 0.02a 4.0 ± 0.02a 0.57 ± 0.004 Values are mean ± standard deviation (n= 3). Means within the same column that have different letters (a-b) are statistically different (P < 0.05) as determined by Tukey’s test. The milk from ruminants is characterized by high casein: whey protein ratio when compared with other groups of mammals (McDougall and Stewart, 1975; Vincenzetti et al, 2008). Among ruminants, most domesticated species are bovids and their milk is readily available and economically important. Hence our knowledge of the milk proteins of ruminants is 30 mainly confined to bovids, but it would be useful to investigate the milk of other ruminant families. The cervids are the largest of these families and appear to have evolved earlier than the bovids (Young, 1962). Consistent with data of Arman et al., (1974) our results showed that deer milk casein and whey contents (Table3.1) had a similar ratio to that found in other ruminants. In vitro Digestion In humans, pepsin digestion and acid hydrolysis at pH of 1.5 – 2.5 are the first steps in the gastrointestinal degradation of protein, followed by stomach emptying and further digestion in the duodenum by pancreatic enzymes at pH ~ 7. To mimic in vivodigestion the present work has used invitrodigestion of defatted deer and cow milk by commercial pepsin and the duodenal enzymes trypsin and chymotrypsin. Pepsin is an aspartic protease which prefers to cleave peptides at bonds with Phe, Tyr, Trp and Leu in position P1’ (Fujimoto et al., 2004). Trypsin cleaves peptide bonds following a positively charged amino acid and chymotrypsin cleaves peptides bonds following bulky hydrophobic amino acid residues (Antal et al., 2001). Therefore digestion pattern with these enzymes will vary depending on the protein structure of cow and deer milks and this could lead to differences in digestibility and digestive products with different bioactivity. 8 7 pH 6 5 4 3 2 0 20 40 60 80 100 Digestion time (min) Figure 3.1. pH during in vitro digestion of deer ( ) and cow ( ) milk.0 to 30 min digestion is simulated stomach. At 30 min pH was adjusted to7.5. 30 to 90 min digestion is simulated duodenum. Data are mean ± S.D. (n = 3). 31 The pH affects the activity of enzymes during in vivo digestion. The pH of stomach increases rapidly from 2 (pH of gastric juice) to pH of the diet immediately following the consumption of meal and then decreases progressively toward its initial value (Savalle et al., 1989). At the beginning of digestion the pH was adjusted to 2.5 with 1 M HCl for the pepsin digestion. The pH increase during digestion was greater (Fig 3.1) in cow milk than deer milk which could indicate a higher buffering effect of deer milk. Milk acts as a complex buffer because it contains carbon dioxide, protein, phosphate, citrate and a number of minor constituents (Ismail et al., 1973). Goat milk has a higher buffering capacity due to its higher content of major buffering components including minerals (Park, 1992). Deer milk had 1.1 ± 0.05 % ash while cow milk had only 0.70 ± 0.04 % (n = 6). This finding was in accordance with mineral composition analysis reported by Arman et al. (1974) which showed a 1.11 % ash content in deer milk (average of 6 hinds in mid lactation). Our results showed (investigated further in Chapter 6 Fig. 6.2) that deer milk had higher buffering effect than cow milk. This could be due to high protein and mineral content and this high buffering quality of deer milk could enhance its value for subject suffering from peptic ulcers and other gastric ailments. At 40 min (10 min into the second stage of digestion) deer milk showed only 0.8 unit pH drop whereas the pH of cow milk decreased by 1.3 (Figure 3.1). Again the buffering effect of deer milk could contribute to the observed differences. In deer milk, the pH change during the start of second stage of digestion was higher than that for the first stage of digestion. It could be a result of the higher digestibility of deer protein in simulated duodenum by trypsin and chymotrypsin than pepsin. Cow milk caseins were more susceptible to hydrolysis by trypsin than camel caseins, whereas camel caseins were more prone to hydrolysis by chymotrypsin than cow casein (Salami et al., 2008). To examine the differences in digestibility of deer and cow protein, peptide production and protein profile were evaluated using OPA assay and SDS – PAGE using quantification by ImageJ software. Proteolysis Assessment Using OPA Assay In this study, the hydrolysis of milk protein was measured using a rapid, sensitive and simple OPA-based spectrophotometric assay (Pescuma et al., 2008; Salami et al., 2008; Salami et al., 2009). The peptide production from the in vitro digestion of milk proteins is shown in figure 3.2. Deer milk produced more hydrolysed products (peptides and amino acids) than cow milk which is consistent with deer milk containing twice the protein available in cow milk. However, peptide production was not two times greater than cow milk. This could be due to differences in protein structures and hence enzyme target sites in deer and cow milk 32 that may lead to formation of different peptides with different lengths. Kopf-Bolanz et al. (2012) demonstrated the formation of different number of peptides with different length during in vitro digestion of cow milk. Therefore the number of N terminals produced by deer milk digestion might not be twice that of cow milk digestion. Peptide production (mM) 0.5 0.4 0.3 0.2 0.1 0.0 0 20 40 60 80 100 Digestion time (min) Figure 3.2. Peptide production during in vitro digestion of deer ( ) and cow ( ) milk (up to 30 min: simulated stomach and then simulated duodenum). Peptide production was measured using OPA assay after TCA precipitation. Data are mean ± S.D. (n = 3). There was a gradual increase of peptide production during digestion with pepsin in the simulated stomach for both milks and then a rapid increase in the simulated duodenum. This was faster in deer milk than cow milk (Fig3.2). Peptide production of simulated duodenum was significantly (P<0.05) higher than simulated stomach for both milks. The analysis of hydrolysis of deer and cow milk (Fig 3.2) revealed greater production (P<0.05) of peptides from deer milk than cow milk in simulated duodenum. Therefore hydrolytic activity was higher in simulated duodenum in deer milk compare to cow milk. After 60min of digestion, peptide production had plateaued. No new peptides were produced by extending the reaction time. Therefore, for gel band quantification only 30min was used for simulated duodenum digestion (stage 2). SDS – polyacrylamide gel electrophoresis (SDS – PAGE) SDS – polyacrylamidegels (4-12%) were used to analyse the milk proteins and digested proteins based on a preliminary study of various concentrations (Appendix A). Inglingstad et 33 al.,(2010) used 12.5 % gel to separate milk protein and digests of cow, goat, horse and human milk. The protein patterns on SDS – PAGE (Figs 3.3 and 3.4), illustrated the protein profile of red deer (lane D of Fig 3.3) and cow (lane C of Fig 3.4) milk and these milks during invitro digestion at 10 min intervals. Protein bands of deer milk were identified based on cow proteins (Preliminary studies inAppendix A). The intensity of casein like bands reduced from 0 min to 30 min in digests of both milks. Deer casein like protein was totally digested after 40 min of digestion (10 min after second stage of digestion) whereas traces of casein (14%) were still present in cow milk (Fig 3.3, 3.4 and 3.5 a). The casein band in cow milk was completely digested after 50 min (Fig 3.4 and 3.5a). This result confirms that deer casein like protein was digested more rapidly than cow casein. The gel results supported the higher hydrolysis activity of deer milk than cow milk in simulated duodenum which was suggested by OPA results. About half (49%) of intact major milk protein (casein) started to degrade at the beginning of simulated duodenum digestion in deer milk while only about a quarter (27%) of intact casein was digested during simulated duodenum in cow milk under the same conditions of time, temperature and pH (Fig 3.3 and 3.4, Fig 3.5 a). The major protein components of milk, the αs1- and β- caseins, contain covalently attached phosphate groups bound to residues of serine and threonine (Medina et al., 1992). The bound phosphate groups influence many functional properties of these proteins, including their digestibility, bioavailability of divalent cations and immunogenicity (Tezcucano Molina et al., 2007). MW: kDa 250 150 100 75 50 37 25 20 15 10 M D D10 D20 IgHC LF SA CN β-lg α-la D30 D40 D50 D60 D90 Figure 3.3. SDS- PAGE (4-12%) of skimmed deer milk & deer milk digested with pepsin and CPP. Major bands; Immunoglobulins heavy chain (IgHC), lactoferrin (LF), serum albumin (SA), casein (CN), β-lactoglobulin (β-lg) and α-lactalbumin (α-la). High molecular weight markeris shown on left-hand side of the gel. The lanes are: Protein molecular marker(M), Deer milk(D), Digest after10 min (D10), 20 min (D20), 30 min (D30) in 34 simulated stomach digestion and digest after 40 min (D40), 50 min(D50), 60 min(D60), 90 min(D90) (simulated duodenum digestion). Each contained had 2 mg/ µl protein. MW: kDa 250 150 100 75 50 37 25 20 15 10 MC IgHC LF SA CN β-lg α-la C10 C20 C30 C40 C50 C60 C90 Figure 3.4. SDS- PAGE (4-12%) of skimmed cowmilk & cowmilk digested with pepsin and CPP. The wells contain; Immunoglobulins heavy chain (IgNC), lactoferrin (LF), serum albumin (SA), casein (CN), β-lactoglobulin (β-lg) and α-lactalbumin (α-la). High molecular weight markeris shown on left-hand side of the gel. The lanes are: High molecular marker(M), Cow milk(C), Digest after10min (C10), 20min (C20), 30min (C30) in simulated stomach and digest after 40min (C40),50min(C50), 60min(C60), 90min(C90) (simulated duodenum). Each lane contained 2 mg/ µl protein. The specific protein pattern and in particular the physico-chemical and biological properties of milk proteins may influence their digestibility (Salami et al., 2008). There is limited information on red deer milk proteins. McDougall (1976) reported amino acid analysis of deer milk β-lactoglobulin, adjusted to lysine = 15 residues (the number of residues is given relative to 15 residues of lysine) showed that it contains one more residue of aspartic acid, alanine and methionine and one less glutamic acid residue and two less leucine residues than cow β-lactoglobulin. From this McDougall (1976) concluded there was only a small difference in amino acid composition of β-lactoglobulin in deer milk compared to cow milk and demonstrated the similarity by gel chromatography and electrophoretic methods. This similarity of β-lactoglobulin in the two species could lead to similarities in digestibility of this protein in milk. β-lactoglobulin is considered the dominant cow milk allergen and its rigid spatial conformation exhibits high resistance to gastric digestion, which in part explain its allergenicity (Prioult et al., 2005). 35 b) 120 120 100 100 80 80 60 60 % intact α−la % intact Casein a) 40 20 20 0 c) 40 0 0 10 20 30 40 50 60 0 Digestion time (min) 10 20 30 40 50 60 Digestion time (min) 120 100 % intact IG 80 60 40 20 0 0 10 20 30 40 50 60 Digestion time (min) Figure 3.5.In vitro digestion of casein (a), α-lactalbumin (b), immunoglobulin (c) in raw milk from deer ( ) and cow ( ) by pepsin at pH 2.5 / 37°C (1 step of digestion up to 30 min) and CPP at pH 7.5 / 37°C (step 2 until 60 min). Values were obtained using ImageJ of SDS-PAGE. Data are means ± S.D. (n = 3). Our results confirmed that the digestibility of β-lactoglobulin is low in milk from both species. After completein vitro digestion 54% and 55% of intact β-lactoglobulin was still intact in deer and cow milk respectively. With respect to digestion of whey proteins, Inglingstad et al. (2010) reported that β-lactoglobulin and α-lactalbumin of cow and goat were very resistant to human gastric and duodenal enzyme digestion, while horse milk showed rapid duodenal degradation of β-lactoglobulin. Cow milk α-lactalbumin possesses 26 potential chymotrypsin-specific target sites and 13 trypsin-specific target sites in its primary structure (Salami et al., 2008).The digestibility of α-lactalbumin like protein was significantly ( P<0.05) higher in deer milk than cow milk after total digestion (Table3.2). At 36 40 min of digestion there was only 14% α-lactalbumin like protein remaining undigested in deer milk, where as 62% remained in cow milk (Fig. 3.5b). Present results are in accordance with those of Pintado and Malcata (2000) who also found that cow milk α-lactalbumin was resistant to hydrolysis by trypsin. β-lactoglobulin and α-lactalbumin are the major milk allergen whey proteins (El-Ghaish et al., 2011; Wal, 1998). Significantly (P<0.05) lower αlactalbumin like proteinconcentration in deer milk digest than cow milk digest (Table 3.2) may suggest less allergenic effect of deer milk than cow milk. Table 3.2. Protein content (%) remaining in raw milk before digestion (start), after stage 1 digested with pepsin at pH 2.5 for 30 min / 37 °C and after stage 2 digested with CPP at pH 7.5 for 30 min / 37 °C. Values are obtained from SDS-PAGE using ImageJ (n=3) Cow Deer Start Stage 1 Stage 2 Start Stage 1 Stage 2 IgHC 100 10 ± 5* 1 ± 2* 100 53 ± 9* 21 ± 5* LF 100 25 ± 2 0±1 100 32 ± 4 1±1 100 25 ± 3* 1 ± 1 SA 100 11 ± 6* 0 ± 0 CN 100 49 ± 9* 0 ± 0 100 27 ± 3* 1 ± 1 100 91 ± 4 55 ± 8 β-lg 100 94 ± 3 54 ± 5 α-la 100 79 ± 8 11 ± 2* 100 82 ± 10 27 ± 5* S1 (stage 1) = simulated stomach SA: serum albumin S2 (stage 2) = simulated duodenum CN: casein IgCN: immunoglobulin heavy chain β-lg: β-lactoglobulin LF: lactoferrin α-la: α-lactalbumin * statistically different between deer & cow (P < 0.05) as determined by Tukey’s test The other whey proteins such as lactoferrin and serum albumin were highly degraded by the gastrointestinal enzymes. In this study, lactoferrin and serum albumin bands disappeared after digestion of both milk samples (Fig 3.3 and 3.4). But for serum albumin like protein this was significantly faster in deer milk than in cow milk, with only 11% intact serum albumin like protein remaining after simulated stomach in deer while cow milk had 25% (Table3.2). Our results showed that deer immunoglobulin is more susceptible to digestion by commercial enzymes than cow milk. Deer immunoglobulin like protein was almost completely digested (1% intact) after simulated stomach and duodenal digestion while 21% of cow milk immunoglobulins remained (Fig 3.5c). Many in vitro studies have shown that cow immunoglobulins are resistant to proteolysis by digestive enzymes and are not inactivated by gastric acid (Korhonen et al., 2000; Hurley &Theil, 2011). 37 The results reveal that less intact protein is present after simulated stomach and duodenal digestion of deer milk than cow milk (Table 3.2). The rate of hydrolysis was different between proteins and between the two species as shown in Figures 3.3-3.5. Commercial proteolytic enzymes degraded milk proteins from deer more rapidly than those from cow. This suggests deer milk may also be more digestible in vivo than cow milk. 3.4. Conclusion In vitro digestion using commercial proteolytic enzymes has provided new knowledge of deer milk protein digestion. Commercial proteolytic enzymes degraded milk proteins from deer milk more rapidly than those from cow. Most noticeable was the difference observed in casein, α-lactalbumin and immunoglobulin. Deer and cow milk β-lactoglobulins were resistant to both gastric digestion (simulated stomach) and simulated duodenal digestion. This study provides better knowledge about the digestion of deer milk, compared with cow milk and may reveal important issues with regard to the proteins in nutrition. The results obtained may be relevant for development of easily digestable products for consumer groups with special needs, such as infants, athletes and the elderly. However, as this is an in vitromodel system, clinical studies are needed in order to confirm results. Deer milk produced more peptides than cow milk after in vitro digestion using commercial enzymes. This may mean that deer milk will have more bioactive peptides. The bioactivity of the peptides produced is currently under investigation. 38 Chapter 4 (Paper from part of this work was accepted in Proceedings of the Nutrition Society of New Zealand, 2011, Volume 35) (Appendix B) Fermentation of Deer and Cow Milk 4.1. Introduction Fermented milk products, in addition to providing energy and nutrients, also have biological functions that may improve health upon ingestion. The health benefits of fermented milk have been recognized and documented for centuries (Hitchins &McDonough., 1989). Empirical observations and scientific demonstrations have concurred, strengthening this evidence. The beneficial health effects of fermented dairy products may be the result of bacterial metabolites, such as cell wall components (Furushiro et al., 1993), bacteriocins (Hernandez et al., 2005) and the hydrolytic action of cell-free extracts containing proteinase / peptidase activities on milk protein substrates (Pan et al., 2005). Casein and whey protein derived peptides can be released from milk proteins during fermentation by various bacterial strains. Moreover, the health benefits of fermented dairy products have been related to the living microorganisms contained in the fermented products (Perdigon et al., 1991; Saucier et al., 1992). Chapter 3results showed that deer milk has 8.8 % protein which is twice as much as in the cow milk. This could be a good substrate for proteolytic activity of LAB strains and may produce more peptides which might have biological functions beneficial to health. LAB utilize the lactose as their first food source producing lactic acid. They then hydrolyse protein). The lactose content is not different between these milks.LAB can withstand the increased acidity from organic acid production (Kandler, 1983 The aim of this study was to compare deer and cow milk during fermentation using three LAB cultures in terms of peptide production before and after in vitro digestion and to compare deer and cow milk protein digestibility. TheLactobacillus delbrueckiisubsp bulgaricus and Streptococcus salivarius subsp thermophilus stains used in this study are commonly used in commercial yogurt making (Tharmaraj and Shah, 2003) while Lactobacillus casei strain Shirota is a probiotic strain (Yuki et al., 1999). 39 This is the first study to investigate the fermentation of red deer milk followed by in vitro digestion. The information from the present work is potentially useful in understanding the release of peptides in animal nutrition and to evaluate the potential use of deer milk products as functional foods for human. 4.2. Material & Methods 4.2.1. Materials Lactobacillus delbrueckiisubsp bulgaricus (Ldb), Streptococcus salivarius subsp thermophilus (Sst) cultures were the kind gifts from Dr. Michelle McConnell, Department of Microbiology and Immunology, Otago University (New Zealand) and Lactobacillus casei strain Shirota (Lcs) was propagated from Yokuth (Australian dairy product).All other materials were those stated in 3.2.1. 4.2.2. Milk Fermentatiom Cultures (Lactobacillus delbrueckiisubsp bulgaricus (Ldb), Streptococcus salivarius subsp thermophilus (Sst) and Lactobacilluscasei strain Shirota (Lcs) were propagated by weekly transfers in skimmed cow milk(heated at 850C for 30 min to killed endogenous bacteria and enzyme activity (Wang et al., 2009))and stored at 4°C after growing for 17 hr at 37°C in closed containers (Matar et al., 1996; Pescuma et al., 2008). Deer and cow milk samples (50 ml) were prepared in triplicate by rehydrating freeze dried defatted milk in 26% and 12% rehydration ratios, respectively. Samples were heated at 850C for 30 min (Wang et al., 2009). Prepared milk samples were inoculated withLactobacillus delbrueckiisubsp bulgaricus, Streptococcus salivarius subsp thermophilus and Lactobacilluscasei strain Shirota with 2% (vol/vol) inoculums separately and incubated at 37°C for 24 hr (Matar et al., 1996). Fermentation was carried out under aerobic conditions (conical flask closed with aluminium foil) without pH control.A control milk sample without any inoculum added to it was maintained in same condition.Lactobacillus delbrueckiisubsp bulgaricus and Lactobacillus casei strain Shirota growth was determined by plating serial 40 dilutions on Lactobacilli MRS agar, incubating anaerobically at 37°C for 72 hr in Oxoid jars and counting colony-forming units (cfu). Similarly Streptococcus salivarius subsp thermophilus were plated in sheep blood agar anaerobically at 37°C for 48 hr. The fermented milk solutions were used for in vitro digestion. 4.2.3. In vitro Digestion The in vitro protein digestion was performed for unfermented and fermented milk in two steps using Pepsin and CPP as described in chapter 3. 4.2.4 Proteolysis Assessment using OPA assay Proteolytic activity was measured after fermentation and after in vitro digestion of fermentations as described in chapter 3. TCA precipitation was done prior to OPA assay. 4.2.5. SDS -polyacrylamide gel electrophoresis (SDS-PAGE) The sodium dodecyl sulphate-polyacrylamide gel electrophoresis was performed to monitorthe protein degradation of deer and cow milks during fermentation and in vitro digestion. SDS-PAGE of unfermented and fermented milk and digest of fermented milk samples were done according to a standard protocol (Laemmli, 1970) using NuPAGE 4-12% Bis-Trisgels. The protein bands in the gels were quantified by ImageJ software (version 1.42) as described in chapter 3.2.8. 4.2.6. Statistical analysis All experiments were carried out in triplicate and the reported values are mean ± standard deviation. The data were subjected to one way analysis of variance (ANOVA), followed by Tukey’s test to determine the significant difference between means at P ˂0.05 level using Minitab (version 16). 4.3. Results Lactobacillus delbrueckiisubsp bulgaricus and Streptococcus salivarius subsp thermophilus were able to grow in both milks at 37°C.Their growth plateaued after 12 hours (Fig. 4.1). 41 There was no growth shown in the control milk sample.In cow milk Streptococcus salivarius subsp thermophilus population reached 107 CFU/ml, whereas it was 106 CFU/ml in deer milk. The growth of Lactobacillus delbrueckiisubsp bulgaricus was also slightly lower in deer milk than cow milk. Lactobacillus caei strain Shirota showed a similar growth pattern in both milks (Fig.4.2). Lactobacillus casei strain Shirota grew slower than the other two organisms reaching its highest level of 108 CFU/ml level after 24 hours fermentation. Figure 4.1. Growth of Lactobacillus delbrueckiisubspbulgaricus (Ldb), Streptococcus salivarius subsp thermophilus (Sst) in deer and cow milk at 37°C for 24 hr. Data are mean of three independent fermentations ± S.D. Figure 4.2. Growth of Lactobacillus casei strain Shirota (Lcs) in deerand cow milk at 37°C for 72hr. Data are mean of three independent fermentations ± S.D. 42 The pH of deer milk was 6.1 whereas it was 6.5 for cow milk. Cow milk fermented by Lactobacillus delbrueckiisubsp bulgaricus and Streptococcus salivarius subspthermophilusshowed a slight pH reduction from the beginning of fermentation and started to decrease more rapidly after 6 hr of fermentation (Fig. 4.3 a and b). In deer milk, pH declined only after 6 hr of fermentation for those two strains and the pH decrease was less than in cow milk fermentation. After 24 hr of fermentation, the pH of cow milk was significantly (P ˃ 0.05) lower than deer milk for all 3 stains. The pH fell below 4.6 for cow milk at which pH the casein precipitated. Although the deer milk fermentation started at a lower pH than cow milk, it did not fall below 4.6 for any of the three LAB fermentations (Fig. 4.3). The pH drop for Lactobacillus casei strain Shirota fermentation was observed after 12hr of fermentation and reached a plateau after 44 hr for both milks whilst pH reached a plateau after 17 hr for Lactobacillus delbrueckiisubsp bulgaricus and Streptococcus salivarius subsp thermophilus. The proteolytic activity of the studied strains was significantly higher (P < 0.05) in deer milk than cow milk for Lactobacillus casei strain Shirota and Lactobacillus delbrueckiisubsp bulgaricus stains. There was no significant difference (P > 0.05) between deer and cow ferments using Streptococcus salivarius subsp thermophilus. The highest production of peptides was shown by Lactobacillus casei strain Shirota (Fig. 4.4) after 24 hr of fermentation at 37°C. 43 Figure 4.3. pH drop during fermentation of deer and cow milk at 37°C with (a) Lactobacillus delbrueckiisubsp bulgaricus (Ldb), (b) Streptococcus salivarius subsp thermophilus (Sst), (c) Lactobacillus casei strain Shirota (Lcs). Data are means of three independent fermentations ± S.D (SD values are too small to view). 44 Figure 4.4. Peptide production measured by OPA assay during fermentation of deer and cow milk at 37°C with (a)Lactobacillus delbrueckiisubsp bulgaricus (Ldb), (b) Streptococcus salivarius subsp thermophilus (Sst), (c) Lactobacillus casei strain Shirota (Lcs).Data are means± S.D. (n = 3) Once ferments were digested in in vitro system, significantly higher (P < 0.05) peptide production was observed in deer milk than in cow milk for all 3 stains. The highest peptide production was shown in digests of Lactobacillus casei strain Shirota fermented deer milk (Fig 4.5). 45 Figure 4.5. Peptide production during in vitro digestion of 24hr fermented (Lactobacillus delbrueckiisubsp bulgaricus, Streptococcus salivarius subsp thermophilus and Lactobacillus casei strain Shirota) deer and cow milk - up to 30 min: simulated stomach (step 1) and 30 – 90 min simulated duodenum (step 2). Peptide production was measured after TCA precipitation prior to OPA assay. Data are means of 3. SD not shown for clarity of graph. Comparison of peptide production of fermented milk digests with milk digests and fermented milk prior to digestion is shown in Figure 4.6. Digestion (with or without fermentation) always produced significantly higher (P < 0.05) peptide levels compared to the level produced from fermentation only for all 3 LAB strains in both deer and cow milk. Digests of fermented milk always had higher concentrations of peptides than digests of raw milk. This was significantly higher for Lactobacillus casei strain Shirota fermented deer milk and ferments using all 3 stains in cow milk than the raw milk digestion. This means the fermentation process of milk favoured an increase in the peptide production during digestion (Fig. 4.6). This was clearer for Lactobacillus casei strain Shirota fermentation than other strains and this showed higher level for deer milk than cow milk (Fig 4.6 c). There was no significant difference (P > 0.05) in peptide production between the three strains fermentations after in vitro digestion for both deer and cow milk. 46 Figure 4.6. Peptide production after in vitro digestion of raw milk (30min simulated stomach + 30min simulated duodenum) , 24hr fermented milk and fermented digests for deer ( ) and cow( ) milk (a)Lactobacillus delbrueckiisubspbulgaricus (b)Streptococcus salivarius subsp thermophilus (c)Lactobacilluscasei strain Shirota) -peptide production was measured after TCA precipitation prior to OPA assay. Data are means± S.D. (n = 3) The protein degradation of fermented milk by all 3 strains was monitored by SDS-PAGE and compared to unfermented deer and cow milk (Fig. 4.7). After 24 hr of fermentation, casein degradation was visible as indicated by the fading (Cf and Df lanes) of the original bands (C and D lanes) on the electrophoresis gel (Fig. 4.7). After in vitro digestion, most of the milk protein bands completely disappeared and new lower molecular mass bands could be seen on the gel (Cfd and Dfd lanes). 47 (a) (b) (c) IgHC LF SA CN β-lg α-la C Cf Cfd D Df Dfd C Cf Cfd D Df Dfd M C Cf Cfd D Df Dfd Figure 4.7. SDS-PAGE (4-12%) of fermented cow and deer milks by (a)Lactobacillus delbrueckiisubsp bulgaricus, (b)Streptococcus salivarius subsp thermophilus and (c)Lactobacillus casei strain Shirota at 37°C for 24 hr and in vitro digestion (30min simulated stomach + 30min simulated duodenum). The lanes are (C) cow milk, (Cf) cow milk ferment, (Cfd) cow milk ferment digest, (D) deer milk, (Df) deer milk ferment, (Dfd) deer milk ferment digest, (M) high molecular marker.Each contained 2 mg/ µl protein. Protein band intensities were quantified using ImageJ software to illustrate degradation of protein after fermentation and in vitro digestion of ferment (Table 4.1). All the main proteins started to degrade after fermentation for both milk. After 24 hr of fermentation, cow milk had significantly higher (P<0.05) intact lactoferrin (LF) than deer milk. LF of cow milk was more resistant to fermentation than that of deer milk for all 3 strains. Specifically in the Lactobacillus casei strain Shirota ferment LF was still intact in cow milk while only 47% remained for deer milk. Digestibility of β-lactoglobulin (β-lg) and α-lactalbumin (α-la) like protein of deer milk was improved by fermentation. The results showed 55% intact β-lg and 11% intact α–la like protein after in vitro digestion of raw deer milk. Fifty one % of β-lg remained intact for Lactobacillus delbrueckiisubsp bulgaricus and Streptococcus salivarius subsp thermophilus fermented digest. At the same time Lactobacillus delbrueckiisubsp bulgaricus ferment digest only had 1% intact α –la like protein in deer milk. Digestibility of cow α –la also improved after fermentation and showed only 13% intact protein in Lactobacillus delbrueckiisubsp bulgaricus ferment digest when it was 27% for unfermented milk digest. There was a dramatic difference observed in digestion of immunoglobulin (Igs) of cow milk. Intact protein level was 21% after in vitro digestion of unfermented milk and decreased to 0 (no intact protein) after in vitro digestion of fermented milk for all 3 strains. Intact β-lg in cow milk was higher (68%) inStreptococcus salivarius subsp thermophilus ferment digest than unfermented milk digests (58%). These improvements or reductions of digestibility of different protein may lead to formation of novel peptides during digestion of fermented milk. 48 Table 4.1. Remaining protein content (%) in in vitrodigests of milk;before and after in vitro digestion of Lactobacillus delbrueckiisubspbulgaricus (Ldb), Streptococcus salivarius subsp thermophilus (Sst)and Lactobacillus casei strain Shirota (Lcs) fermented (24 hr at 37°C) milk (30min simulated stomach + 30min simulated duodenum). Values are obtained by ImageJ. Lactobacillus delbrueckiisubsp bulgaricus IgHC LF SA CN β-lg α -la Milk Digest Deer Cow 1± 2 21±5 ND 1±1 ND 1±1 ND 1±1 54±5 55±8 11±2 27±5 Ferment Deer Cow 71±4 74±3 42±5 63±4 62±7 63±6 76±8 82±4 85±2 91±7 87±2 90±3 Ferment Digest Deer Cow ND 8±1 ND 2±1 ND 1±1 1±0 1±1 51±1 57±4 1±1 13±4 Streptococcus salivarius subspthermophilus Ferments Deer Cow 73±3 77±3 48±2 69±5 70±1 67±6 85±2 84±1 83±4 78±2 85±3 91±2 Ferment Digest Deer Cow ND ND ND ND ND ND 2±0 51±1 15±3 2±0 68±1 23±4 Lactobacillus caei strain Shirota Ferment Deer 62±1 47±3 77±1 83±2 87±1 92±2 Cow 64±2 101±1 68±1 85±1 86±1 90±1 Ferment Digest Deer Cow ND ND 1±1 2±1 1±0 ND ND ND 52±1 8±4 57±1 17±1 Data are means ± S.D. (n=3) Not detected (ND) 49 4.4. Discussion Lactobacillus delbrueckiisubsp bulgaricus,Streptococcus salivarius subsp thermophilus and Lactobacillus casei strain Shirotaare widely used LAB in the dairy industry. Lactobacillus delbrueckii subsp. bulgaricus is commonly used alongside Streptococcus salivarius subsp thermophilus as a starter for yoghurt making and is also found in other naturally fermented products. Lactobacillus casei strain Shirotahas been extensively studied and it is widely available as functional food (e.g.Yakult, http://www.yakult.com.au/index.html). The lower growth of fermentative organisms in deer milk may suggest some kind of inhibitory effect of deer milk. There was a historical use of reindeer milk as a medical remedy to heal wound, frostbites and other injuries (Park & Haenlein, 2006). Milk contains several antimicrobial compounds, including lactoferrin, lactoperoxidase, and lysozyme, which may be involved in protecting against bacterial growth. Milks of different species contain different amounts of the various antimicrobial factors (Aimutis, 2004). Cow milk has high lactoperoxidase, but low lactoferrin and lysozyme, while human breast milk has high lactoferrin and lysozyme, but low lactoperoxidase (Aimutis, 2004). The antibacterial properties of milk may be due to synergistic activity of naturally occurring proteins and peptides, in addition to peptides generated from inactive protein precursors (Clare & Swaisgood, 2000). Minervini et al. (2003) found an antibacterial peptide from hydrolysis of human β casein, which had a wide spectrum of antibacterial activity, including activity against Gram-positive and Gram-negative species. This peptide (β-CN f184-210) inhibited the growth of Lactobacillus delbrueckiisubspbulgaricusB15. However the identity of the factors responsible for these low microbial growths is unknown and further studies should be done on the antibacterial effect of deer milk. Deer milk is slightly more acidic (6.1 pH) than cow milk (6.5 pH). Differences in pH and buffering capacity of fresh milk reflect compositional variation (McCarthy, 2002). After 24 hr of fermentation, deer milk showed significantly higher (P < 0.05) pH than cow milk for all three strains and after fermentation, cow milk pH decreased below the isoelectric point of casein resulting in precipitation of casein (Fig. 4.3). LAB growth in milk is low at higher pH closer to 7 (Dat et al., 2011) than lower pH. The higher pH during later part of fermentation in deer milk than cow milk may be a reason for the low growth in cultures in deer milk compared to cow milk during fermentation. Lower pH drop of deer milk may be due to several factors such as low bacterial growth resulting in low lactic acid formation or higher buffering capacity of deer milk than cow milk. The ultimate pH of cheese results from the 50 lactic acid produced (from starter culture breaking down lactose) and is moderated by the buffering capacity of the milk (Pendey et al., 2003). Buffering action of milk is due to the presence of acid buffers (weak acid–conjugate base pairs) and base buffers (weak base– conjugate acid pairs) (McCarthy, 2002). Milk contains many acidic and alkaline groups that result in buffering action over a wide pH range. Principal buffer components in milk are soluble phosphate, colloidal calcium phosphate, citrate, bicarbonate, casein, salt and a number of minor constituents (Ismail et al., 1973; McCarthy, 2002). Goat milk has high buffering capacity due to its high content of major buffering components including minerals (Park, 1992). The mineral content of red deer milk is about two times that of cow milk (Arman et al., 1974). Also deer milk has twice as much as casein as cow milk (Chapter 3). This high casein and mineral content may lead to high buffering quality of deer milk and could reduce the pH drop during fermentation compared to cow milk. However, further studies should be carried out to confirm the buffering effect of deer milk. Nielsen et al. (2009) reported that the total amount of peptides produced was significantly affected by final fermentation pH using 4 species of LAB in cow milk. In that study more peptides were produced at a final pH of 4.3 than 4.6. In the present study pH did not affect the same way (more peptide from lower pH)since; milks are from two species of animals. In this study high pH milk ferment from deer milk yielded more peptides than low pH cow milk ferment. Lactobacillus delbrueckiisubsp bulgaricus and Lactobacillus caei strain Shirota ferment of deer milk produced significantly (P < 0.05) higher peptide concentrations than in cow milk ferments. Deer milk fermented with Lactobacillus casei strain Shirota produced significantly (P < 0.05) higher peptide levels followed by Lactobacillusdelbrueckiisubsp bulgaricus. Gobbetti et al. (2000) showed that during milk fermentation, probiotic strains may produce several oligopeptides which generate bioactive peptides only after subsequent digestion by pepsin and trypsin. Peptide bonds that are hidden within the native protein structure might be exposed by the action of LAB enzymes, thereby allowing the release of new peptides. In terms of peptide level there is no significant difference (P < 0.05) between three strains for both milk type after in vitro digestion of ferments (Fig. 4.5). Bioactive peptides are inactive within the sequence of the parent protein and can be released by enzymatic hydrolysis by digestive enzymes and fermentation of milk. In many studies use of both fermentation and digestion has proven more effective in generating biofunctional peptides than fermentation or digestion alone (Korhonen & Pihlanto, 2007). Both milk 51 digestions (with or without fermentation) produced significantly higher (P < 0.05) peptide level than fermentation alone for all three strains. This proved that more peptides are produced by digestion than fermentation. Mata et al., (1996) reported that cow milk fermentation by Lactobacillus helveticus resulted in a very low degree of proteolysis. They concluded that proteolysis during fermentation enhanced the release of peptides and may lead to the formation of novel peptides during gastrointestinal digestion. A large number of studies have demonstrated that hydrolysis of milk proteins by digestive enzymes, prominently pepsin, trypsin and chymotrypsin, can produce biologically active peptides (Korhonen & Pihlanto, 2006). When comparing the digestions with and without fermentation, deer and cow milk acted in different ways. In deer milk only Lactobacillus casei strain Shirota produced significantly higher (P < 0.05) peptide levels after digestion compared to unfermented digest, whereas in cow milk ferment digest for all 3 strains produce significantly higher (P <0.05) peptide levels than unfermented digest (Fig. 4.6). In contrast digestion of deer milk produces more peptides than cow milk and was further improved by fermentation prior to digestion. Highest peptide concentrations were observed in deer milk digest followed by fermentation and there were no significant difference between LAB strains. Proteolysis is considered to be one of the most important biochemical processes involved in the manufacture of many fermented dairy products, irrespective of the contribution of the proteolytic/peptidolytic enzymes of LAB to organoleptic properties of the final milk products. The ability to produce extracellular proteinases is a very important feature of LAB. They catalyse milk proteins, providing the amino acids essential for growth of LAB (Fira et al., 2001). Proteolysis by microbial enzymes in yogurt is a desirable process for improving milk digestibility and enhancing the nutritional quality of yogurt. It is accepted that the proteolytic system of LAB degrades proteins and hence, changes the texture, the taste and the aroma of fermented products (El-Ghaish et al., 2011). In this study, LAB fermentation improved the digestibility of β-lg like protein of deer milk more than that of cow milk (Table 4.1). There was 54% intact β-lg like protein in deer milk digest without fermentation. It decreased to 51% in digest of Lactobacillus delbrueckiisubsp bulgaricus and Streptococcus salivarius subsp thermophilus deer ferment. β-lg is the main cause of milk allergies causing about 80% of all cases in children and infants. β-lg is the major whey protein in milk and dairy products and it is of particular interest since it is the only whey protein of cow milk absent in human milk (El-Ghaish et al., 2011). The lower β-lg like protein level in ferment digest in deer milk than cow ferment digest may lead to less allergenicity. Kleber et al.(2006) 52 studied the ability of some LAB strains to reduce the antigenicity of β-lg using skim milk and sweet whey by indirect competitive ELISA, using polyclonal antibodies. They observed a reduction of antigenicity of skim milk by 90% and sweet whey by 70% compared to the initial value. α-lactalbumin (α –la) is another whey protein which has lesser extent of allergenicity compared to β-lg (Wal, 1998). Intact α –la like protein of deer milk reduced to 1% in digests of Lactobacillus delbrueckiisubspbulgaricus ferment and to 8% in Lactobacillus casei strain Shirota ferment from 11% intact α–la of unfermented digest (Table 4.1). The digestibility of α–la in cow milk was also improved by fermentation with the above two strains. There was always significantly low intact α–la like protein level in deer ferment digest than cow ferment digests for all three LAB strains. Bu et al. (2010) found combined strains of LAB reduced the antigenicity of cow skim milk α –la and β-lg. Therefore, our results suggest fermented deer milk digest may have less allergenicity than fermented cow milk digest. There was a significant improvement of digestibility of cow Igs after fermentation by all tested LAB strains (Table 3). Intact Igslevel of cow unfermented digests was 21% and this went down to 8% in Lactobacillus delbrueckiisubsp bulgaricus ferment digest and 0% with other 2 strains. The milk Igsare relatively resistant to digestive enzymes in the gastrointestinal tract but can be sensitive to a group of microbial enzymes (Marnila & Korhone, 2011). In this study lactoferrrin (LF) in cow milk was significantly (P < 0.05) more resistant to fermentation than that in deer milk for all 3 strains. Lactoferrin is an 80 kDa iron-binding glycoprotein of the transferrin family that is expressed in most biological fluids and is a major component of the mammalian innate immune system (Gonzalez-Chavez et al., 2009). By characterising the various peptides generated by hydrolysis of LF, the antimicrobial activity of the peptides that have minimal variations in the amino acid sequence change was found. For example, LFampin 268–284 and LFampin 265–284, differ in only three amino acids (265Asp-Leu-267Ile) but exhibit different strength of antibacterial activity (Kraan et al., 2006). Therefore different levels of hydrolysis in deer and cow milk fermentation may form different peptides with different biological activity. Similar to present cow milk fermentation results of Franco et al., (2010) indicated that LF structure does not seem to be altered by the activity of commercial (yogurt) LAB bacteria. Hence, their study demonstrated that yogurt is an excellent product for supplementation with LF though it should be added after milk pasteurization because heat treatment could make LF more susceptible to proteolysis by LAB. This work results suggest deer milk will be a better option than cow 53 milk for this purpose. In summary, digestibility of deer milk was higher than cow milk and this was further improved by LAB fermentation prior to digestion. 4.5. Conclusion Fermentation prior to digestion increased the production of peptides from and the digestibility of major milk proteins from both deer and cow milk. Digestion of fermented deer milk produced more peptides than digestion of fermented cow milk. There was no significant difference in peptide level produced after digestion among three LAB strains used in this experiment. Digestibility of major milk proteins was higher in deer ferment than cow ferment. The study demonstrates unique characteristics of deer milk which may prove useful in understanding the potential use in human or animal nutrition and generate new information which will help in understanding fawn nutrition. Immunomodulation activity of deer and cow peptides will be examined in the following chapters. 54 Chapter 5 (Paper was prepared for submission toFood and Bioprocess Technology Journal) Immunomodulatory Activity of Fresh and Fermented Red Deer and Cow Milks 5.1. Introduction Milk provides essential nutrients during neonatal development and plays an important protective role in the development of the immune system of newborns (Inglingstad et al., 2010). While milk contains components such as immunoglobulin that can modulate the immune system, an increasing number of studies suggest that milk proteins, may also contain biologically active peptides with immunomodulating properties within their primary sequences (Kayser & Meisel 1996; Eriksen et al., 2008; Korhonen, 2009; Phelan et al., 2009). The concept of developing nutraceuticals based on peptide-enriched fractions from milk to target the immune system is attractive and is an area of active research (Bhat & Bhat, 2011). The goal of this study was to investigate the in vitro immunomodulatory activity of hydrolysed deer and cow milk protein obtained by in vitro digestion using pepsin and CPP, with and without prior fermentation using three LAB strains [Lactobacillus delbrueckii subsp bulgaricus (Ldb), Streptococcus salivarius subspthermophilus (Sst) and Lactobacillus casei strain Shirota (Lcs)]. The effects of hydrolysates on lymphocyte proliferation and cytokine production (IL2 and IFNγ) were determined. 5.2. Material & Methods 5.2.1. Materials Oxytocin was purchased from Pharm Distributors (Auckland, New Zealand). Pepsin from porcine stomach mucosa (66 units / mg solid), O-phthaldialdehyde (OPA), Leucine and trichloroacetic acid (TCA) were purchased from Sigma (St. Louis, MO, USA) and Corolase PP (CPP) (350 proteolyticU/mg) from pig pancreas was from AB Enzymes (Darmstadt, 55 Germany). Corolase PP is a mixture of trypsin, chymotrypsin and several amino- and carboxypeptidases. Ficoll-Paque PLUS was from GE Healthcare (Sweden) and Concanavalin A (Con A) and Trypan blue were from GIBCO (Invitrogen, Grand Island, NY, USA). Complete RPMI (RPMI media was developed by Royal Park Memorial Institute) was prepared from; Lglutamine supplemented RPMI 1640, 9 mL/L non-essential amino acid, 9 mL/L sodium pyruvate, 10 mL/L Penstrep (GIBCO, Invitrogen, Grand Island, NY, USA ) and 10% heat inactivated foetal calf serum (Bio International, New Zealand ). All cell culture plates were sterilized individually packed, flat bottom 96-well cell culture plates from Costar (Corning, NY, USA). Bovine serum albumin (BSA) was obtained from Sigma, New Zealand. Human IL-2 and Human IFNγ enzyme-link immunosorbent assay (ELISA) Ready-SET-Go kits were purchased from eBioscience (USA). All incubations of cells were performed at 37°C in a humidified 5% CO2 incubator (Function line BB15, BioLab Scientific LTD, Heraeus). 5.2.2. Collection and Preparation of Milk Samples Pooled deer milk was obtained from the Lincoln University Deer Farm (Lincoln, New Zealand) as described in previous work (Chapter 3.2.2). Approval for this work was given by Lincoln University Animal Ethics Committee (# 377). Pooled cow milk was obtained from Lincoln University Dairy Farm. Fat was removed after centrifugation at 4000 ×g for 30 min at 4°C. Defatted milk was freeze dried and stored at room temperature in airtight containers until analysis. 5.2.3. Fermentation Cultures (Lactobacillus delbrueckii subsp bulgaricus (Ldb), Streptococcus salivarius subsp thermophilus (Sst) and Lactobacillus casei strain Shirota (Lcs) were propagated by weekly transfers in skimmed cow milk and stored at 4°C after growing for 17h at 37°Cin closed container (as per chapter 4.2.2.)(Matar et al., 1996; Pescuma et al., 2008). Deer and cow milk samples (50 ml) were prepared to the original concentration by rehydrating freeze dried defatted milk in 26% and 12% rehydration ratio, respectively. Samples were heated at 850C for 30 min (Wang et al., 2009). Prepared milk samples were inoculated in triplicate with Ldb, Sst or Lcs strains with 2% (vol/vol) inoculums separately and incubated at 37°C for 24 hr (Matar et al., 1996). Fermentation was carried out under 56 aerobic conditions without pH control and the resultant ferment was used for in vitro digestion. 5.2.4. in vitro Digestion Unfermented and fermented deer and cow milk samples (15 ml) were digested in triplicate. In vitroprotein digestion was performed using pepsin and CPP according to Eriksen et al. (2008). The procedure mimics “normal digestion” in the human gastro intestinal tract. In the first incubation, which mimics digestion in the stomach, the sample was adjusted to pH 2.5 with 1M HCl and incubated with pepsin (~4mg/g milk protein) at 37°C for 30 min. The second incubation, mimicking digestion in the small intestine, used CPP (~4 mg/g milk protein) at 37°C for 60 min after the pH of the sample was adjusted to 7.5 with 1M NaOH. Continuous shaking (150 rpm) was maintained during digestion. The hydolysates were used for further analysis. 5.2.5. BCA Protein Assay Protein concentration in each sample was determined using Bicinchoninic acid reagent (Pierce, Rockford, Il., USA) according to the manufacturer’s instructions. Samples (10 µl) were assayed in triplicate and compared to a standard curve generated using dilutions of 2 mg/mL Albumin Standard (Pierce, Rockford, Illinois, USA), to provide concentrations ranging from 0.0625 mg/ml to 1 mg/ml. Samples were diluted before BCA assay whenever needed. 5.2.6. Isolation of human peripheral blood mononuclear cells (PBMC) Human peripheral blood mononuclear cells (PBMC) were isolated from whole blood collected from a healthy donor (Lincoln University Human Ethics Committee approval # 2011-2) using Ficoll-Paque PLUS as per manufacturer’s instructions. The isolated PBMC were adjusted to the appropriate cell concentration in complete RPMI. 5.2.7. In vitro lymphocyte proliferation assay Lymphocyte proliferation assays followed the method of De Fries & Mitsuhashi,(1995) and Zhi-Jun et al. (1997).Digested fresh and fermented milks were tested for their effects on lymphocyte proliferation. The protein concentration of each sample was diluted to 0.125 mg/ml, 0.25 mg/ml and 0.5 mg/ml in complete RPMI. The positive control had no milk 57 proteins while the negative control contained BSA as in Eriksen et al. 2008 which used the same condition with human PBMC. A 100 µL cell suspension (105 cells/ml) was added to each well in a 96-well cell culture plate. 10 µL Con A (10 µg/ml) (Eriksen et al. 2008) was added to the wells to stimulate cells. Triplicate 100 µl aliquots of each concentration of the milk protein samples were added to wells. The plates were incubated at 37°C in a humidified 5% CO2 incubator for 48 hr. Alamar Blue (20 µl) (Invitrogen, Camarillo, CA 93012) was added to each well and plates were incubated at 37°C and measured after 24 hr. Fluorescence readings were determined at wavelengths of 544 nm excitation and 590nm emission using a FLUOstar Omega (BMG LABTECH) plate reader. Proliferation was expressed as the percentage increase of fluorescence compared to the fluorescence of the positive control. % Change in proliferation= Sample fluorescence reading – Positive control fluorescence reading x100 Positive control fluorescence reading The effects of Con A and protein concentration on lymphocyte proliferation were also tested using this assay procedure with and without Con A and by using different concentrations of protein (10 to 640 µg/ml). Deer and cow milk hydrolysates with and without Lactobacillusdelbrueckiisubsp bulgaricus fermentation were tested. 5.2.8. Cell viability test The viability test was carried out according to Eriksen et al. (2008). Aliquots (100 µl) of 0.125 mg/ml, 0.25 mg/ml and 0.5 mg/ml deer and cow milk digestions and ferment digests were added to 100 µl lymphocytes (105 cells/ml) in complete RPMI and incubated for up to 4 days. A 20 µl sample from each incubation was then mixed with 20 µl Trypan blue and allowed to stand for 5 min at room temperature. A haemocytometer was used to count living (unstained) and dead (stained) cells using a light microscope. Living (viable) cells were expressed as a percentage of total cell number. 5.2.9. Cytokine production Cytokine production by PBMC was stimulated by Con A (Laffineur et al., 1996, Phelan et al., 2009). PBMC (105 cells/ml) were supplemented with 10 µg/ml Con A in the presence or absence of milk protein hydrolysates and incubated for 24 hr in 96-well plates with final volume of 200 µl. The production of IL-2 and IFNγ were assessed using ELISA kits as per the manufacturer’s instructions (Burrells et al., 1999). Absorbance was read at 450 nm 58 wavelength and cytokine concentrations were quantified using the standard curve (IL-2 and IFNγ standard solutions in the kit). 5.2.10. Statistical analysis Data were presented as the mean ± standard deviation of three independent experiments with triplicate measurements (n = 3). The lymphocyte proliferation and cytokine production data were subjected to factorial analysis of variance using GenStat 12.2 (GenStat Release 12.2, VSN International Ltd, UK). Animal species (deer and cow), treatment (digests of unfermented and fermented with three LAB strains) and protein concentrations (0.125, 0.25 and 0.5 mg/ml) were used as variable factors and interaction of all factors were tested. Significant differences between means were determined by Tukey’s test and the level of statistical significance was taken as P < 0.05. Cell viability and production of cytokines with and without Con A data were subjected to one way analysis of variance (ANOVA), followed by Tukey’s test to determine the significant differences between samples at P < 0.05 level using Minitab statistical software (16 version, Minitab Inc., USA). 5.3. Results and discussion Effect of milk protein samples on in vitro lymphocyte proliferation The immunomodulatory activity of in vitro digestions of deer and cow milk and digests of these milks after fermentation with three lactic acid bacteria commonly used in fermented dairy products was investigated. Previous researchers have revealed both suppressive and stimulating effects of cow milk proteins on in vitro lymphocyte proliferation (Cross &Gill, 2000; Gauthier et al., 2006). The degradation rate of milk protein and production of peptides by LAB fermentation and subsequent in vitro digestion of deer and cow milk were previously reported (Chapter 4, Opatha Vithana et al., 2011). The aims of the present study were to investigate whether these digests exhibited immunomodulatory activity and whether differences in such activity exist due to the milk source. 59 b) 50 50 40 40 * * 30 % change in proliferation % change in proliferation a) 20 10 * ** * ** 30 20 10 0 0 Milk digest Ldb fer di Sst fer di Lcs fer di Milk digest 0.125 mg/ml protein Ldb fer di Sst fer di Lcs fer di 0.25 mg/ml protein Deer Cow Deer Cow c) 50 * ** % change in proliferation 40 * * 30 * * 20 10 0 Milk digest Ldb fer di Sst fer di Lcs fer di 0.5 mg/ml protein Deer Cow Figure 5.1. Percent change of lymphocyte proliferation of 10 µg/ml Con A stimulated human PBMC at a) 0.125mg/ml, b) 0.25mg/ml and c) 0.5mg/ml protein level for in vitro digestions of deer and cow milk, Lactobacillus delbrueckiisubsp bulgaricus (Ldb fer di), Streptococcus salivarius subsp thermophilus (Sst fer di), Lactobacillus casei strain Shirota (Lcs fer di) fermented milk. BSA (negative control) values for a,b & c were -1.5%, -5.7% & -10.8% respectively. Data are means± S.D. (n = 3) ٭Deer significantly higher than cow P<0.01 ٭٭Deer significantly higher than cow P<0.001 To test the effect on in vitro lymphocyte proliferation, three different concentrations (0.125, 0.25, 0.5 mg/ml) of milk protein digests were added to cultures of PBMCs which were 60 stimulated with 10 µg/ml Con A. De Fries & Mitsuhashi (1995) has shown use of Con A stimulated human PBMC with Almar Blue assay as a reliable method to assess proliferation. Results were evaluated as percentage change of proliferation compared to the control without milk proteins. Positive values indicate proliferation had increased and negative values indicate proliferation had decreased compared to the control. All samples caused significant proliferation of lymphocytes (P < 0.05) except for unfermented cow milk digestions at 0.25 and 0.5 mg/ml protein concentration (Fig. 5.1) and BSA which was the negative control. BSA significantly (P < 0.01) suppressed the proliferation at 0.5 mg/ml protein concentration. This is in agreement with Eriksen et al., (2008) who showed a suppressive effect for BSA on human PBMC proliferation. Also, in agreement with Eriksen et al., (2008), the highest proliferation activity was found with 0.125 mg/ml protein concentration and the proliferation activity was decreased with an increase in protein concentration (Fig. 5.1). Our results for cow milk are consistent with the substantial body of evidence that indicates cow milk contains a number of potent immunoregulatory peptides (Cross & Gill, 2000; Gauthier et al, 2006) while there are no published studies on deer milk immunomodulatory activity. Lymphocyte proliferation was higher (P < 0.001) for deer milk protein than cow milk protein (Table5.1). At 0.125 mg/ml protein concentration, deer milk digest stimulated the production of significantly more lymphocytes (P < 0.01) than cow milk digest (Fig. 5.1). This suggests that deer milk protein has higher immunomodulatory activity than cow milk protein at the same protein concentration (Figure 5.1a, b and c). Reindeer milk has a long history in Mongolian traditional medicine for curing digestive problems and healing wounds (Park &Haenlein, 2006). Our findings suggest that the efficacy of deer milk as a medical remedy may be the result of the immunomodulatory effects of peptides derived from deer milk proteins. This result taken with previous results of a higher protein content of 8.8 %, which is twice the level in cow milk (Chapter 3, Opatha Vithana et al., 2012), suggests deer milk could be a good source to purify bioactive peptides. Fermentation of the milk prior to digestion significantly increased effectiveness (P < 0.001) at inducing lymphocyte proliferation than without fermentation (Table5.1) for both deer and cow milks. This suggests fermentation prior to digestion increases the release of immunomodulatory peptides from both deer and cow milk. There was no significant difference (P > 0.05) between digested deer and cow ferments at the lower protein concentration (0.125 mg/ml), although there was a significant difference in lymphocyte proliferation between deer and cow milk digests without fermentation at the same concentration (Fig. 5.1a and Fig. 5.2). Cow milk digests at higher protein concentrations 61 (0.25 and 0.5 mg/mL) did not significantly (P>0.05) enhance the lymphocyte proliferation; however once it had been fermented with LAB (specifically with Sst) and digested, there was significantly higher (P < 0.05) proliferation with all three concentrations (Fig. 5.1). This suggests LAB fermentation of cow milk might generate more immunostimulative peptides which counteract the immunosuppressive peptides generated by digestion. The type of microorganism seems to be important in the net activity. 35 ٭ %change inproliferation 30 ٭ 25 ٭ 20 15 ٭ 10 5 0 0.1 0.2 0.3 0.4 0.5 0.6 Protein (mg/ml) Deer milk digests Cow milk digests Figure 5.2. Percent change of lymphocyte proliferation of digest deer ( ) and cow ( ) milk at 0.125, 0.25 and 0.5 mg/ml protein concentrations. Data are means± S.D. (n = 3) ٭Significantly enhance proliferation compared to control (P < 0.001). The results from the extended protein concentration trial (10 to 640 µg/ml) which was carried out in the presence and absence of Con A for digests of unfermented milk and Lactobacillus delbrueckii subsp bulgaricus fermented deer and cow milk supported the above conclusion of improvement of immunostimulation effect by LAB fermentation (Fig. 5.3). When PBMCs were not treated with Con A, there was no significant increase of proliferation by cow milk digest. Once cow milk was fermented with Lactobacillus delbrueckiisubsp bulgaricus and digested, it showed significantly higher (P< 0.05) proliferation without Con A at 40 and 80 µg/ml (Fig. 5.3) than unfermented. This evidence of the release of immunostimulatory peptides during LAB fermentation of cow milk is in accordance with previous published work (Matsuziki, 1998; LeBlanc et al., 2002 and 2004; Vinderola et al., 2007; Korhonen, 2009). This study represents the first documented evidence that peptides derived from deer milk after digestion and LAB fermentation has potentially enhancethe proliferation of lymphocytes. 62 a) * * 50 * ** * 40 %change inproliferation * * 30 * * 20 10 0 -10 0 100 200 300 400 500 600 700 500 600 700 Protein (µg/ml) Deer milk digests with ConA Deer milk digests without ConA b) 30 * * %change inproliferation 20 * * 10 0 -10 -20 0 100 200 300 400 Protein (µg/ml) Cow milk digests with Con A Cow milk digests without Con A Figure 5.3. Percent change of lymphocyte proliferation with ConA ( ) and without ConA( ) for different protein concentrations of digested a)Deer and b) Cow. Data are means± S.D. (n = 3). ٭Significantly enhance proliferation compared to control (P < 0.05). 63 a) * ** * 120 %changeinproliferation 100 80 * * * * 60 40 * * * * * * 20 0 -20 0 100 200 300 400 500 600 700 Protein (µg/ml) DL with Con A DL without Con A b) 100 %changeinproliferation 80 * * ** * * * * 60 * * * * 40 20 0 -20 0 100 200 300 400 500 600 700 Protein (µg/ml) CL with Con A CL without Con A Figure 5.4. Percent change of lymphocyte proliferation with ConA ( ) and without ConA( ) for different protein concentrations of digests of Lactobacillus delbrueckiisubsp bulgaricus ferments of a) Deer (DL)and b) Cow (CL). Data are means± S.D. (n = 3). ٭Significantly enhance proliferation compared to control (P < 0.05). 64 Fermentation with lactobacillus strains appeared more effective at producing immunomodulatory peptides than with streptococcus. At 0.125 mg/ml protein concentration digest of Lactobacillus casei strain Shirota ferment, deer milk showed significantly higher (P < 0.05) proliferation compared with Streptococcus salivarius subps thermophilus but was not significantly (P > 0.05) different from Lactobacillus delbrueckiisubsp bulgaricus ferments(Fig. 5.1a).Lactobacillus casei strain Shirota ferment of cow milk produced significantly higher lymphocyte proliferation than milk fermented with Streptococcus salivarius subsp thermophilus (P< 0.05)and Lactobacillus delbrueckiisubsp bulgaricus (P < 0.001). Table 5.1.ANOVA for percent change in lymphocyte proliferation for deer and cow unfermented and fermented (Lactobacillus delbrueckiisubsp bulgaricus, Streptococcus salivarius subspthermophilus, Lactobacillus casei strain Shirota) milk digests at three protein concentrations (0.125 mg/ml, 0.25 mg/ml and 0.5 mg/ml). Variable Species (deer vs cow) Unfermented vs fermented Protein concentration Species x fermentation Species x protein concentration Fermentation x protein concentration Species x fermentation x protein concentration d.f. 1 1 2 1 2 6 6 ms 3344.84 4789.65 4118.11 382 79.37 162.34 169.8 F pr < 0.001 < 0.001 < 0.001 0.034 0.389 0.076 0.063 Values are degrees of freedom (df), mean squares (ms), and significance (F pr) from variance analysis. (P < 0.05) significantly different There was a significant (P < 0.001) inverse effect of protein concentration on proliferation of lymphocytes (Table5.1). The highest proliferation was shown at the lowest protein concentration (0.125 mg/ml) and gradually decreased with increased protein concentration (Fig. 5.1 and 5.2) for all treatments as can be clearly seen in Figure 2 for deer and cow unfermented digests. This could be due to cytotoxic effect of milk proteins at high concentration (Phelan et al., 2009). The viability test confirmed there was a significant (P < 0.05) reduction in the viable cell percentage at the highest protein concentration after 72 hr of incubation. Phelan et al., (2009) reported exposure to increased concentrations of hydrolysed milk protein (0 – 50 %, v/v) resulted in a gradual decline in cell viability by affecting cell membrane integrity. 65 In the second trial the effect of protein concentration in presence and absence of Con A was considered for unfermented (Fig. 5.3) and Lactobacillus delbrueckiisubsp bulgaricus fermented digests (Fig. 5.4) on the proliferation of human PBMC. The proliferation activity with presence of Con A was initially increased with increased concentration of protein and reached a maximum between 60 - 120 µg/ml for all unfermented and fermented deer and cow digests. Then the proliferation decreased with increased protein concentration. Sizemore et al. (1991) studied the effects of cow milk-derived immunomodulatory bioactive peptides YG (Tyr-Gly) and YGG (Tyr-Gly-Gly) on Con A induced regulatory T cell activity on cell proliferation. They also observed a biphasic effect as YGG stimulated proliferation at low concentrations (10-13 – 10-14 mol/l) and inhibited proliferation at higher concentrations. Kayser and Meisel (1996) also studied the effect of YGG on human peripheral blood lymphocytes previously activated with Con A and estimated cell proliferation by BrdU incorporation. The maximum increase in lymphocyte proliferation induced by YGG was about 20-30% greater than of the control. In addition, the stimulatory effect of YGG on cell proliferation was abolished at higher peptide concentrations (10-4 - 10-5 mol/l). Laffineur et al. (1996) showed that unfermented and Lactobacillus helveticus 5089 fermented cow milk (at protein concentration of 2.5 to 2500 µg/ml) had higher proliferation response at lower protein concentration and this effect was decreased with the increase in protein concentration. Digested deer milk at 160 µg/ml protein concentration even without Con A (Fig.5.3.a), which is a proliferation stimulant, significantly (P < 0.05) enhanced lymphocyte proliferation. None of the protein concentrations of unfermented cow milk digest enhanced the lymphocyte proliferation without Con A (P > 0.05). As shown in figures 5.1, 5.2 and 5.3, the sensitivity of lymphocyte proliferation to protein concentration was significantly greater (P < 0.001) for cow milk than deer milk. When the protein concentration increased from 0.125 mg/ml to 0.5 mg/ml, cow milk digests (fermented and unfermented) showed a more rapid decline in proliferation than cells treated with deer milk digests. Milk digestions are mixtures of peptides which might have both immune stimulating and immunosuppressive properties (Gauthier et al., 2006). It could be suggested that cow milk digests might have more immunosuppressive peptides than deer milk digests. This may leads to have more immunosupresive peptides than immunostimulative peptides in cow milk digests when the protein concentration increases. Alternatively deer digest might have more immunostimulatory peptides than cow digest. So the net balance of peptides appears to be immunostimulatory in digested deer milk. 66 Deer peptides enhanced lymphocyte proliferation even without mitogen and thereby may show the same immunostimulating properties in vivo. Immunomodulatory peptides have potential application in the maintenance of immune health to protect against infections involving bacterial, viral and parasitic infections (Gauthier et al., 2006; Szwajkowska et al., 2011) and may suppress tumours (Matsuzaki, 1998; Xu et al., 2011). Therefore,it can be suggested that there is potential to use deer milk protein for immune health. Cell Viability A trypan blue viability test was carried out to determine whether the observed effects could be due to the protein samples being toxic to the cells. The results of this test are shown in Table5.2. Only deer and cow digests at 0.5 mg/mL and cow digest at 0.25 mg/ml appeared to decrease the number of viable lymphocytes after 72 hr of incubation (P < 0.05). This could be explained by the toxic effect of protein to cells at higher protein concentrations (Phelan et al., 2009). Jacquot et al. (2010) showed that hydrophobic peptides generated from trypsin and chymotrypsin digestion of milk proteins were toxic to murine splenocytes. On the other hand, there was no significant effect on the cell viability for any concentration of both deer and cow milk digests during the 48 hr incubation for proliferation or cytokine assays. Table 5.2. Proportion of viable cells compares to control sample after up to three days incubation with different protein concentrations. Control cells were incubated without milk protein samples. Protein concentration After 24 hr (mg/mL) incubation Deer digest Cow digest Control % Viable cells After 48 hr incubation After 72 hr incubation 0.125 0.250 0.500 92 ± 1 90 ± 2 90 ± 2 90 ± 2 88 ± 4 86 ± 2 88 ± 2 84 ± 1 82 ± 3* 0.125 0.250 0.500 91 ± 1 91 ± 2 91 ± 1 90 ± 5 89 ± 2 87 ± 1 85 ± 1 83 ± 1* 80 ± 1* 0 89 ± 1 90 ± 2 86 ± 1 *Significantly different compared to control (P < 0.05). Data are means± S.D. (n = 3) 67 Cytokine production To develop a better understanding of the immune response, cytokine production by human PBMC treated with milk proteins was investigated (Barth et al., 2000; Phelan et al., 2009). T helper -1 (Th1) cells produce IL-2 and IFNγ and TNF-α cytokines resulting in enhanced cellmediated or cytotoxic responses, whereas T helper -2 (Th2) cells produce IL-4, IL-6, IL-5 and IL-10 which generate a humoral or antibody-mediated immune response (Phelan et al., 2009). 80 IL-2 production (pg/ml) ٭٭ ٭٭ 60 ٭ ٭ 40 20 0 Control D C DL CL DS CS Dsh Csh Milk digests & ferment digests control 0.125 mg/ml 0.25 mg/ml 0.5 mg/ml Figure 5.5. Interleukin-2 (IL-2) production by human peripheral blood mononuclear cells (PBMC) at different protein concentrations of deer (D) and cow (C) milk digestions and fermented milk digestions; Lactobacillus delbrueckiisubsp bulgaricus digest of deer (DL) and cow (CL), Streptococcus salivarius subsp thermophilus digest of deer (DS) and cow (CS), Lactobacillus casei strain Shirota digest of deer (Dsh) and cow (Csh). PBMCs were stimulated by Con A. Control cells stimulated by Con A without addition of proteins. Detection limit 4 pg/ml. ٭Significantly different compared to control P < 0.05 ٭٭Significantly different compared to control P < 0.001 68 100 INF Production (pg/ml) ٭٭ ٭٭ 80 ٭٭ ٭ 60 ٭ 40 20 0 Control D C DL CL DS CS Dsh Csh Milk digests & ferment digests Control 0.125 mg/ml 0.25 mg/ml 0.5 mg/ml Figure 5.6. IFNγ production by human peripheral blood mononuclear cells (PBMC) at different protein concentration of deer (D) and cow (C) milk digest and fermented milk digests; Lactobacillus delbrueckiisubsp bulgaricus digest of deer (DL) and cow (CL), Streptococcus salivarius subsp thermophilus digest of deer (DS) and cow (CS), Lactobacillus casei strain Shirota digest of deer (Dsh) and cow (Csh). PBMC, were stimulated by Con A. Control cells stimulated by Con A without addition of proteins. Detection limit 4 pg/ml. ٭Significantly different compared to control P<0.05 ٭٭Significantly different compared to control P<0.001 Production of IL-2 by PBMC (105 cells/mL) supplemented with 10 µg/ml Con A and without milk digestion acted as a control and is shown in Figure 5.5. All deer milk digests at 0.125 mg/ml protein produce significantly (Figure 5.5.) higher IL-2 levels than control. At the same time IL-2 production was significantly higher (P < 0.001) with deer milk than cow milk and showed significantly higher (P < 0.001) production at lower protein concentration (0.125 69 mg/ml) than higher protein concentration (Fig. 5.5). Phelan et al., (2009) also reported that cow milk protein hydrolysates had generated a Th1 response by enhancing Con A-induced IL-2 production and Jacquot et al., (2010) showed three peptides from cow milk protein (β lactoglobulin and α lactalbumin) induced cytokine production (including IL-2 (9.9 pg/ml) and IFNγ (63.9 to 717.5 pg/ml) ) using murine splenocyte. At 0.125 mg/ml protein, digested ferments produced significantly higher (P < 0.05) IL-2 levels than unfermented milk digest for both deer and cow milk (Fig. 5.5). This is in accordance with results of Vinderola et al. (2007), which showed Lactobacillus helveticus R389 fermented cow milk regulated immune response by IL-2 production. Galdeano et al., (2011) observed that fermented cow milk increased the number of IL-2 producing cells in the small intestine of mice. Digests of deer milk fermented with Lactobacillusdelbrueckiisubsp bulgaricus,Lactobacillus casei strain Shirota (P < 0.001) and Streptococcus salivarius subsp thermophilus and unfermented milk digest produced significantly higher IL-2 levels than the control (P < 0.05). When comparing the three fermented digests of deer milk, Lactobacillus casei strain Shirota produced significantly higher (P < 0.001) IL-2 level than Streptococcus salivarius subsp thermophilus, but the IL-2 level was not different (P > 0.05) from ferments with Lactobacillusdelbrueckiisubsp bulgaricus. Cow milk fermented with Lactobacillus casei strain Shirota produced significantly higher IL-2 levels than Streptococcus salivarius subsp thermophilus (P < 0.001). These results showed the same pattern of high IL-2 production at 0.125 mg/ml protein concentration (Fig.5.5) correspondent with high lymphocyte proliferation at the same protein concentration (Fig. 5.1). This is further evidence to support the finding that lactobacillus strains were more effective than streptococcus for production of immunomodulating peptides as shown earlier by the lymphocyte proliferation results. In vivo study of Vinderola et al., (2007) showed mice fed with fermented milk produce more IL-2 cytokine by increasing IL-2 producing cell numbers. Deer milk digests produced significantly higher IFNγ in PBMC (P < 0.001) than cow milk digests and production was higher (P< 0.001) at 0.125 mg/ml protein concentration than the other two concentrations (Fig. 5.5). Similar to IL-2, deer digest (except Streptococcus salivarius subsp thermophilus ferment digest) produced significantly higher (P < 0.05) IFNγ levels compared to control. At low (0.125mg/ml) protein concentration unfermented deer milk digests significantly induced IL-2 and IFNγ production (P<0.05). This was further improved (P < 0.001) by fermentation with Lactobacillus delbrueckiisubsp bulgaricus and Lactobacillus casei strain Shirota prior to digestion (Fig. 5.4 and 5.5). Similarly Mao et al. (2007) reported that Yak 70 milk casein hydrolysate increased Con A induced IL-2 and IFNγ production in spleen cells. Our findings clearly indicate that digestion products (fermented or unfermented) act on the cytokine network, as illustrated by IFNγ and IL-2. Comparison of IFNγ and IL-2 production with the proliferation response of lymphocytes indicated evidence of parallelism. Cytokine production (Fig. 5.4 and 5.5) and proliferation response (Fig. 5.1) were maximal at 0.125 mg/mL protein concentration. There was no significant difference (P > 0.05) compared to control at higher concentration of proteins. Similarly using Con A stimulated human PBMC, Laffineur et al., (1996) reported Lactobacillus helveticus 5089 fermented cow milk to have the highest IFNγ and IL-2 productions at protein concentrations of 19 and 9 µg/ml, respectively, and the production of the cytokines was decreased with increasing protein concentration. IFNγ is a typical type 1 helper T cytokine, which enhances immune response. Matsuzaki, (1998) showed that Lactobacillus casei strain Shirota had a potent anti-tumour effect on transplanTable tumour cells by inducing production of several cytokines including IFNγ, resulting in the inhibition of tumour growth. IFNγ production has been considered as a key factor for anti-tumour activity of mushroom bioactives (Xu et al., 2011). Blattman et al., (2003) reported that the specific interaction of casein hydrolysates with IL-2 might prove useful in modulating dysregulated immune responses as well in the treatment of various immune processes such as chronic viral infections. Our finding suggests deer milk digests and digests of LAB fermentation can enhance Con A stimulated IL-2 and IFNγ secretion, which would potentially amplify a lymphocyte (T cell) mediated response and differentiate helper T cells into Th1 cells. Therefore, these immunomodulatory deer milk digests (unfermented and fermented) could serve as a potential immunotherapeutic agent by selectively increasing the pool of activated T lymphocytes. 5.4. Conclusion The findings from the present study suggest that deer milk digests exhibit immunomodulatory effects on human PBMC cultures and this effect was further improved by LAB fermentation prior to digestion. Immunoregulatory activities were measured as the stimulation of lymphocyte proliferation and the production of IL-2 and IFNγ cytokines. Fermentation with lactobacillus strains was more effective at producing immunomodulatory peptides than with streptococcus. To our knowledge, this is the first report of the immunomodulatory activity of unfermented and fermented deer milk digests although there are historical therapeutic uses of deer milk. 71 Deer milk is a good source for purification of bioactive peptides as it has twice the protein content of cow milk (Chapter 3, Opatha Vithana et al., 2012) and the immunomodulatory activity of deer milk digests were higher than cow digests at the same protein concentration. New Zealand has 1.2 million farmed deer which is half of world farmed deer population. Their current use is mainly for venison and velvet (DINZ, 2009). Therefore, there is a good potential for isolating immunomodulatory peptides from deer milk for pharmaceuticals or nutraceuticals. This area requires further in vitro and in vivo research to the durability and sustainability of peptides during digestion and their mechanisms of action. In future work deer milk digests will be fractionated to isolate specific immunomodulatory peptides. 72 Chapter 6 Comparative Study of Deer Milk with Three Other Mammalian Milks 6.1. Introduction The chemical composition of the milk of different species is designed by natural selection to provide the nutritional needs of the neonate of that species (Park, 2011). Within a given species, genetic factors and environment conditions such as climate, diet, number and stage of lactation influence the chemical composition (Blasi et al., 2008). Cow milk has been the major source of milk and dairy products in developed countries, especially in the Western world (Haenlein, 2001), although traditional consumption of milk from other mammals such as goat, sheep, reindeer, buffalo, camel and yak is common many parts of the world. Information on the milk of some of these species is not readily available, perhaps since the milk of these mammals is produced for human consumption only in certain regions of the world (Park, 2011). Milk is a good source of minerals, which are essential nutrients for human and animals (Osorio et al., 2007). These may be considered as two groups: the major elements (Ca, K, Mg and Na) and minor or trace elements (Fe, Cu, Mn and Zn) (Rincon et al., 1994). Milk protein mainly consists of caseins which include αs1-, αs2-, β- and κ-casein, and whey proteins which include β-lactoglobulin, α-lactalbumin, serum albumin, immunoglobulins, lactoferrin and lysozyme (Inglingstad et al., 2010). Milk proteins are natural vehicles for bioactive peptides (Yoav, 2010). There are many studies and reviews of cow milk bioactives (Minervini et al., 2003; Gobbetti, 2007; Korhonen, 2009 and Picariello et al., 2010) while only a few study milk from different species such as sheep and goat (Silva et al., 2006; Papadimitriou et al., 2007; HernandezLedesma et al., 2011). The aim of this chapter is to compare the composition of deer, cow, sheep and goat milk and the immunomodulatory activity of their milk proteins after in vitro digestion. 6.2. Material and Methods 6.2.1. Materials 73 Deer milk was obtained from the deer farm at Lincoln University (Canterbury, NZ). Fresh milk was collected from 6 red deer hinds with an age range from 6 to 11 years. All hinds were calved between 7/09/2010 to 26/09/2010. The samples were collected as per chapter 3.2.2. Fresh sheep milk samples from individual animals (n = 6) were a kind gift from Blue River Dairy (Southland, NZ). Fresh cow (n = 10) and goat (n = 6) milks were purchased from a local farm (Otago, NZ). A silicabased C-18 RP-HPLC column (250 mm length x 4.6 mm i.d., Microsorb MV C-18, particle size: 5 µm, pore size: 30 nm), was used for protein separation (Rainin Instruments, Woburn, MA). Acetonitrile (Fisher Scientific, Pittsburgh, PA) was of HPLC grade, and BisTris buffer, dithiothreitol (DTT), guanidine hydrochloride (GdnHCl), sodium citrate, trifluoroacetic acid (Sigma, St. Louis, MO) and cow milk protein standards were purchased from Sigma (St. Louis, MO). Tetramethylammonium Hydroxide (TMAH) 25% solution in water was purchased from Sigma-Aldrich, USA. All the milk samples obtained in this research are from mid-lactation (except analysis of minerals which used milk through lactation). Other materials are as listed in chapters 3.2.1 and 5.2.1. 6.2.2. Compositional Analysis Proximate analysis Protein content was measured by methods described in chapter 3.2.3. Milk fat, ash and lactose and moisture contents were determined according to standard procedures (AOAC, 2000) and expressed as % of the sample wet weight. Quantification of milk protein from Deer, Cow, Goat and Sheep Milk Milk proteins were identified using cow milk protein standards as described by Bobe et al. (1998). A solution containing 0.1 M Bis-Tris buffer (pH 6.8), 6 M GdnHCl, 5.37 mM sodium citrate, and 19.5 mM DTT (pH 7) was added directly to 500 µl milk in a 1:1 ratio (v:v) and incubated for 1 hr at room temperature, then centrifuged for 5 min at 16 000g in a microcentrifuge. The fat layer was removed with a spatula. The remaining solubilized sample was diluted 1:3 (v:v) with a solution containing 4.5 M GdnHCl and solvent A, which consisted of acetonitrile, water, and trifluoroacetic acid in a ratio 100:900:1 (v:v:v; pH 2). The concentration of milk protein in the final diluted solution was approximately 4 mg/ml. 74 The standard proteins were prepared as per the manufacturer’s instructions. Milk samples of 5-80 µl (usually 20 µl) and standard (20-100 µl) were chromotographed by Reversed-Phase HPLC (RP-HPLC). Standard curves were developed by measuring the peak areas of various known amounts of injected milk protein standards. The standard curves were used to calculate the amount of protein represented by peak areas from milk samples of unknown composition. Mineral analysis of Deer, Cow, Goat and Sheep Milk Mineral analysis was determined by Inductively Coupled Plasma Optical Emission Spectrophotometer (ICP-OES) as per Ribeiro et al. (2003). A 1 ml sample of milk was mixed with 1 ml of TMAH and heated for 800C before analysis by ICP-OES (model 720 ICP-OES, Varian Australia Pty Ltd, Australia). The sample, in an aerosol form, was introduced into high energy plasma that dissociates the sample into atoms and ions which emit electromagnetic radiation. The emitted light is spectrally resolved by diffractive optics, and the intensity of light is measured with a detector (Nolte, 2003). The instrument allows complete wavelength coverage from 167-785 nm with a resolution of 7 pm and all wavelengths are captured in one simultaneous reading. The concentration of a specific element in a sample is related to the intensity of lines in its optical spectrum. 6.2.3. Determination of Buffering Capacity (BC) of Deer, Cow, Goat and Sheep Milk Buffering capacity of milk samples were tested using the procedure of Park (1991). Initial pH values of all milk samples were determined. Aliquots (25 ml) of each sample were placed in 50 ml beakers and titrated slowly with 0.5N hydrochloric acid (HCl) by adding 1 ml each time with thorough stirring. The pH was measured after completion of each addition and BC was determined mathematically using the buffering capacity (intensity) formula given below (Ismail, et al., 1973; Park, 1991). dB = (ml acid added) (normality of acid) dpH (volume of milk) (pH change) BC values were plotted against pH (end pH) after each addition of HCl. 6.2.4. In vitro Digestion of Deer, Cow, Goat and Sheep Milk 75 In vitro protein digestion of milk was performed in two steps using Pepsin and CPP as described in chapter 3.2.5. 6.2.5. Sodium Dodecyl Sulphate Polyacrylamide Gel Electrophoresis (SDSPAGE) of Deer, Cow, Goat and Sheep Milk SDS-PAGE was performed for milk before and after digestion to monitor the digestion according to a standard protocol (Laemmli, 1970) using NuPAGE 4-12% Bis-Trisgels (Chapter 3.2.5.2). Bio-Rad Precision Plus Protein TM standard was used as a molecular weight marker. 6.2.6. Immunomodulatory Activityof in vitro Digested Deer, Cow, Goat and Sheep Milk 6.2.6.1. In vitroLymphocyte Proliferation Assay The effect of milk digests on in vitro lymphocyte proliferation was determined in triplicate using PBMC isolated from human blood by the method described in chapter 5.2.6. Three different protein concentrations (0.125, 0.25 and 0.5 mg/ml) were tested for each milk digest. Proliferation was expressed as percentage increase in fluorescence compared to the fluorescence of the control (no added protein). % Change in proliferation = Sample fluorescence reading – Control fluorescence reading x 100 Control fluorescence reading 6.2.6.2. Cytokine Production IL-2 and IFNγ production of PBMC treated with milk digests at three different protein concentrations (0.125, 0.25 and 0.5 mg/ml) were determined using ELISA as per chapter 5.2.4. 6.2.7. Statistical Analysis Data from proximate analysis and protein concentrations were analysed by Minitab 16 using one way ANOVA to test for species effect. Significant differences among the means were separated using Tukey’s test. 76 Mineral data from all the species were analysed by one way ANOVA followed by t-test. The deer mineral data for four different stages of lactation were analysed by canonical variates analysis (CVA) (Chope and Terry, 2008). In canonical variates analysis all measured variables (all minerals) were considered jointly to investigate differences between four milking times. Depending on the dimensionality required, the analysis calculates the linear composite (that separates different groups in one dimension) called canonical variates 1 and an orthogonal composite (that separate different group in another dimension) called canonical variates 2. The analysis generates the percentage of variation due to the linear and orthogonal components and latent vectors (called loadings) that indicate the contribution level of each variable to the linear and orthogonal components, thus the importance of each variable to the overall separation of different stages of lactation. Data for buffering capacity were fitted to a general linear model (GLM) using end pH as a covariate for linear and quadratic effects and species as a classificatory variable. Data for the biological activities were analysed using the REML routine and the significance of treatment terms and their interactions were determined by Wald statistical tests. In the REML analysis, species and protein concentration were set as fixed factors, whereas interaction between species and animals within the same species were set as random factors. All the sample analyses were performed in triplicates and statistical analyses were carried out using Genstat (GenStat Release 14.1, Lawes Agricultural Trust, VSN Int. Ltd., Rothamsted, U.K.). 6.3. Results Proximate analysis of Deer, Cow, Goat and Sheep Milk The chemical composition of deer milk compared with milk from cow, goat and sheep is shown in Table 6.1. Moisture, dry matter, protein, fat and ash content of deer milk were significantly different (P<0.05) from cow and goat milk, while there were no significant differences (P>0.05) between cow and goat milk for the above constituents. Deer milk had approximately twice the concentration of protein as cow milk. The major protein in deer milk was β casein and its content was significantly higher (P<0.05) than cow and goat milk β casein content but not significantly different (P>0.05) from sheep milk. κ-casein-like and αs1casein-like content of deer milk was significantly lower (P<0.05) than the other three species. 77 Of the whey proteins, deer milk had significantly lower (P<0.05) concentration of αlactalbumin-like than all the other species. Table 6.1. Mean of proximate composition for deer (n = 6), cow (n = 10), sheep (n = 6) and goat (n = 6) milks and concentration of milk proteins (mg/ml) of deer, cow, sheep and goat milks (n = 6 each). Values are reported as means± standard deviation. Proximate composition Species Moisture (%) Deer 79.4 ± 1.5b Cow 86.9 ± 0.6 Dry matter (%) 20.6 ± 1.5a Protein (%) Sheep Goat b 79.6 ± 0.8 87.4 ± 1.2a 13.1 ± 0.6b 20.4 ± 0.8a 12.6 ± 1.2b 7.3 ± 0.4a 3.7 ± 0.3b 6.3 ± 0.7a 3.9 ± 0.3b Fat (%) 8.1 ± 1.7a 4.7 ± 0.4b 8.1 ± 0.2a 3.8 ± 1.2b Lactose (%) 3.9 ± 0.3b 3.9 ± 0.2b 5.0 ± 0.4a 4.1 ± 0.2a Ash (%) 1.2 ± 0.1a 0.7 ± 0.1b 0.9 ± 0.1b 0.9 ± 0.1b a Protein profile κ-casein 4.99 ± 0.61c 9.76 ± 0.61b 12.23 ± 0.08a 9.4 ± 0.10b c b αs2-casein 0.76 ± 0.05 2.56 ± 1.16 13.3 ± 0.07a 0.74 ± 1.15bc αs1-casein 6.92 ± 0.22c 21.24 ± 0.34a 11.9 ± 1.06b 17.35 ± 2.95ab β-casein 15.11 ± 0.15d 36.64 ± 0.81a 26.29 ± 1.13c 32.87±1.01b c α-Lactalbumin 2.13 ± 0.01 2.99 ± 0.30b 4.02 ± 0.41a 3.49 ± 0.52ab 8.95 ± 0.91b β-Lactoglobulin A 10.58 ± 0.05a 9.57 ± 0.37a 8.58 ± 0.09b 0.83 ± 0.05b β-Lactoglobulin B 1.15 ± 0.06b 2.53 ± 0.19a Not delected β-Lactoglobulin C Not detected 0.60 ± 0.06 Not detected Not detected Mix (Ig~s + Serum c b 7.68 ± 0.20 13.55 ± 0.24 29.10 ± 0.78a 2.63 + 0.23d albumin) Lactoferrin 2.60 ± 0.60a 2.33 ± 0.54a 1.94 ± 0.32ab 1.38 ± 0.37b b Lysozyme Not detected 9.76 ± 0.61 0.11 ± 0.03b 1.24 ± 0.05a a-d Values within each row with different superscripts are significantly different (P < 0.05). Mineral composition of Deer, Cow, Goat and Sheep Milk Mineral composition of deer, cow, sheep and goat milks is shown in Table 6.2. The concentrations of Ca, P and S which are major elements and Zn which is a trace or minor element were significantly higher (P < 0.05) in deer milk than any of the other three milk types. Deer milk had significantly higher (P < 0.05) Mg level than cow and goat milk but less (P < 0.05) than sheep milk. There were no significant differences (P < 0.05) in Fe content among deer, cow and goat milk, while sheep milk had a significantly higher (P < 0.05) Fe content than milk from the other three species. Goat milk had significantly higher (P < 0.05) K, Mn and Cu levels than deer, cow and sheep milk. 78 Table 6.2. Major and minor mineral contents of deer (n=6) of four milking, cow (n=10), sheep (n=6) and goat (n=5) milk. Values are reported means± standard deviation. Elements Deer (µg/ml) Ca P K Na Mg S Fe Mn As Cr Cu Mo Se Zn Al Pb 2958 ± 101 a 2219 ± 102 b 1148 ± 79 271.6b ± 13 182.7b ± 11 602.3a ± 23 1.23b ± 0.31 0.15b ± 0.023 0.62 ± 0.020 a 0.04 ± 0.003 b 0.11 ± 0.015 0 1.11a ± 0.02 12.09a ± 0.78 6.14b ± 0.28 0.04± 0.03 a Cow (µg/ml) c 1601 ± 180 c 1209 ± 104 b 1187 ± 85 391.6a ±45 139c ± 20 354.9c ± 34 1.36b ± 0.71 0.11b ± 0.029 0.60 ± 0.070 b 0.02 ± 0.003 b 0.11 ± 0.04 0.03a ± 0.01 1.00b ± 0.07 6.27c ± 0.65 6.65b ± 0.74 0.06 ± 0.04 Sheep (µg/ml) b 2427 ± 140 b 1966 ± 86 b 1009 ± 49 366.6a ± 14 229.3a ± 12 533.8b ± 27 2.09a ± 0.14 0.19b ± 0.011 0.62 ± 0.06 a 0.04 ± 0.003 b 0.14 ± 0.01 0 1.10a,b ± 0.14 8.39b ± 0.32 8.02a ± 0.37 0.08 ± 0.10 Goat (µg/ml) c 1459 ± 206 c 1343 ± 115 a 1626 ± 227 277.8b ± 18 156.8b,c ± 22 349.5c ± 31 1.58a,b ± 0.23 0.54a ± 0.244 0.60 ± 0.02 b 0.03 ± 0.002 a 0.22 ± 0.14 0 1.04a,b ± 0.11 5.32c ± 0.65 6.64b ± 0.46 0.12 ± 0.02 Recovery (%) Limits of detection 98.6 103 105 97 108.1 1.62 0.02 0.14 2.21 0.28 0.19 0.003 0.0003 0.015 0.0002 0.003 0.0006 0.031 0.023 0.246 0.005 105.6 108.2 100 104.8 104.9 106.8 90 106.1 103.6 110 Co, Ni and Cd were not detected in any of the milk Mo was detected in only one sample of sheep milk and other samples and deer and goat milk were below quantification limit. a-c Values within each row with different superscripts are significantly different (P < 0.05). 79 Table 6.3. Mineral composition (µg/ml) of red deer milk (n=6) early, middle and late lactation. Values are reported as means± standard deviation. Elements Ca Time 1 (µg/ml) 3100 ± 636 Time 2 (µg/ml) 2955 ± 1056 Time 3 (µg/ml) 2942 ± 338 Time 4 (µg/ml) 2833 ± 396 Recovery (%) 98.6 Limits of detection(µg/ml) 1.62 P 2370 ± 389 2182 ± 771 2176 ± 168 2146 ± 273 103 0.02 K 1205 ± 201 1202 ± 424 1150 ± 80 1036 ± 141 105 0.14 Na 289.4 ± 33 272.6 ± 100 258.6 ± 20 266.0 ± 32 97 2.21 Mg 191.8 ± 30 192.4 ± 69 175.7 ± 20 170.9 ± 23 108.1 0.28 S 621.9 ± 109 577.0 ± 194 587.7 ± 41 622.7 ± 85 a ab ± 0.29 ab 1.06 ± 0.17 - 0.19 b 0.921 ± 0.24 105.6 0.003 Fe 1.64 ± 0.66 1.32 Mn 0.176 ± 0.10 0.16 ± 0.04 0.12 ± 0.03 0.13 ± 0.06 108.2 0.0003 As 0.64 ± 0.08 0.64 ± 0.23 0.60 ± 0.06 0.61 ± 0.11 100 0.015 Cr 0.05 ± 0.01 0.04 ± 0.01 0.05 ± 0.01 0.04 ± 0.01 104.8 0.0002 Cu 0.14 ± 0.05 0.11 ± 0.04 0.11 ± 0.03 0.10 ± 0.03 104.9 0.003 Se 1.13 ± 0.07 1.10 ± 0.43 1.08 ± 0.08 1.13 ± 0.10 90 0.031 Zn 13.24 ± 2.09 11.58 ± 3.93 11.64 ± 1.26 11.91 ± 2.09 106.1 0.023 Al 6.47 ± 0.71 6.26 ± 2.27 6.00 ± 0.20 5.83 ± 0.47 103.6 0.246 Pb 0.06 ± 0.01 0.03 ± 0.09 0.01± 0.01 0.07 ± 0.03 110 0.005 Mo, Co, Ni and Cd not detected Time 1: 17/12/2010 Time 2: 07/01/2011 a-b Time 3: 21/01/2011 Time 4: 10/02/2011 Values within each row with different superscripts are significantly different (P < 0.05). 80 The changes in mineral composition of red deer milk across lactation were studied using four collection times and the results are shown in Table 6.3. Only Feshowed significant changes (P < 0.05) during lactation. There was a steady decline in Fe content with the first date tested (17/12/2010) being significantly higher (P<0.05) than that at the end of lactation (10/02/2011). Canonical variate analysis is a powerful statistical technique that considers the measured variables (the concentrations of 15 minerals) jointly to separate milking (stage 1-4) into groups and illustrate the overall differences in mineral composition among the four groups (Fig. 6.1). Canonical variate 1 reflects the linear component of the analysis and it can be seen that it contributes to the majority of segregation between stage (time) of lactation. Canonical variate 2 is the orthogonal component that had much more limited contribution to separating the lactation times (Table 6.4.). Contributions of each mineral to the differentiate lactations are shown by loading values (Table 6.4.). K, Mg, Al and Fe seem to be the major contributors in differentiating (P<0.05) the milking times based on canonical variate 1. Figure 6.1. Canonical analysis for 15 minerals at four milking times/stages (time 1: 17/10/2010, time 2: 07/01/2011, time 3: 21/01/2011, time 4: 10/02/2011)of 6 red deer hinds. 81 Table 6.4. Canonical variate analysis for the red deer minerals Elements Percentage variation Ca K Mg Na Al Fe Mn P S As Cr Cu Pb Se Zn Variate 1 79.7 0.205 0.409 0.377 0.359 0.506 0.64 0.307 0.287 0.01 0.198 -0.111 0.341 0.034 0.047 0.286 Variate 2 16.94 -0.044 0.24 0.159 -0.193 0.017 -0.083 -0.077 -0.195 -0.347 0.052 -0.417 -0.136 -0.342 -0.245 -0.367 The linear component of the analysis is represented by variate 1 and orthogonal component of the analysis is represented by variate 2. The value in the Table represented the contribution of variate 1 and variate 2 in the separation of the different minerals (percentage variation). The coefficient of mineral content contributes to separation (loadings). The loadings are treated as vector, which mean that they indicate a direction and have the same weight regardless of the +/- sign. Buffering Capacity (BC) of Deer, Cow, Goat and Sheep Milk Initial pHs of deer, cow, goat and sheep milks were 6.51, 6.56, 6.75 and 6.6 respectively. The buffering capacity and end pH among the four milks upon titration with 0.05 N HCl are presented in figure 6.2. Deer milk had significantly greater (P<0.05) BC than any of the other three milks. BC of sheep milk was significantly higher (P<0.05) than that of cow and goat milk. At the beginning of titration, buffering index was increased with the decrease of end pH for all four milk types. Then it reached a plateau at around pH 4 for cow,goat and sheep milk. Deer milk buffering index continued to increase even after the addition of 5 ml 0.5 N HCl. 82 Buffering Index ( dB/dpH) 0.12 Deer Cow Goat Sheep Deer (fit) Cow (fit) Goat (fit) Sheep (fit) 0.10 0.08 0.06 0.04 0.02 2 3 4 5 6 7 End pH Figure 6.2. Buffering index (buffering capacity) of cow (n=6), sheep (n=2) and goat (n=5) milks compared with deer milk (n=6). SDS-PAGE of Deer, Cow, Goat and Sheep Milk Milk from four different species was digested in vitro and the intact proteins remaining in the digested milk samples were analysed by SDS-PAGE (Figure 6.3). The results revealed that the casein of all four milks was well digested, while β-lg was still intact. The intensity of β-lg bands of deer and cow milk digests were less than those of sheep and goat milk digests. 83 MW: 250 kDa 150 100 75 IgHC LF SA 50 37 25 20 15 CN β-lg α-la 10 M D C S G Dd Cd Sd Gd Figure 6.3. SDS- PAGE (4-12%) of Deer, Cow, Sheep and Goat milk before and after digestion with pepsin and CPP. Major bands; immunoglobulins heavy chain (IgHC), lactoferrin (LF), serum albumin (SA), casein (CN), β-lactoglobulin (β-lg) and α-lactalbumin (α-la). Standard molecular weight markers are shown on left-hand side of the gel. The lanes: Molecular weight marker (M), Deer (D), Cow (C), Sheep (S), Goat (G) milk and in vitro digestion of Deer (Dd), Cow(Cd), Sheep(Sd), Goat(Gd) milk.Each contained had 2 mg/ µl protein. Immunomodulatory Activityof In vitro Digested Deer, Cow, Goat and Sheep Milk Lymphocyte proliferation Lymphocyte proliferation was significantly different (P<0.05) between species (Table 6.5). Positive values show increased proliferation while negative values demonstrate decrease of proliferation compared with the positive control. Lymphocyte proliferation was significantly higher at 0.125 mg/ml protein concentration for deer (P<0.001), cow and sheep (P<0.01) than the control (Fig. 6.4). At the same protein concentration (0.125 mg/ml) deer milk digest showed significantly higher lymphocyte proliferation compared to cow, sheep (P<0.01) and goat (P<0.001) milk digestswhile there were no significant differences (P>0.05) among cow, sheep and goat milk digests. Table 6.5. ANOVA for % change in lymphocyte proliferation. Fixed term Species Protein Concentration Species. Protein Concentration Wald statistic 10.66 60.13 11.62 n.d.f. 3 2 6 F statistic 3.55 30.07 1.94 d.d.f. 19.0 176.0 176.0 F pr 0.034 >0.001 0.077 84 Lymphocyte proliferation was significantly different (P<0.001) at different protein concentrations (Table 6.5). Proliferation decreased with increasing concentration of protein for all four species (Fig. 6.4). ٭ ٭ ٭ ٭٭ Figure 6.4.Percentage change of lymphocyte proliferation at a) 0.125mg/ml, b) 0.25mg/ml and c) 0.5mg/ml protein concentration for deer, cow, sheep and goat milk digests.Data are means± S.D. (n = 6 for deer, cow, sheep and n = 5 for goat). ٭Significantly different from control P<0.01 ٭٭Significantly different from control P<0.001 Cytokineproduction IL-2 production (Fig. 6.5) was affected by the type of milk digest from different species (P<0.001) and the protein concentration (P<0.001). Digested deer milk produced significantly higher IL-2 levels than cow, and goat milk at 0.125 mg/ml protein concentration (P<0.05). At this protein concentration all milk types showed significantly higher (P<0.001) IL-2 levels than the control. IL2 production was reduced with increased protein concentration. IL-2 production was significantly lower than control (P<0.001) at 0.5 mg/ml protein concentration, except for lymphocytes treated with sheep milk digests. IFNγ production (Fig. 6.6) by PBMC was significantly different when treated with milk digests from different species and at different protein concentrations (P < 0.001). All samples produced significantly higher (P < 0.001) IFNγ levels than control. PBMC incubated with deer milk at 0.125 mg/ml protein concentration produced significantly higher (P < 0.001) IFNγ levels than those treated similarly with cow and sheep milks, while there was no significant difference with goat milk (P > 0.05) treatment. 85 ٭٭ ٭٭ ٭٭ ٭ ٭ ٭ ٭٭ ٭٭ ٭ ٭ Figure 6.5. Interleukin-2 (IL-2) production by Con A stimulated human peripheral blood mononuclear cells (PBMCs). Production of IL-2 by PBMCs with different protein concentrations of deer, cow, sheep (n=6) and goat (n=5) milk in vitro digestion. Control represents cells stimulated by Con A without addition of proteins. Values are the means± S. D. Detection limit 4 pg/ml. ٭Significantly different from control P<0.01 ٭٭Significantly different from control P<0.001 ٭٭ ٭٭ ٭٭ ٭٭ ٭٭ ٭٭ ٭٭٭٭ ٭٭ ٭٭٭٭ ٭٭ Figure 6.6. IFNγ production by Con A stimulated human peripheral blood mononuclear cells (PBMCs). Production of IFNγ by PBMCs with different protein concentrations of deer, cow, sheep (n=6) and goat (n=5) milk in vitro digestion. Control represents cells stimulated by Con A without addition of proteins. Detection limit 4 pg/ml. ٭٭All samples are significantly different compared to control (P<0.001). 86 6.4. Discussion Compositional Analysis Milk composition varies according to several factors, such as animal, feed and environment (Mackle et al., 1999). The 20% dry matter content of deer milk was significantly higher (P<0.05) than cow and goat milks. Thus deer milk has the highest dry matter content among these four milks. Protein & fat which are constituents of milk dry matter and ash, were all significantly higher (P<0.05) in deer milk than cow and goat milk. The results for proximate analysis (protein, fat, ash and lactose) of cow, goat and sheep milks in this study were in accordance with literature (RaynalLjutovac et al., 2008; Ceballos et al., 2009; End et al., 2009). Deer milk had about two times the protein content of cow milk and these results are consistent with our previous results (Chapter 3, Opatha Vithana et al., 2010). Similarly deer milk protein of 7.3% in this study is consistent with Arman et al., (1974) which showed 7.39% protein in red deer milk using six hinds. There was no significant difference (P<0.05) in lactose content among deer, cow and goat milks. Deer milk had 3.9% lactose in this study versus 5% in sheep milk. It has been reported that sheep milk contains 4.88% lactose (Raynal-Ljutovac et al., 2008). Milk proteins were identified and quantified by HPLC using cow milk protein standards to get a general idea of different milk proteins in milk from each species. The β casein-like content of deer milk was significantly higher (P>0.05) than cow and goat milk and not significantly different (P>0.05) from sheep milk. Cow milk protein is one of the most common food allergen in children.Cow milk contains more than 20 proteins (allergens) that can cause allergic reactions (ElAgamy, 2007). Casein and β-lg are the main allergens in cow milk (Natale et al., 2004) and of the caseins, α-s1 is the major allergen (Cocco et al., 2003). Jarvinen et al., (2002) found that five IgEbinding epitopes (2 on αs1-casein, 1 on αs2-casein, and 2 on κ-casein) were recognized in patients with persistent allergy. Goat milk is less allergenic than cow milk and β-casein is the major fraction in goat casein, which is similar to human casein, while αs1-casein is the major fraction of cow casein (El-Agamy, 2007). The present results showed that the major casein in deer milk is β casein and that it is low in αs1-casein, which suggests that deer milk might be less allergenic than cow milk. Further studies should be done to investigate the potential use of deer milk proteins as an alternative for cow milk for allerginic patients. In milk, the casein exists as large colloidal particles, 50-600 nm in diameter called “casein micelles” that are composed of four main caseins: αs1-casein, αs2-casein, β-casein and κ-casein (Semo et al., 87 2006). Many of the technologically important properties of milk, e.g. its white colour, stability to heat or ethanol, and coagulation by rennet are due to the properties of the casein micelles (Fox &Brodkord, 2008). The milk of different species is more or less white due to light scattering for which the micelles are mainly responsible (Fox &Brodkord, 2008). Therefore our observation of different colour intensity of different species milk (visual observation) might be due to the differences of casein micelles based on their compositions. Deer milk was whiter than the milk from the other three species. κ-casein-likeprotein content of deer milk was significantly lower (P>0.05) than the other three species. The size of casein micelle is inversely related to their κ-casein content (Inglingstad et al., 2010). This suggests that deer milk may form bigger casein micelles than other species. Most importantly the micelles are coagulated in the stomach of the neonate by chymosin, a proteinase designed for this function, and coagulation delays the entry of milk into the small intestine, thereby improving digestibility (Fox &Brodkord, 2008). Inglingstad et al., (2010) studied the comparative in vitro digestion of cow, goat, horse and human milk proteins and found that horse milk casein had very rapid gastric digestion compared to the other species. They concluded that lower content of κcasein and larger size of casein micelles in horse milk than other species (cow, goat and human) may be the reason for the high susceptibility to hydrolysis by gastric enzymes. This suggests deer milk which showed low content of κ-casein may form bigger casein micelles than other species and ultimately show higher casein digestibility than other species. This requires further research to be confirmed. β-lactoglobulin-like protein, the major whey protein content of deer milk was not significantly different (P<0.05) to cow milk, when β-lactoglobulin standard of cow milk was used (HPLC), and also SDS-PAGE results (Fig 6.3.) β-lactoglobulin band of deer milk can be clearly visualized. McDougall and Stewart, (1975) studied red deer whey proteins by chromatographic separation (Sephadex G-75 column) using cow milk markers and was able to detect a component which eluted similarly to cow β-lactoglobulin. Their results also indicate the concentration of β-lactoglobulin changes with lactation time. Although there are similarities of red deer and cow milk βlactoglobulin, McDougall and Stewart, (1975) reported that differences in the amino acid composition of β-lactoglobulin were found. Deer β-lactoglobulin contained one more residual of aspartic acid, alanine and methionine and one less glutamic acid and two less leucine residues than cow β-lactoglobulin. Another difference was deer β-lactoglobulin A and B genetic variation were more acidic than those of the corresponding cow β-lactoglobulin. 88 Deer milk had the lowest level of α-lactalbumin-like compared to the other three species. βlactoglobulin and α-lactalbumin are the major whey protein allergens (El-Ghaish et al., 2011; Wal, 1998). Therefore allergenicity caused by whey proteins might be less for deer milk than other milk types, but this will need to be confirmed in future work. In this study the mineral composition of deer milk was compared with three other milk types which are more commonly consumed. The Ca, P and S content of deer milk were higher than cow, goat and sheep milk. Minerals play an essential role in human health and wellbeing. It is well known that milk and dairy products are good dietary source of Ca and P (Birghila et al., 2008; Ceballos et al., 2009). There was 2958 µg/ml Ca in deer milk while cow milk had only 1601 µg/ml. These findings are in agreement with Arman et al. (1974) who showed 2200 - 2500 µg/g Ca content in deer milk and Ceballos et al., (2009) who showed 1135.8 µg/g Ca content in cow milk. Sheep milk had second highest Ca content which was 2427 µg/ml. Similar to our findings, Rincon et al., (1994) reported sheep milk has significantly (P<0.05) higher Ca level (2056 µg/g) than cow or goat milk. Mineral results of cow, goat and sheep were in agreement with studies done by Rincon et al. (1994), Wendorff (2006), Birghila et al. (2008), Raynal-Ljutovac et al. (2008) and Haenlein and Ceballos et al. (2009). At the same time, red deer milk mineral results of this study generally did not vary from those of Arman et al. (1974). Zn was significantly (P<0.05) higher in deer milk than other milk types. Zinc is the trace element in milk that is present in the largest concentration and found in the milk fat globule. Zn is generally considered being a stabilizing agent of biological membranes (Linden et al., 2004). Wiking and Sehested, (2008) reported that the transfer of fat from diet to milk might facilitate transfer of Zn from diet to milk. This might be the reason that the highest fat containing deer milk has highest Zn content and was followed by sheep milk which has second highest Zn and fat contents amongthe four studied milk types. Sheep milk had significantly higher (P<0.05) Mg and Fe contents than any other species of milk in this study and this was in agreement with Rincon et al. (1994) who showed that sheep milk has more Mg and Fe contents than cow or goat milk. The level of Mg in red deer milk was consistent with that reported by Arman et al. (1974) and slightly higher than the results reported by Vergan et al., (2003). Goat milk had higher K level than deer, cow and sheep milks. Goat milk is reported to be distinguished by its high K and Cl contents (Raynal-Ljutovac et al., 2008). Although mineral composition of milk may be affected by the nutrition of the animals, there are certain aspects that are characteristic for each species which enable the mineral composition of the milk to be used to identify the species (Rincon et al., 1994; Ceballos et al., 2009). 89 Changes in mineral composition of deer milk during four milking times were studied. Fe concentration declined during lactation while all other mineral showed no significant differences (P>0.05) over the four milking times. Fe content at first milking was significantly higher (P>0.05) than last milking. Feely et al., (1983) showed similar results in human milk where Fe content was significantly higher (P<0.05) in early lactation and decreased with lactation time. There was no consistent pattern according to which stage of lactation had highest and lowest concentration of each element (Table 6.3). However since ANOVA is a unvariable analysis which allows comparisons to be made between milking based on a single variate, it does not give an insight into how the milking times are grouped or which is the most important element in defining group. Canonical variates analysis allows these type of conclusions to be drown, and has previously been used in discrimination between ultrafiltered milk permeates (Hansen et al., 2010), to differentiate onion cultivars by mineral content (Chope &Terry, 2009) and jointly separated New Zealand fish products using five colour parameters (Bekhit et al., 2009). Canonical variates results differentiate the four milking times considering all the minerals as a whole (Fig. 6.3). Among all the minerals K, Mg, Al and Fe seem to be major contributors in differentiating (P<0.05) milking times based on canonical varitae 1 (Table 6.4). Buffering Capacity of Deer, Cow, Goat and Sheep Milk The buffering capacity (BC) of milk is an important physico-chemical characteristic that corresponds to the ability of the milk product to be acidified or alkalinized. This value depends on several compositional factors such as inorganic phosphate, citrate, organic acids, salts and milk proteins (Salaun et al., 2005). BC results of this study showed that deer milk had significantly higher (P<0.001) BC than that of the milk from the other three species. BC of sheep milk was significantly higher (P<0.05) than that of cow and goat milks.There was no significant difference (P>0.05) between cow and goat milk BC. Cow and goat milk reached maximum BC between 5.5 – 4.0 pH after addition of 3 ml HCl while sheep milk showed maximum BC after addition of 4 ml HCl (Fig. 6.2.). Deer milk BC was still increasing even after addition of 5 ml HCl (Fig. 6.2.). The BC of caseins and whey proteins are maximal at about pH 5.0 –5.5 and pH 3-4, respectively (Salaun et al., 2005). High protein and mineral contents in deer milk could be the reason for the higher buffering capacity than other milks. Cations (Ca+2, Mg+2) can modify the acid-base equilibrium of anions and hence their pKas (negative logarithm of acid dissociation constant) (Salaun et al., 2005). Deer milk had high P, Ca, Mg and protein levels which may explain its higherBC. Park (1992) showed that goat milk has higher BC than cow milk and his results supported the idea that goat 90 milk can be utilized in treatment of gastric ulcers. In this experiments deer milk had significantly higher (P<0.05) BC than cow, goat and sheep milks (Fig.6.2). Therefore deer milk might be a better source for treatment of gastric ulcers. The high BC may be one reason for the historical use of deer milk to cure digestive disorders (Park &Haenlein, 2006). In vitro Digestion SDS-PAGE showed that casein of all four species was digested completely after in vitro digestion designed to mimic human digestion in the stomach and intestine (Fig. 6.3). These results were consistent with the in vitro digestion study of Inglingstad et al. (2010) on cow, goat, horse and human milks and Almaas et al. (2006) on cow and goat milks. β-lg of all milk types was not completely digested during the in vitro digestion. The intensity of the β-lg band after in vitro digestion was lower in deer and cow milk than sheep and goat milk, which suggests β-lg digestibility of deer and cow milk was greater than for sheep and goat β-lg. Inglingstad et al., (2010) reported that cow β-lg was very resistant to in vitro digestion by human gastric and duodenal enzymes while horse milk β-lg showed better digestibility than cow and goat milk β-lg. Opatha Vithana et al., (2012) (Chapter 3) reported there was 54% and 55% intact β-lg after in vitro digestion of deer and cow milks, respectively. In vitro Lymphocyte Proliferation All tested milks which had been digested in vitro increased the human lymphocyte proliferation (positive value) except sheep milk digest at 0.5 mg/ml protein concentration. At 0.125 mg/ml protein concentration lymphocyte proliferation of deer (P<0.001), cow and sheep milks were significantly higher (P < 0.01) than the control, while goat milk did not show any significant difference of proliferation (Fig. 6.4). Cross and Gill (2000) results revealed both suppressive and stimulating effects on in vitro lymphocyte proliferation, by whole cow casein, α-, β-, κ-casein (and their derivatives), whole whey protein and lactoferrin. There is sufficient evidence to show digested cow milk casein and whey proteins stimulate the lymphocyte proliferation (Cross &Gill, 2000; Silva &Malcata, 2004; Gauither et al., 2006; Korhonen, 2009). The proliferation stimulation activity may be caused either by whole protein or a specific fraction of protein. Wong et al. (1996) showed that cow β-casein significantly enhanced the mitogen-induced proliferation of ovine T and B lymphocytes. Mercier et al. (2004) showed that in vitro proliferation of murine spleen 91 lymphocytes is stimulated by micro filtered cow whey protein isolates (hydrolysed and unhydrolysed). The immunomodulating potential of peptide fractions isolated from cow β-lg enzymatic hydrolyzates has also been demonstrated (Prioult et al., 2004). Likewise, peptides corresponding to cow β-lg fragments f(15–20), f(55–60), f(84–91), f(92–105), f(139–148), and f(142–148) have been reported to stimulate murine splenocytes proliferation through the modulation of cytokine secretion (Jacquote et al., 2010). This can suggest immunostimulation property shown by deer milk digestions in this study may not limited to one protein but majority of effect may be due to β-casein, since it is the most abundant protein in deer milk. There was a significant difference (P<0.05) among milks from the four different species in terms of lymphocyte proliferation (Table 6.4). At 0.125mg/ml protein concentration deer milk digest showed significantly higher lymphocyte proliferation compared to cow, sheep (P<0.01) and goat (P<0.001) milks while there are no significant differences (P>0.05) among cow, sheep and goat milk (Fig. 6.4.). While there is sufficient evidence to show cow milk digest stimulate the lymphocyte proliferation as shown before, very little work has compared the activity to milk from other species. This is the first reported study on lymphocyte proliferation of deer milk. A few studies have reported the release of immunostimulating peptides from sheep and goat milk proteins (HernandezLedesma et al., 2011). Peptic hydrolyzates of sheep α-la and β-lg has been demonstrated by ElZahar et al. (2004) to inhibit the growth of Escherichia coli HB101, Bacillus subtilis Cip5262 and Staphylococcus aureus 9973 in a dose dependent manner, but the peptides responsible for this activity were not identified. Also Haza et al. (1995) reported immunological characterization of goat casein by an indirect ELISA procedure. The results presented in this chapter confirm those reported in chapter 5 which showed higher lymphocyte proliferation of deer digests than cow digests. Goat milk digestion stimulated the least lymphocyte proliferation. This could be due to low level of immunstimulating peptides or more immunosuppressive peptides in goat milk digests than digests of other species since milk protein hydrolysatesare a mixture of immunostimulating and immunosuppressive peptides.Both inhibition and stimulation of the immune system could be useful (Cross and Gill, 2000; Gauthier et al., 2006). Suppressive effect of lymphocyte proliferation might be of great importance when ensuring a state of tolerance toward non-self-substances such as food molecules entering the body (Eriksen et al., 2008). By enhancing the proliferation of immune cells, the body may be defended more quickly from infection (Meisel and Bockelmann, 1999; Gauthier et al., 2006; Szwajkowska et al., 2011) and suppress tumour growth (Matsuzaki, 1998; Xu et al., 2011). Different milk protein derived immunomodulating peptides somehow exhibit a regulatory effect on each other to avoid an 92 unfavourable activation or suppression of the neonatal immune system (Cross and Gill, 2000). Both immunostimulating and immunosuppressive peptides of cow α1-casein have been observed (Gill et al., 2000). On the other hand, goat milk (which has α1-casein as main protein) is considered to be less allergenic than cow milk (Eriksen et al., 2008). Results of this study show goat milk protein did not stimulate (P>0.05) human PBMC at any tested concentrations and exhibited significantly lower (P<0.001) lymphocyte proliferation at 0.125 mg/ml protein concentration than the other three species (Fig. 6.3). This could be due to low allergenic protein in goat milk compare to other species. Further studies should be carried out to explore the mechanisms that regulate these effects. Protein concentration had a significant (P<0.001) effect on proliferation (Table 6.3). At the lowest protein concentration (0.125 mg/ml) all milk protein samples showed higher proliferation than at 0.25 mg/ml and 0.5 mg/ml protein concentration (Fig. 6.4). The results in chapter 5 showed concentration effect on deer and cow milk digest (10 – 360 µg/ml protein) and showed lymphocyte proliferation increased with increasing protein concentration at first phase and then started to decrease with the increase in protein concentration. Similar to that all milk digests from four species showed higher proliferation at lower concentration (0.125 mg/ml) and the proliferation activity decreased with the increase in protein concentration. This may due to toxic effect of protein to cells at high concentrations (Phelan et al., 2009). Similar results of lymphocyte proliferation effect with different concentration was shown by Sizemore et al. (1991), and Kayser and Meisel (1996) using immunomodulatory di- and tri-peptides. Jacquote et al. (2010) studied seven immunomodulatory peptides, namely β-lg f15–20 VAGTWY, f55–60 EILLQK, f84–91 IDALNENK, f92–105 VLVLDTDYKKYLLF, f139–148 ALKALPMHIR, f142–148 ALPMHIR and α-la f10–16 RELKDLK, and found they stimulated cell proliferation to varying degrees depending on their concentration. Some peptides showed decreased lymphocyte proliferation (murine splenocyte) with increased peptide concentration (10 – 2000 µg/ml) as in the current study. Sheep milk protein at 0.5 mg/ml showed inhibition of Con A stimulation of PBMC (Fig. 6.4) which could be due to a toxic effect. Cytokine Production The present study demonstrated potential immunomodulatory effects of peptides (encrypted in the milk protein) from milk of four species. Cytokines are involved in the regulation of many biological systems, including the immune system (Friberg et al., 1994). IL-2, IFNγ and TNF-α are T helper-1 (Th1) related cytokines and IL-4, IL-6, IL-5 and IL-10 are T helper -2 (Th2) related cytokines (Phelan et al., 2009; Jacquote et al., 2010). At low protein concentration (0.125mg/ml) deer milk 93 peptides treated PBMCs produced significantly higher IL-2 level than cow and goat peptides (P<0.05). Similarly IFNγ levels were significantly higher for deer milk digest than other milk digestions except for lymphocytes treated with goat milk digest which showed no significant difference to deer milk digest at same protein concentration. Jacquote et al., (2010) showed that cow peptide (β-lg fragment 139–148) exhibited high lymphocyte proliferation of Con A stimulated murine splenocyte and also showed significantly higher (P<0.01) IFNγ secretion (63.9 to 717.5 pg / ml) compared to control. The authors reported another immunomodulatory peptide (β-lg fragments 55–60) with higher lymphocyte proliferation and IL-2 production compared to control. The present study showed deer milk digests at 0.125 mg/ml protein concentration exhibit higher lymphocyte proliferation and higher IL-2 and IFNγ production compared to control. Cytokine expression is a complex mechanism and several cytokines could be responsible for the proliferation response and it could be by increased or decreased level of cytokines (Laffineur et al., 1996). Laffineur et al. (1996) showed the stimulation of proliferation was modulated by more cytokines other than IL-2 and IFNγ. Cytokines such as IFNα or IL-12 can stimulate IFNγ production by natural killer (NK) cells and lymphocytes (Chan et al., 1991). In general IL-2 induces proliferation and differentiation of T and B cells (Belardelli and Ferrantini, 2002). But in this study at high protein concentration (0.5 mg/ml) sheep milk digest with less proliferation than the control value exhibited better production of IL-2, which is unusual compared to other results. IL-2 stimulates the growth of NK cells and enhances the cytolytic function of these cells, producing lymphokine-activated killer cells (Belardelli &Ferrantini, 2002). Therefore it may suggest that there might be a cytotoxic effect of sheep digest at the higher concentration and result incell death. In accordance with our results,a similar effect was shown by Laffineur et al.(1996) for cow β casein fermented by lactic acid bacteria. There are cow milk derived immunomodulatory peptides which stimulate lymphocyte proliferations and at the same time reduce the secretion of IL-4 and IL-2 cytokines (Jacquote et al., 2010). PBMC of children with cow milk protein allergy produce significantly higher IL-10 (P<0.001) and significantly lower TNFα (P<0.05) levels with goat milk protein than cow milk proteins. Although there are many cytokines responsible for immunomodulation, in this study the digested deer milk significantly increased the production of IL-2 and IFNγ by human PBMC. The specific interaction of cow casein hydrolysates with IL-2 might prove useful in modulating in vivo immune response and treatment of chronic viral infections (Blattman et al., 2003). Therefore, there might be a potential for use of deer milk casein to treat chronic viral infection as well. Further investigation should be carried out to see in vivo immune responses on deer milk. Cow milk proteins can cause 94 immunological problems for human, such as allergy (El-Agamy, 2007). Mechanism of allergic reactions to milk protein fall into two categories which are IgE mediated allergy and non IgE mediated allergy (Crittenden &Bennett, 2005). A pathway of IgE regulation is essentially based on reciprocal activities of IL-4 and IFNγ (Ebner et al., 1997). In this study deer milk protein at 0.125mg/ml induced lymphocytes to produced significantly (P<0.001) higher IFNγ levels than cow milk which contain more than 20 allergen proteins (EL-Agamy, 2007) and was not significantly different (P>0.05) from goat which is less allergenic than cow milk (Alvarez and Lombardero, 2002; Muraro et al., 2002). Human T cells produced more IFNγ after immunotherapy with bee venom for grass pollen allergy (Jutel et al., 1995). This can suggest high level of IFNγ could exhibit less allergenic reactions and thereby deer milk might be a good alternative for cow milk allergicsubjects. But further in vivo studies with animal models should be carried out before coming to any conclusion. 6.5. Conclusions The results of this study revealed that red deer milk is a good source of protein, fat and minerals (especially Ca, P, Zn and Se) compared with cow, sheep and goat milk. The higher buffering capacity of deer milk than that of milk from the other three species suggests deer milk may be useful to treat patient with gastric ulcers. Deer milk proteins were digested well during simulated stomach and duodenum digestion and these hydrolysed products (peptides) exhibited greater immunostimulating properties compared to cow, sheep and goat milks in terms of proliferation and IL-2 and IFNγ cytokines production by Con A stimulated human PBMC in vitro. 95 Chapter 7 Fractionation of Immunomodulatory Bioactive Peptides of deer and Cow Milk Ferments and Digests 7.1. Introduction One of the primary functions of milk is to protect the health of new born mammal (Korhonen &Pihlanto, 2006; Szwajkowska et al., 2011). Bioactive peptides including immunomodulatory peptides are encrypted in milk proteins and can be released by food processing or gastrointestinal digestion (LeBlanc et al., 2002). Thus the ingestion of milk and its subsequent digestion releases bioactive peptides from the milk proteins throughout the course of digestion. A spectrum of opportunities has been created by the formation of bioactive peptides through lactic fermentation (Szwajkowska et al., 2011). The immunomodulatory action of peptides is related to the stimulation of proliferation of human lymphocytes and phagocytic activity of macrophages (Clare et al., 2003). Generally, three strategies are used to identify and characterize biologically active peptides: (i) isolation from in vitro enzymatic digestion of precursor protein; (ii) isolation from in vivo gastrointestinal digestion of precursor protein; (iii) chemically synthesised peptides which have a structure identical to that of those known to be biologically active (Meisel, 2001; Minervini et al., 2003). Fast protein liquid chromatography (FPLC), a technique developed for the purification of protein in their native state, has become an increasingly useful tool in the dairy sector and reversed phase chromatography is used for peptide separation (Gonzalez-Llano et al., 1990). Jolles et al., (1981) were the first to report that extracts of trypsin hydrolysed human milk possess immunostimulating activity. In particular, the hexapetide Val-Glu-Pro-Ile-Pro-Tyr, corresponding to f54-59 of human milk β casein, was isolated from its tryptic hydrolysate (Parker et al., 1984). Several other immunomodulatory peptides were later isolated, namely f63-68 and f191-193 from cow milk β casein and f194-199 from cow milk αs1 casein (Parker et al., 1984; Migliore-Samour & Jolles, 1988) and others from cow whey proteins (Prioult et al., 2004; Gauthier et al., 2006). Most of the studies isolating bioactive peptides have used cow milk protein as a precursor (Gobbetti et al., 2002), and only a few have used milk from different species such as goat and sheep (Minervini et al., 2003; Silva et al., 2006; Papadimitriou et al., 2007; Hernandez-Ledesma et al., 2011). Chapter 5 showed whole deer milk was more immunostimulatory (increased human lymphocyte 96 proliferation and IL-2 and IFNγ production) than cow milk after in vitro digestion. LAB fermentation of deer and cow milk prior to in vitro digestion further improved the immunostimulating activity. The goal of this study was to fractionate deer and cow milk in vitro digestions (unfermented and fermented) by FPLC and test their immunomodulatory activity by Con A stimulated human PBMC proliferation. Then the most active immunostimulating and immunosuppressive fractions were selected for further studies by human lymphocyte proliferation and IL-2 and IFNγ production after adjusting the protein concentration to 0.125 mg/ml. Finally one immunostimulating fraction was tested for lymphocyte proliferation at different protein concentrations with and without Con A stimulation. 7.2. Material and Methods 7.2.1. Materials Deer and cow skimmed milk digestions were prepared as described in chapter 3.2.5 and digestions of Lactobacillusdelbrueckiisubsp bulgaricus,Streptococcus salivarius subsp thermophilus and Lactobacillus casei strain Shirota fermented deer and cow milks were as described in chapter 4.2.3 (three independent unfermented and fermented digests from each). ResourceTM RPC 1 ml (ResourceTM reverse phase column, GE Healthcare, Sweden) was purchased from GE Healthcare Bio-Science AB, Sweden. Trifluoroacetic acid (TFA) and acetonitrile were purchased from Sigma (St. Louis, MO, USA). BCA protein assay (bicinchoninic acid assay) kit was from ThermoScience, USA. 7.2.2. Fractionation of Peptides by FPLC Peptides were separated from deer and cow milk (unfermented and fermented) in vitro digests by reverse phase FPLC (RP-FPLC) (Biorad) as per Minervini et al. (2003). The absorbance of the eluate was monitored with a UV detector operating at 280 nm and also the absorbance of fractions was measured at 220 nm using a FLUOstar Omega (BMG LABTECH) plate reader. Aliquots (500 µl) of the digests were diluted 1: 4 with 0.05 % (vol/vol) TFA (buffer A) and centrifuged at 12,000 xg for 10 min, and 1 ml of the supernatant was loaded into the column. Elution was carried at a flow rate of 1 ml/min with a gradient of acetonitrile (5 to 100 %) in 0.05 % 97 TFA (buffer B). The concentration of acetonitrile was increased linearly from 5 to 46 % between 16 and 62 ml and from 46 to 100 % between 62 and 72 ml. A total of 51 fractions (2 ml each) were collected and were assayed for immunoactivity using the lymphocyte proliferation assay. Then selected active fractions were freeze dried and protein concentrations were adjusted to 0.125 µg/ml by dissolving in water. A lymphocyte proliferation assay was carried out and the cytokine production was measured with human PBMC. 7.2.3. In vitro Lymphocyte Proliferation Assay PBMCs were isolated from human blood and in vitro lymphocyte proliferation assay was carried out as in chapter 5.2.3 for FPLC fractions. Proliferation of each fraction was expressed as percentage increase of fluorescence compared to the fluorescence of the control (no added proteins). % Change in proliferation = Sample fluorescence reading – Control fluorescence reading x 100 Control fluorescence reading 7.2.4. Cytokine Production IL-2 and IFNγ production by PBMC after 24 hr incubation with selected FPLC fractions were measuredas described in section 5.2.5. 7.2.5. BCA Protein Assay Protein concentration in each sample was determined using Bicinchoninic Acid reagent (Pierce, Rockford, Il., USA) according to manufactures instructions. 10 µl samples were assayed in triplicate and compared to a standard curve generated using dilutions of 2 mg/ml albumin Standard (Pierce, Rockford, Illinois, USA), to provide concentrations ranging from 0.0625 mg/ml to 1 mg/ml. Samples were diluted before BCA assay where necessary. 7.2. 6. Statistical Analysis Data are the means and standard deviations of three independent experiments in triplicate. The data were subjected to factorial analysis of variance (factors were deer and cow, unfermented and fermented and different protein concentrations), followed by t-test to determine the significant difference between means using GenStat 14.1. The level of statistical significance was taken as P < 0.05. 98 7.3. Results Prior to fractionation by RP-FPLC, unfermented and LAB fermented deer milk in vitro digests showed significantly higher lymphocyte proliferation and cytokine production compared to cow unfermented and fermented digest (chapter 5). Deer and cow digestions (unfermented and fermented) were separated using Reverse Phase-FPLC based on their hydrophobicity. The absorbance at 220 nm of the fractions is shown in Fig. 7.1. The absorbance profiles from deer milk digests were different to the corresponding cow digests peaks. The Con A stimulated lymphocyte proliferation caused by fractions of unfermented and fermented (three species of LAB) deer and cow milk digests is also shown in Fig. 7.1. Positive values indicated an increase in proliferation compared to controls, while negative values indicated decreased proliferation. Deer milk digests had more immunostimulating fractions than cow digests. All digests contained fractions with a considerable lymphocyte proliferation activity, which did not necessarily correspond to large absorbance peak area. Three fractions with the highest lymphocyte proliferation for most digests (11, 22 and 30) and three fractions which showed suppressive lymphocyte proliferation (13, 24 and 36) were selected for further studies. The protein concentrations of these fractions were adjusted to 0.125 mg/ml. Immunostimulating fractions The proliferation response of human PBMC (ConA stimulated) for positive fractions 11, 22 and 30 for unfermented and fermented deer and cow digests is shown in Fig 7.2. All three peptide fractions from all the digests (unfermented and fermented) significantly stimulated (P < 0.001) lymphocyte proliferation compared to the control. There was significantly higher (P < 0.001) lymphocyte proliferation for all three fractions from unfermented deer milk than unfermented cow milk (Fig. 7.2 A, B, C). Fractions 11 and 30 of Lactobacillus casei strain Shirota ferment digests (Fig. 7.2 A and C), and fraction 11 of Streptococcus salivarius subsp thermophilus ferment digests (Fig. 7.2 A) exhibited significantly higher (P < 0.05) lymphocyte proliferation for deer than cow. However no fractions from the Lactobacillus delbrueckiisubsp bulgaricus ferment digests showed significant differences (P > 0.05) between deer and cow. 99 3.5 40 3.0 30 2.5 20 2.0 10 1.5 0 1.0 -10 40 3 20 2 0 1 -20 0 0.5 -20 -30 0.0 10 20 30 40 50 -40 60 0 10 FPLC Fractions 20 30 40 50 60 FPLC Fractions Absorbance (220 nm) % change in proliferation Absorbance (220 nm) % change in proliferation (C) (D) 3.5 40 3.5 40 2.0 1.5 0 1.0 0.5 -20 Absorbance (220 nm) 2.5 20 % change in proloferation 3.0 3.0 2.5 20 2.0 1.5 0 1.0 0.5 -20 0.0 0 10 20 30 FPLC Fractions Absorbance (220 nm) % change in proliferation 40 50 60 Absorbance (220 nm) 0 % change in proliferation Absorbance (220 nm) 50 Absorbance ( 220 nm) (B) % change in proliferation % change in proliferation (A) 0.0 0 10 20 30 40 50 60 FPLC Fractions Absorbance (220 nm) % change in proliferation 100 (F) (E) 3.5 3.5 40 40 2.0 0 1.5 -20 1.0 Absorbance (220 nm) 2.5 % change in proliferation 2.5 2.0 0 1.5 -20 1.0 -40 -40 0.5 0.5 -60 -60 0.0 0 10 20 30 40 50 0.0 0 60 10 20 30 40 50 60 FPLC Fractions FPLC Fractions Absorbance (220 nm) % change in proliferation Absorbance (220 nm) % change in proliferation (G) (H) 3.5 3.5 40 2.5 20 2.0 1.5 0 1.0 0.5 -20 Absorbance (220 nm) 3.0 % change in proliferation % change in proliferation 40 3.0 2.5 20 2.0 1.5 0 1.0 0.5 -20 0.0 0 10 20 30 FPLC Fractions Absorbance (220 nm) % change in proliferation 40 50 60 Absorbance (220 nm) % change in proliferation 20 20 Absorbance (220 nm) 3.0 3.0 0.0 0 10 20 30 40 50 60 FPLC Fractions Absorbance (220nm) % change in proliferation Figure 7.1. RP-FPLC chromatograms of the unfermented and fermented deer and cow milk after in vitro digest.Deer milk digests (A); cow milk digests (B); digests of Lactobacillus delbrueckiisubsp bulgaricus ferment of deer (C) and cow (D); digests of Streptococcus salivarius subsp thermophilus ferment deer (E) and cow (F); digests of Lactobacillus casei strain Shirota ferment of deer (G) and cow (H). The dashed line refers to the % change of lymphocyte proliferation compared to positive control. Data are means of individual samples measured in triplicates, SD not shown for clarity of graph. 101 Fermentation with Lactobacillusdelbrueckiisubsp bulgaricus had no significant effect (P>0.05) on lymphocyte proliferation for any of the three fractions (11, 22 and 30) of either deer and cow, while fermentation with the other two strains significantly lowered (P<0.05) lymphocyte proliferation by deer and cow digests except for Streptococcus salivarius subsp thermophilus deer fractions11 and 30 and cow 22 and Lactobacillus casei strain Shirota deer fraction 11 (Fig. 7.2.). There was no significant difference (P>0.05) between fractions (11, 22 and 30) in terms of proliferation. (A) (B) 60 60 ٭ ٭٭ ٭ 50 % change in proliferation % change in proliferation 50 ٭٭ 40 30 20 10 40 30 20 10 0 0 Milk digest Ldb digests Sst digests LcS digests Deer Cow Milk digest Ldb digests Sst digests LcS digests Deer Cow (C) 60 ٭ % change in proliferation 50 ٭ 40 30 20 10 0 Milk digest Ldb digests Sst digests LcS digests Deer Cow Figure 7.2. Percentage (%) change in lymphocyte proliferation in 10 µg/ml Con A stimulated human PBMC (compared to positive control) of FPLC fraction 11 (A), 22 (B) and 30 (C) of unfermented and fermented deer ( ) and cow ( ) milk in vitro digests at 0.125mg/ml protein concentration . Fractions from deer and cow milk digests and digests of Lactobacillus delbrueckiisubsp bulgaricus (Ldb), Streptococcus salivarius subsp thermophilus (Sst)and Lactobacillus casei strain Shirota (Lcs) ferment. Data are means± S.D. (n = 3). Samples measured in triplicates. ٭Deer significantly different than cow P<0.05 ٭٭Deer significantly different than cow P<0.001 102 The cytokine production by human PBMC, a metabolic event that preceded cell proliferation (Hopkins, 2003) was investigated to determine the mechanism of the immunomodulatory activity of the selected peptide fractions. All three selected fractions (11, 22 and 30) from all digests (unfermented and fermented) which showed high proliferation, exhibited significantly higher (P<0.01) IL-2 production by human PBMC compared to the control (Fig. 7.3). At the same time all three fractions (11, 22 and 30) from both deer and cow produced significantly higher (P<0.05) IFNγ level when incubated with human PBMC except for fraction 22 of cow unfermented digest, Lactobacillus delbrueckiisubsp bulgaricus and Streptococcus salivarius subsp thermophilus digests and fraction 30 of unfermented cow digest (Fig. 7.4). As shown in figure 7.3, human PBMC with fraction 11 of unfermented deer digest produced significantly higher (P<0.01) IL-2 level than with the same fraction of cow digest. Similarly IFNγ production by human PBMC was significantly higher (P<0.05) with all three (11, 22 and 30) deer fractions (except for fraction 11 of Streptococcus salivarius subsp thermophilus and fraction22 of Lactobacillus casei strain Shirota) than with same fractions from cow digests (Fig. 7.4). There was no significant difference (P>0.05) between fractions (11, 22 and 30) in terms of IL-2 production while fractions 11 and 30 showed significantly higher (P<0.001) IFNγ production than fraction 22. 103 (B) (A) 120 120 ٭ 100 IL2 production (pg/ml) IL2 production (pg/ml) 100 80 60 40 20 80 60 40 20 0 0 Control Milk digest Ldb digests Sst digests LcS digests Control Milk digest Ldb digests Sst digests LcS digests Control Deer Cow Control Deer Cow (C) 120 IL2 production (pg/ml) 100 80 60 40 20 0 Control Milk digest Ldb digests Sst digests LcS digests Control Deer Cow Figure 7.3. Interleukin-2 (IL-2) production by human peripheral blood mononuclear cells (PBMC) stimulated by Con A treated with FPLC fraction (after 24 hr) 11 (A), 22 (B) and 30 (C) of unfermented and fermented deer ( ) and cow ( ) milk in vitro digests (0.125mg/ml protein). Fractions from deer and cow milk digests and digests of Lactobacillus delbrueckiisubsp bulgaricus (Ldb), Streptococcus salivarius subsp thermophilus (Sst)and Lactobacillus casei strain Shirota (Lcs) ferment. Control cells were stimulated by Con A without the addition of proteins. Data are means ± S.D. (n = 3). Samples measured in triplicates. Detection limit 4 pg/ml. ٭Deer significantly different than cow P<0.01 104 (A) (B) 160 160 *٭ ٭ 120 ٭ 100 80 140 INF production (pg/ml) INF production (pg/ml) 140 ٭ 60 120 100 ٭٭ ٭ 60 40 40 20 20 0 ٭ 80 0 Control Milk digest Ldb digests Sst digests LcS digests Control Deer Cow Control Milk digest Ldb digests Sst digests LcS digests Control Deer Cow (C) 160 ٭٭ INF production (pg/ml) 140 120 ٭٭ 100 ٭ ٭ 80 60 40 20 0 Control Milk digest Ldb digests Sst digests LcS digests Control Deer Cow Figure 7.4. IFNγ production by human peripheral blood mononuclear cells (PBMC) stimulated by Con A treated with FPLC fraction (after 24 hr) 11 (A), 22 (B) and 30 (C) of unfermented and fermented deer ( ) and cow ( ) milk in vitro digests (0.125mg/ml protein).Fractions from deer and cow milk digests and digests of Lactobacillus delbrueckiisubsp bulgaricus (Ldb), Streptococcus salivarius subsp thermophilus (Sst)and Lactobacillus casei strain Shirota (Lcs) ferment. Control cells were stimulated by Con A without the addition of proteins. Data are means ± S.D. (n = 3). Samples measured in triplicates. Detection limit 4 pg/ml. ٭Deer significantly different than cow P<0.05 ٭٭Deer significantly different than cow P<0.001 Another experiment was carried out using fraction 30 of unfermented deer digest to investigate the proliferation behaviour of human PBMC with and without Con A and to test a wider range of immunostimulating peptide concentrations (10 to 640 µg/ml). The same experiment was carried out with whole deer digests in chapter 5. Fraction 30 was selected for further study because there were 105 no significant differences (P>0.05) between tested immunostimulating fractions of deer digests (11, 22 and 30) on lymphocyte proliferation, and it had more protein (peptide) than the other two fractions (Fig. 7.1). The proliferation response of human PBMC with different concentrations of peptides with and without Con A stimulation is shown in Figure 7.5. All peptide concentrations with or without Con A, stimulation significantly induced (P<0.05) lymphocyte proliferation. In the absence of Con A there was no significant difference (P>0.05) between different peptide concentrations. When the cells were stimulated with ConA the proliferation was higher at 20 to 80 µg/ml protein concentration range than at other concentrations. 100 a % increase in proliferation 80 a ab bc cd 60 de e 40 20 0 0 100 200 300 400 500 600 700 Protein (µg/ml) With con A Without Con A Figure 7.5. % change of lymphocyte proliferation with ConA ( )and without ConA( ) for different protein concentrations of deer milk digests FPLC fraction 30. Data are means± S.D. (n = 3). Different letters within each curve are significantly different (P < 0.05). 106 Immunosuppressing fractions Although deer and cow milk digests (unfermented and fermented) as a whole exhibited immunostimulating properties (Chapter 5), there were some immunosuppressing fractions (Fig. 7.1). Three fractions (13, 24 and 36) which suppressed proliferation in common for all deer and cow digests (fermented and unfermented) were further studied after adjusting the protein (peptides) concentration to 0.125 mg/ml. Table 7.1 summarises the statistical results from the lymphocyte proliferation. There was no overall significant difference (P>0.05) between deer and cow milk but they behaved differently (interaction) in different fractions (P<0.001). In fraction 13 all cow digests gave lower lymphocyte proliferation than corresponding deer fractions, while fraction 36 was higher for deer. At the same time there was no significant difference (P>0.05) for human PBMC proliferation by fermented digests compared to unfermented digests. There were significant differences (P<0.001) between fractions with fraction 24 inhibiting proliferation significantly more (P<0.001) than fraction 13 and 36. Table 7.1. ANOVA analysis for % change of lymphocyte proliferation (compared to positive control) for FPLC fractions 13, 24 and 36 of unfermented and fermented deer and cow milk digests at 0.125 mg/ml protein concentration. Source of variance d.f. s.s m.s. F Sig. Animals (deer and cow) 1 74.8 74.8 0.55 0.46 Unfermented Vs Fermented Fractions (13, 24, 36) 1 2 107.5 9176.9 107.5 4588.5 0.79 33.6 0.376 <0.001 Animal. Unfermented Vs Fermented Animal. Fractions 1 2 23.6 20523.8 23.6 10261.9 0.17 75.14 0.678 <0.001 Fractions 13, 24 and 36 of both deer and cow digests (both unfermented and fermented) produced significantly less (P<0.05) IL-2 with human PBMC compared to the control. Fraction 24 results are shown in figure 7.6 (A). There was no significant difference (P>0.05) between deer and cow in terms of IL-2 production for fraction 24 and it is same for the other fractions too (Appendix C). Similarly there was no significant difference (P>0.05) between deer and cow in fraction 24 for IFNγ production by human PBMC (Fig 7.6 (B). In these negative proliferation fractions (13, 24 and 36) IL-2 and IFNγ production by human PBMC were less than control for both deer and cow digests (Fig. 7.6) while positive proliferation fractions (11, 22 and 30) produce higher IL-2 and IFNγ than control (Fig. 7.3 & 7.4). 107 (B) (A) 80 50 INF production (pg/ml) IL2 production (pg/ml) 40 30 20 60 40 20 10 0 0 Control Milk digest Ldb digests Sst digests LcS digests Control Ldb digests Sst digests LcS digests Protein 0.125 mg/ml Protein 0.125 mg/ml control deer cow Milk digest control deer cow Figure 7.6. IL-2 (A) and IFNγ (B) production by human peripheral blood mononuclear cells (PBMC) stimulated by Con A with FPLC fraction 24 of unfermented and fermented deer ( ) and cow ( ) milk in vitro digests (0.125mg/ml protein). Fractions from deer and cow milk digests and digests of Lactobacillus delbrueckiisubsp bulgaricus (Ldb), Streptococcus salivarius subsp thermophilus (Sst)and Lactobacilluscasei strain Shirota (Lcs) ferment. Control cells were stimulated by Con A without the addition of proteins. Data are means ± S.D. (n = 3). Samples measured in triplicates. Detection limit 4 pg/ml. 108 7.4. Discussion After in vitro digestion unfermented and fermented deer milk showed more immunomodulatory activity than cow milk (Chapter 5). These digests are a mixture of peptides originating from the different milk proteins. In order to investigate this further, these digests were separated into fractions.The fractions with the greatest immunomodulating effects were identified. As a general rule, the immunomodulatory effects of individual milk components become more clearly defined as they are progressively purified from the primary milk protein (Cross & Gill, 2000). RP-FPLC was used in this study to generate fifty one peptide fractions for each sample. Fast protein liquid chromatography (FPLC), a technique developed for the purification of protein and peptides in their native state, has become an increasingly useful tool in the dairy sector (Gonzalez-Liano et al., 1990). Absorbance detections were done at 280 nm (Appendix D) and 220 nm (Fig. 7.1.). Separation was not clearly seen from 280 nm absorbance readings as this depends on the content of tyrosine, tryptophan (aromatic ring) and cysteine (disulphide bond) (Pace et al., 1995). Amarowicz and Shahidi et al. (1997) reported that protein absorbance reading at 220 nm measured the peptide bond and therefore 220 nm reading was used in this study. At 280 nm absorbance reading one fraction had very high reading while other had very low readings. High branched-chain amino acid to aromatic amino acid ratio (Fischer’s ratio) is important to get good absorbance reading at 280 nm (Pederoche et al., 2004). The 280 nm measurement suggests that most of the fractions have peptides with less aromatic ring containing amino acids which could be due to smaller peptides (few amino acids) than big peptide chains (where the chance of having aromatic ring is high). As shown in figure 7.1 some high absorbance (peak) fractions did not produce big proliferation differences (stimulating or inhibiting), while some fractions exhibited the highest proliferation changes but showed very low absorbance readings (no big peak). This suggests some peptides present in small quantities contribute to the activity and may have very high immunomodulating activities. The lymphocyte proliferation activities of each fraction were shown in figure 7.1 for all digests. Some fractions stimulated lymphocyte proliferation while others inhibited proliferation activities. Fractions with a considerable lymphocyte proliferation activity did not necessarily correspond to peaks with higher absorbance (220 nm). Similarly Minervini et al. (2003) reported large peaks of RP-FPLC fractions of hydrolysed casein from six species (cow, goat, sheep, buffalo, pig and 109 human) did not necessarily have high ACE inhibitory activity, while fractions with small quantities of peptides had high ACE inhibitory activity. LeBlanc et al. (2002) showed an HPLC fraction with lower protein exhibited higher immunomodulating effect than two fractions which had very high protein content (as shown by high absorbance at 214 nm). There were more fractions exhibiting lymphocyte proliferation activity in deer than cow milk, while cow milk digests had more lymphocyte inhibitory fractions than deer milk digests (Fig. 7.1.). Immunostimulating fractions All three selected fractions (proliferation stimulating) from deer and cow milk digests (unfermented and fermented) showed significant (P<0.001) lymphocyte proliferation (Fig. 7.2.) of Con A stimulated human PBMC in vitro. Tested immunostimulating unfermented and fermented deer digests fractions showed significantly higher lymphocyte proliferation than cow digests (unfermented and fermented). There is now a substantial body of evidence to suggest cow milk hydrolysates as a whole (Laffineur et al., 1996; Vinderola et al., 2006; Eriksen et al., 2008; Phelan et al., 2009), as well as purified individual constituents (Berthou et al., 1987; Zucht et al., 1995; Kayser & Meisel, 1996) or fractions (Cross and Gill, 2000; LeBlance et al., 2004; Prioult et al., 2004), can regulate immune function. Otani et al. (1995) demonstrated different FPLC fractions of in vitro digests of cow κ-caseinoglycopeptide possess different immunomodulatory capabilities. Yun et al. (1996) isolated a sub fraction from cow κ-caseinoglycopeptide by size-exclusion chromatography which promotes proliferation of murine spleen cells. Therefore findings of cow digests immunostimulating fractions in this study are in accordance with the above studies. To our knowledge, this study is the first to fractionate the deer milk digests (unfermented and fermented) and investigate the lymphocyte proliferation activity on human PBMC. There was a significant difference of proliferation (P<0.05) between unfermented and Streptococcus salivarius subspthermophilusand Lactobacillus casei strain Shirota fermented digests of all three fractions (except Streptococcus salivarius subspthermophilusdeer fractions 11 and 30 and cow 22 and Lactobacillus casei strain Shirota deer fractions 11) for both deer and cow (Fig. 7.2.) Although ferment digests showed higher Con A stimulated lymphocyte proliferation than unfermented digests (chapter 5) as a whole, some purified fermented fractions showed lower lymphocyte proliferation than the same fraction of unfermented digests. This could be due to formation of different peptides after fermentation. There is evidence that immunomodulatory activity was different in purified fractions compared to original milk products (Otani et al., 1993; Wong et al., 1997;Cross &Gill, 1999). 110 One immunostimulating fraction (fraction 30) of deer (unfermented) was selected to investigate its proliferation response with and without Con A. RP-FPLC fraction 30 of unfermented deer digests showed stimulation of human PBMC with or without Con A (Fig.7.6). Con A is a mitogen that induces cell proliferation (Moller et al., 1986; Boilard et al., 2001; Zhang et al., 2002). A similar study by Saint-Sauveur et al. (2008) using fractions isolated (RP-HPLC) from cow whey digests showed enhanced proliferation of both Con A stimulated and un stimulated splenocytes. Proliferation was significantly higher (P<0.05) at 20 – 80 µg/ml protein concentration than other concentrations for Con A stimulated PBMC, while there were no proliferation difference (P>0.05) observed between different protein concentrations for PBMC without Con A stimulation. Since our present results showed that fraction (30) stimulates human PBMC in vitro even without Con A.This may be due to peptides (or a peptide) present in this fraction which are responsible for cell proliferation. Therefore we can suggest the same immunostimuating effect may be exhibitedin vivoin the absence of mitogen. Stimulation of cytokine production on human PBMC was detected using the ELISA method (Burrells et al., 1999; Phelan et al., 2009) as a second measure of immunomodulatory activity. Both IL-2 and IFNγ productions by Con A stimulated human PBMC were increased together with all three fractions of deer and cow digests (unfermented and fermented). Cytokines are involved in the regulation of many biological systems including the immune system (Friberg et al., 1994). Cytokine IL-2 and IFNγ are produced by T helper-1 (Th1) cells and are responsible for enhancing cell mediated or cytotoxic immune response (together with cytokine TNFα which is produced by Th1) (Phelan et al., 2009). This suggests increased level of IL-2 and IFNγ cytokine produced by PBMC with peptide fractions, may be due to changes in immune response. Already there are some studies showing cow milk has peptides which modulate immune response via cytokine regulation (Laffineur et al., 1996; LeBlance et al., 2004; Prioult et al., 2004; Vinderola et al., 2006). Prioult et al. (2004) reported an acidic peptide fraction of cow β lactoglobulin exhibited increased lymphocyte proliferation and increased IFNγ production in mouse splenocytes. When comparing the IL-2 cytokine production there was no difference observed between unfermented and LAB fermented milk digests (for both deer and cow) (Fig. 7.3.). But there were some differences for IFNγ production as shown in Fig. 7.4. Deer milk fermented with Lactobacillusdelbrueckiisubsp bulgaricus (except fraction 30)and Lactobacillus casei strain Shirota ferment digests fractions showed significantly greater (P<0.05) IFNγ production than unfermented fractions (Fig. 7.4). Similarly all cow LAB ferment fractions showed significantly greater (P<0.05) 111 IFNγ production than the corresponding unfermented fractions (except fraction 22 of Lactobacillusdelbrueckiisubsp bulgaricus and Streptococcus salivarius subsp thermophilus). Consistent with our findings Laffineure et al. (1996) reported LAB fermentation of cow milk significantly improved the IFNγ productionwhile no significant improvement can be observed in IL-2 levels. The stimulation of proliferation response (Fig. 7.2) of fractions has been associated with significantly higher level of IL-2 (Fig. 7.3), the major growth factor activated lymphocyte (Morgan et al., 1976; Laffineur et al., 1996; Ceyhan et al., 2004) and IFNγ (Laffineur et al., 1996; Meixner et al., 2004) (except fraction 22 of cow unfermented digests, Lactobacillus delbrueckiisubsp bulgaricus and Streptococcus salivarius subsp thermophilus digests and fraction 30 of unfermented cow digests) compared to control (Fig. 7.4). This contrasting result of IFNγ in some fractions suggests the intervention of cytokines other than IL-2 and IFNγ in lymphocyte proliferation. Cytokines such as IL-12 (Meixner et al., 2004; Heinzel et al., 1993), IL-4 (Ebner et al., 1997; Meixner et al., 2004; Jacquot et al., 2010) and IL-10 (Ceyhan et al., 2004; Meixner et al., 2004; Jacquot et al., 2010) can regulate cell proliferation. Immunosuppressing fractions The immunomodulatory potential of peptides can be either enhancement (immunostimualtion) or suppression (immunosuppression) of immune system (Cross and Gill, 2000; Gauthier et al., 2006). The main focus of thisstudy was on immunostimulating peptides (since deer milk digestions showed immunostmulating effect as a whole (chapter 5), but to examine the presence of both immunostimualtion and immunosuppression type of peptides, three fractions, which suppressed lymphocyte proliferation for all milk digests (unfermented and fermented) were further studied after adjusting the protein concentration to 0.125 mg/ml. Although deer showed significantly higher proliferation than cow in immunostimulating peptide fractions (11, 22 and 30), there was no significant difference (P>0.05) between deer and cow for proliferation suppression fractions (Table 7.1). The presence of proliferation suppressive peptides has been reported in cow milk digests (Prioult et al., 2004; Eriksen et al., Cross &Gill, 2000) which explains the proliferation suppressive fractions of cow digestions in present study. Also LAB fermentation did not significantly affect (P>0.05) proliferation for these fractions from both deer and cow milk compare to unfermented milk (Table 7.1). Similarly Laffieur et al. (1996) reported 112 eight strains of LAB (out of 10 stains tested) did not have significant proliferation effect compared to unfermented milk. Similar to lymphocyte proliferation response there were no significant difference (P>0.05) between deer and cow in cytokine production (IL-2 and IFNγ) by human PBMC. The proliferation and cytokine production results of immunostimulating and immunosuppressive peptide fractions suggest it is more worthy to study immunostimulating peptides of deer milk than cow milk, since deer milk digest as a whole (Chapter 5, fig.5.1) showed immunostimulating effect than cow milk digest. 7.5. Conclusion Both deer and cow digests (unfermented and fermented) had immunostimmulating and immunosuppressive peptide fractions, but deer digest had more proliferation stimulation fractions than cow digest. Selected high immunostimulating deer digests (unfermented and fermented) FPLC fractions (11, 22 and 30) showed higher lymphocyte proliferation and higher cytokine IL-2 and IFNγ production compared to corresponding fractions of cow digests when incubated in vitro with Con A stimulated human PBMC. Immunostimulating fraction 30 of unfermented deer digests was able to stimulate the human PBMC even without Con A. The findings of this research suggest that deer milk digests (and LAB ferment digests) have more immunostimulating activity than cow digests. Further investigation should be carried out to identify the specific peptide or peptide which is responsible for immune activity. 113 Chapter 8 Identification of Peptides from Immunostimulating Fractions of Deer and Cow Milk Digestions 8.1. Introduction Bioactive peptides of cow and other mammals (sheep, goat, buffalo, pig and human) milk have been studied previously after separation of proteolysis products by chromatography (FPLC or HPLC) and the identification of the peptides were carried out by biochemical methods (Minervini et al., 2003; Jacquot et al., 2010). Mass spectrometry (MS) is commonly used to identify and sequence purified peptides (Juillard et al., 1995; Rohit et al., 2012; Hou et al., 2012). The use of liquid chromatography–mass spectrometry (LC-MS) makes it possible to determine the molecular weight of each peptide, even when testing fractions contain more than one peptide (Juillard et al., 1995). According to the literature there has been no investigation to identify bioactive peptides from deer milk protein hydrolysates. At present, deer milk protein sequence information is not available in any sequencing databases. Therefore in this study, database searching for deer peptides was done on Bovidae taxonomy; cow, sheep, goat and buffalo. The aim of this study was to identify the peptide or peptides present in the three most active immunostimulating fractions (11, 22 and 30) isolated by reverse-phase FPLC(Chapter 7).In vitro digestions of unfermented and Lactobacillus delbrueckiisubsp bulgaricus fermented deer and cow milk proteins were used. 8.2. Material and Methods 8.2.1. Materials Immunostimulating fractions 11, 22 and 30 of deer and cow (unfermented and Lactobacillus delbrueckiisubsp bulgaricus fermented) digests (chapter 7) were isolated by reverse-phase FPLC. The fractions were freeze dried and used for analysis. Formic acid (FA) and acetonitrile were purchased from Sigma (St. Louis, MO, USA). Ultimate nanoflow HPLC equipment with Famos autosampler and Switchos column switching module were 114 from LC-Packings, The Netherlands. Nanospray needle was purchased from Proxeon, Denmark and QSTAR Pulsar I mass spectrometer was from AB Sciex, USA. 8.2.2. Liquid Chromatography–Mass Spectrometry (LC-MS/MS) Freeze dried samples were reconstituted in 25 µl loading solvent (2% acetonitrile, 0.2% FA). LCMS/MS was carried out on an HPLC. A 10 µl of sample was loaded on a C18 precolumn (300 µm ID, 5 µm particles, 300 Å pore size) at a flow rate of 8 µl/min. The precolumn was then switched in line with the analytical column (C18, 20 cm, 75 µm ID, 5 µm particles, 300 Å pore size), and eluted at a flow rate of 150 nl/min, with a linear gradient from 2% to 55% solvent B in 50 min. Solvent A was HPLC-grade water with 0.2% FA, solvent B was LCMS-grade acetonitrile with 0.2% FA. Using a stainless steel nanospray needle, the column outlet was directly connected to a QSTAR Pulsar I mass spectrometer which was programmed to acquire MS/MS traces of the top three 1+, 2+, 3+, 4+ and 5+ peptides (cycle time 6 seconds). 8.2.3. Database searching Mascot Daemon (v2.2.2) was used to convert the data files to peak lists (Mascot Script for Analyst v1.6b25). Peak lists were imported in to ProteinScape V2.1 (Bruker) and submitted for searching to an in-house Mascot server (v2.2.0.6) (Matrix Science, UK). The following search parameters were used: No enzyme; MS tolerance 75 ppm; MS/MS tolerance 0.3 Da; database NCBInr 14/09/2011. Bos taurus and Bovidae taxonomy was used for cow and deer milk samples, respectively. Peptides and proteins with a Mascot score higher than 25 and 50, respectively, were accepted. 8.3. Results and Discussion Peptides have been identified by coupling high-performance liquid chromatography (HPLC) and MS. All tested fractions had more than 15 different peptides and one fractions contained more than 100 peptides (fraction 30 of cow milk unfermented and fermented digests) (Table 8.1). Even after further purification, RP-FPLC fractions of casein hydrolysates of cow, sheep, goat, pig, buffalo and human milk had mixture of different peptides (Minervini et al., 2003). Peptides present in immunostimulating RP-FPLC fractions (11, 22 and 30) of deer and cow milk were identified. The samples in the present work were hydrolysates of casein and whey protein which contribute to the presence of many different peptides. Mass spectrometric analysis done by Juillard et al. (1995) identified over 100 different β-casein-derived peptides from cow β casein after fermentation with Lactobacillus lactis subsp. lactis MG611. 115 Table 8.1. Total number of identified peptides contained and source of protein in FPLC fractions 11, 22 and 30 from unfermented (Cow digests and Deer digests) and Lactobacillus delbrueckiisubsp bulgaricus fermented cow (CL) and deer (DL) in vitro digestions. Source Total number of peptides Source of protein Number of peptides Fraction 11 Cow digests 32 CL digests 49 Deer Digests 16 DL digests 36 β Casein αs1 casein αs2 casein κ casein β Lactoglobulin β Casein αs1 casein αs2 casein αs1 casein β Casein β Lactoglobulin β Casein αs1 casein αs2 casein β Lactoglobulin 14 10 3 4 1 31 15 3 10a 5a 1a 12a,h 10a 4b 10a Fraction 22 Cow digests 79 CL digests 73 Deer Digests 51 DL 35 β Casein αs1 casein αs2 casein κ casein β Lactoglobulin αs1 casein β Casein αs2 casein κ casein β Casein αs1 casein αs2 casein κ casein β Lactoglobulin β Casein αs1 casein αs2 casein κ casein β Lactoglobulin 41 22 8 6 2 37 23 9 4 25a,b 12a,b 7a,c 4a,d 3a 14a 13a,b,h 2c 2g 4a Fraction 30 Cow digests 100 αs1 casein β Casein 39 35 116 CL 104 Deer Digests 51 αs2 casein κ casein β Casein αs1 casein αs2 casein κ casein β Casein αs2 casein κ casein β Lactoglobulin DL 50 β Casein αs1 casein αs2 casein κ casein β Lactoglobulin Below taxonomy was used for identification of peptides in deer milk samples a: Bos taurus e: Ovis vignei bocharensis b: Capra hircus g: Ovis orientalis gmelini c: Ovis aries h: Bubalus bubalis d: Ovis vignei blanfordi 17 9 46 40 12 6 21b,h 2c 6e 4a 22a,h 13b,h 8c 2d 5a In this study, identification of deer milk peptides was carried out by database search of cow, sheep, goat, buffalo milk proteins since there was no sequencing data available for deer milk proteins. The main protein source of identified peptides in most tested fractions was β casein. Therefore we can suggest that immunostimulating activity (chapter 7) in tested fraction was possibly from β casein originated peptides for both deer and cow milks. The immunomodulatory activities of β casein derived peptides have been well documented (Coste et al., 1992; Kitazawa et al., 2007; Phelan et al., 2009). Some differences in amino acid sequence of deer and cow milk proteins were identified (Table 8.2). There were four peptides of β casein origin (f 204-222, f 205-222, f 206–222 and f 207-222) present in fraction 22 of deer milk unfermented digests, which showed sequence differences with cow β casein where 207th position is leucine in deer as with goat milk versus isoleucine in cow protein (Table 8.2). Also fraction 11 of digest of Lactobacillus delbrueckiisubsp bulgaricus ferment of deer milk (11 DL) contained a peptide (β casein f 31–48) which showed a difference with cow β casein amino acid composition (Table 8.2). In 39th position Arginine (R) was found in deer milk similar to domestic water buffalo, while cow β casein has Glutamine (Q). A similar study by Masoodi and 117 Shafi (2010) showed the differences in amino acid composition of α1 casein and α2 casein of cow milk compared to those of sheep and goat milk. Bovidae (cow, sheep, goat and buffalo) taxonomy was used for identification of peptides in deer milk protein samples. There are no reported works on amino acid sequencing of deer milk protein but McDougall (1976) did compare the amino acid composition of red deer milk β lactoglobulin to that of cow milk. He found that deer milk β lactoglobulin contained one more residue of aspartic acid, alanine and methionine and one less glutamic acid residue and two less leucine residue than cow β-lactoglobulin composition. The results of this study show similarities (Fig. 8.1) and differences (Table 8.2) of deer milk proteins (especially casein) to homologous cow milk proteins which might lead to altered bioactive properties. As shown in figure 8.1 many of the peptides are identical in deer and cow fraction 30. This similarity of peptide sequence could be the reason why both deer and cow fraction showed immunostimulating activity (Chapter 7). At the same time, there are slight differences observed between deer and cow milk proteins (Table 8.2). This could lead to a difference of immunostimulating activity and might be the reason why deer milk fractions showed higher immunostimulating activity than the corresponding cow fraction (Chapter 7). Table8.2. Comparison of amino acid residues in milk protein of deer with cow giving its specific position based on results of peptides found in FPLC fractions 11, 22 and 30 of unfermented and Lactobacillus delbrueckiisubsp bulgaricusfermented cow and deer milkin vitro digestions. Amino acid position β casein 39 β casein 207 α1 casein 163 α2 casein 215 Amino acid in cow milk Glutamine (Q) Isoleucine (I) Glutamic acid (E ) Lysine (K) Amino acid in deer milk Arginine ( R) - Similar to goat milk Leucine (L) - Similar to domestic water buffalo milk Glutamine (Q) - Similar to goat and sheep milk Asparagine (N) - Similar to goat and sheep milk Most abundant peptides identified from each fraction with a mascot value > 70 are shown in Table 8.3. Mascot score is a measure of effectiveness of peptide identification. The fragment β casein 5766 (fraction 22 of cow digests) contained (Table 8.3) the sequence of β casomorphine-7 (β casein 60-66), which has been previously identified as an immunomodulating cow milk peptide (Kayser & Meisel, 1996). The authors showed β-casomorphin-7 stimulated human lymphocyte proliferation. β-casomorphin-7 may also affect the human mucosal immune system, possibly via opiate receptors in lamina propria lymphocytes (Elitsur et al., 1991). The β casein 184-209 fragment present in fraction 11 of cow digests (Table 8.3) contained another known cow immunostimulating peptide (β casein 192-209) which enhanced the proliferation of rat lymphocytes (Coste et al., 1992). Similarly 118 the β-cascochemotide (f114-118) an immunomodulating peptide (Kitazawa et al., 2007) exists within the range of β casein 114-128 peptide (Table 8.3, Fig. 8.1) present in fraction 30 of cow digest fermented with Lactobacillus delbrueckiisubsp bulgaricus. Cow β casein residues 63-68 and 191-193 have been shown to stimulate phagocytosis of sheep red blood cells by murine peritoneal macrophages, and to exert a protective effect against Klebsiella pneumoniae infection in mice after intravenous treatment (Migliore-Samour & Jollès 1988) and these two amino acid sequences can be seen in peptides detected in cow β casein 57-66 and β casein 184-209, respectively (Table 8.3). Therefore, it can be suggested that cow milk fractions (11, 22 and 30) which showed high immunostimulating activity (Chapter 7) may partially have resulted from some of above mentioned peptide fragments which have been identified in literature. There might be other peptides contributing to the activity, which have not been identified before. Although each of the deer milk FPLC fractions exhibited higher lymphocyte proliferation than the corresponding cow milk fraction (Chapter 7), we did not identify any previously known immunomodulating peptides in deer samples. Deer fractions had higher activity compared with cow fractions suggesting new sequences may potentially contributeto this. Also immunostimulating activity of each fraction may be due to interaction of peptides present in each fraction or few peptides and their concentration. Further experiments should be carriedout to identify these peptidesafter purification as well as testing the immunostimulating activity of each peptide which should be confirmed by synthetic peptides constructed with the same sequence. 119 Table 8.3. Sequences and corresponding milk protein fragment of peptides contained in FPLC fractions 11, 22 and 30 from unfermented (Cow digests and Deer digests) and Lactobacillus delbrueckiisubsp bulgaricus fermented cow (CL) and deer (DL) in vitro digestions.m/z represents measured mass-to-charge ratio and ∆ m/z represents mass error between the measured mass m/z and the theoretical m/z for that sequence Sequence position Sequencea m/z ∆ m/z z βCN 124-139 βCN 184-209 β lg 92-100 SLTLTDVENLHLPLPL DMPIQAFLLYQEPVLGPVRGPFPIIV VLVLDTDYK 888.0039 975.8757 533.2904 3.12 6.10 -8.58 2 3 2 CL βCN 124-139 βCN 34-48 SLTLTDVENLHLPLPL QQEEQQQTEDELQDK 887.9974 938.4144 -4.18 0.70 2 2 Deer Digests αs1CN 119 - 134 (Bos taurus) αs1CN 189 - 208 (Bos taurus) β lg 110-118 (Ovis aries) YKVPQLEIVPNSAEER 651.3319 14.66 3 TDAPSFSDIPNPIGSENSEK 1052.9881 0.99 2 VLVLDTDYK 533.2990 7.49 2 SLTLTDVENLHLPLPL 887.9942 -7.77 2 DVENLHLPLPLLQSWM 953.0054 5.10 2 QQEEQQQTEDELQDK 938.4139 0.17 2 βCN 33-52 βCN 57-66 βCN 145-162 βCN 190-202 αs1CN 15- 28 αs1CN 189- 208 αs2CN 116- 128 β lg 10-29 FQSEEQQQTEDELQDKIHPF SLVYPFPGPI HQPHQPLPPTVMFPPQSV FLLYQEPVLGPVR HQGLPQEVLNENLL TDAPSFSDIPNPIGSENSEK QGPIVLNPWDQVK SLAMAASDISLLDAQSAPLR 852.6958 1089.6059 679.6958 765.9394 802.4236 1052.9829 747.3992 682.6950 -7.72 7.32 17.32 2.33 -2.50 -3.99 -13.29 8.21 3 1 3 2 2 2 2 3 CL αs1CN 119- 134 αs1CN 181- 200 YKVPQLEIVPNSAEER TDAPSFSDIPNPIGSENSEK 651.3189 -5.27 1052.9829 -4.04 3 2 Deer Digests αs1CN 140- 164 (Bos taurus) αs1CN 140- 164 EGIHAQQKEPMIGVNQELAYFYPEL EGIHAQQKEPMIGVNQELAYFYPEL 968.8255 974.1516 3 3 Fraction Source Cow 11 digests DL Cow 22 digests βCN 124-139 (Bos taurus,Bubalus bubalis) βCN 129-144 (Bos taurus,Bubalus bubalis) βCN 34-48 (Bos taurus) 13.20 7.41 120 (Bos taurus) αs1CN 197- 208 (Bos taurus, Capra hircus) β lg 92-100 (Bos taurus) IPNPIGSENSGK 606.8213 11.12 2 VLVLDTDYK 533.2993 8.06 2 βCN 124-139 (Bos taurus) SLTLTDVENLHLPLPL 888.0153 16.00 2 βCN 124-139 αs1CN 50- 65 αs1CN 50- 67 αs1CN 132- 156 SLTLTDVENLHLPLPL DIGSESTEDQAMEDIK DIGSESTEDQAMEDIKQM EGIHAQQKEPMIGVNQELAYFYPEL 888.0093 972.3567 1109.8898 974.1546 9.22 10.06 -3.67 10.46 2 2 2 3 CL βCN 114-128 βCN 124-139 βCN 144-163 βCN 145-162 βCN 145-163 αs1CN 23- 36 αs1CN 172- 199 αs2CN 125- 138 YPVEPFTESQSLTLT SLTLTDVENLHLPLPL MHQPHQPLPPTVMFPPQSVL HQPHQPLPPTVMFPPQSV HQPHQPLPPTVMFPPQSVL HQGLPQEVLNENLL YVPLGTQYTDAPSFSDIPNPIGSENSEK TPEVDDEALEKFDK 856.4202 888.0062 761.0555 679.6815 717.3756 802.4202 1009.4803 545.9335 -5.48 5.69 -4.41 -3.72 -4.38 -6.67 -0.02 6.72 2 2 3 3 3 2 3 3 Deer Digests βCN 124-139 (Bubalus bubalis) βCN 126-144 (Bubalus bubalis) β lg 10-24(Bos taurus) β lg 10-29 (Bos taurus) β lg 92-100 (Bos taurus) DL Cow 30 digests DL SLTLTDVENLHLPLPL 888.02 20.9 2 TLTDVENLHLPLPLLQSWM 1118.5817 -5.42 2 SLAMAASDISLLDAQ 761.3813 5.76 2 SLAMAASDISLLDAQSAPLR 682.7030 19.96 3 VLVLDTDYK 533.3198 46.56 2 βCN 124-139 (Bubalus bubalis) βCN 129-138 (Bos SLTLTDVENLHLPLPL 888.0030 2.16 2 taurus) DVENLHLPLP 573.8124 1.89 2 SLAMAASDISLLDAQSAPL 937.4762 -6.67 2 β lg 10-28 (Bos taurus) a Single letter amino acid code is used Peptides with > 70 mascot score were shown 121 10 20 30 40 50 60 70 80 90 100 RELEELNVPG EIVESLSSSE ESITRINKKI EKFQSEEQQQ TEDELQDKIH PFAQTQSLVY PFPGPIPNSL PQNIPPLTQT PVVVPPFLQP EVMGVSKVKE AMAPKQKEMP 120 FPKYPVEPFT 130 ESQSLTLTDV ENLHLPLPLL 140 150 160 QSWMHQPHQP LPPTVMFPPQ 170 180 SVLSLSQSKV LPVPQKAVPY PQRDMPIQAF 190 200 LLYQEPVLGP VRGPFPIIV 110 209 C CL D DL Figure 8.1. Localization of identified peptides in FPLC fraction 30 of unfermented cow (C) and deer (D) milk digests and digests of Lactobacillus delbrueckiisubsp bulgaricus ferment of cow (CL) and deer (DL) on cow β casein. Peptides with > 70 mascot score were shown 122 β casein 124–139 peptide was found in all tested fractions of both deer and cow milks (Table 8.3). This unexpected result is fully unknown since separation is based on hydrophobicity of peptide. The mascot score for the 124–139 peptides is different in different fractions. Therefore it could be suggested that due to high abundance of this peptide, it diffused to more than one fraction. These results are similar to those reported by Minervini et al. (2003) which reported the appearance of the same peptides in different FPLC fractions which use hydrophobicity as separation principle. This study used three fractions (11, 22 and 30) out of fifty FPLC fractions, where a high immunostimulating activity was shown (Chapter 7) and β casein 124 – 139 peptide was found in most of these fractions (both deer and cow) abundantly. This suggests there might be immunostimulating property of this peptide and there could be really interesting findings of this particular peptide and further investigation is strongly recommended. Di- and tripeptides are too small to be reliably identified with this method and therefore another method should be used in future work. 8.4. Conclusion Mixtures of different peptides with different protein origins have been identified in immunostimulating FPLC fractions from both deer and cow milk digests. The main protein source was found to be β casein. The results obtained in this study showed that there are differences in the amino acid sequence of deer and cow milk proteins. Some previously identified immunostimulating peptide sequences were found in tested FPLC fractions in cow digests whereas there were no previously identified immunostimulating peptides in deer digests. Further studies should be carried out to identify these unknown immunostimulating peptides after further purification and the activity confirmed by synthesis. 123 Chapter 9 General Discussion, Conclusion and Future Work Digestion and fermentation of milk protein produces bioactive peptides and currently milk proteins are considered the most important commercial source of bioactive peptides (Korhonen, 2009). Using deer and cow milks obtained from Lincoln University deer and dairy farm, respectively, the present study has shown that deer milk has twice protein content of cow milk. Also deer milk produced more peptides than cow milk after in vitro digestion (Chapter 3). LAB fermentation (Lactobacillus delbrueckiisubsp bulgaricus, Streptococcus salivarius subsp thermophilus and Lactobacillus casei strain Shirota) prior to in vitro digestion improved the peptide production compared to unfermented milk digestion. There were more peptides generated after an in vitro digestion of deer milk ferment than cow milk after similar treatment (Chapter 4). Immunomodulating activities of the above unfermented and fermented milk digestions were tested using human PBMC and deer milk showed more immunostimulating properties than cow milk after in vitro digestion and this was further improved by LAB fermentation prior to digestion based on lymphocyte proliferation and cytokine production (IL-2 and INFγ). Immunostimulating activities were higher at lower protein concentration (0.125 mg/ml) than higher concentrations for both milk types which could be explained by cytotoxic effect at higher concentrations of protein (Phelan et al., 2009). Similar results of higher lymphocyte proliferation at lower protein concentration were shown by several authors (Sizemore et al., 1991, Kayser & Meisel, 1996; Jacquote et al., 2010). In vitro assays,as used in this work, are useful for identification of potential bioactive peptides in food and the results of in vitro assays may indicate what may happen when potentially immunomodulating peptides are consumed (Eriksen et al., 2008; Agyei & Danquah, 2012). The action of immunomodulatory peptides is relatively nonspecific and the exact mechanism of action as well as the in vivo fate of these peptides is largely unknown (Pihlanto, 2011; Agyei & Danquah, 2012). It is known some small peptides are easily absorbed in the intestine while little is known about the absorption of larger bioactive peptides (Pihlanto, 2011). When the bioactive peptides are not absorbed in the intestinal tract, their activity may result either directly in the intestinal tract or via receptors and cell 124 signalling in the gut (Pihlanto, 2011). Immunomodulatory peptides which are absorbed from the gut can either suppress or stimulate certain immune responses (Agyei & Danquah, 2012). Therefore it is of great importance to establish if a protein (or peptide/peptides) has the same biological function in vivo as it has in vitro before using for human. Variation in milks between animal species was considered in chapter 6 and immunomodulating activity of deer milk was compared with three other domestic species (cow, goat and sheep). The immunostimulatoryactivity of deer milk digests was not only higher than cow digestions, but also goat and sheep milk digestions (two other commonly used milk types). The peptides in unfermented and fermented digests of deer and cow milk were fractionated using FPLC technique and three high immunostimulating peptide fractions (11, 22 and 30) were identified (Chapter 7). Each of these deer milk digests FPLC fractions showed more immnostimulating activity than corresponding cow milk digest fractions. Identification of peptides present in above immunostimulating fractions was done using LCMS/MS. Mixtures of different peptides were found in each fraction and most of them were from β casein (Chapter 8). Some previously characterised immunostimulating peptides sequences were found within peptides present in unfermented and fermented cow digest fractions (β casomorphine-7, β-cascochemotide, β casein f 192-209, f 63-68 and f 191-193). There were no previously identified immunostimulating peptides found in deer fractions suggesting deer milk might have novel (unidentified) immunostimulating peptides which have very high activity. Peptide identification was done only in three high immunostimulating fractions (11, 22 and 30) which we selected previously from 51 FPLC fractions. There was a common peptide (β casein fraction 124 – 139) observed in most of the above immunostimulating fractions for both deer and cow. Also some differences of amino acid sequence of deer milk protein (β casein , α1 casein, α2 casein) to cow milk protein were identified, which could be another reason to have different level of immunostimulating activities by deer and cow milk proteins. As it is discussed and pointed out throughout this thesis there were so many previous studies on immunomodulating activity of cow milk and some on other domestic species like sheep, goat and camel and still the interest of milk from these species can be seen as there are sufficient amount of very recent studies and reviewed on bioactive peptides on above milk species (Tanabe, 2012; Nagpal et al., 2012; Choi et al., 2012 and Ebaid et al., 2012). There is 125 no reported work on bioactive peptides on red deer milk which could have potential immunobioactivity based on historical use of deer milk to cure some medical problems (Fondahl, 1989; Park &Haenlein, 2006). The present work was able to fulfil that gap by identifying immunostimulating activity of deer milk and showing higher immunostimulating activity than cow, goat and sheep milk. Although the main research area of this study is immunostimulating peptides of deer milk, some other observations during this research were very interesting and led to studying other properties of deer milk such as buffering capacity and mineral content. During the first experiment (Chapter 1) there was the observation of high tolerance of deer milk to pH changes with addition of acid (1M HCl) or base (1M NaOH) during in vitro digestion pH adjustment prior to enzyme addition. Also pH of deer milk did not drop below 4.6 after LAB fermentation while cow milk pH dropped below 4.3 where casein is precipitated (Chapter 4). These observations led to the measurement ofthe buffering capacity of deer milk compared to cow milk. In this study higher buffering capacity of deer milk than cow, sheep and goat milk was identified, which may have potential to treat patient with gastric ulcers (Chapter 6). But further studies should be carried out to confirm the suggested property. At the same time,it was found that deer milk is a better source of minerals (especially Ca, P and Zn) compared with cow, sheep and goat milk. New information generated through this research were that red deer milk is a better source of immunomodulating bioactive peptides than cow milk protein and LAB fermentation prior to digestion improved the formation of bioactive peptides in both deer and cow milks. This potentially could open commercial opportunities for the deer industry in New Zealand. New Zealand has 1.2 million farmed deer which is half of world farmed deer population. They are farmed mainly for meat and velvet (DINZ, 2009). This present research is an initial indication of the potential of utilising milk as another deer product. Based on present results there is considerable potential to isolate immunomodulatory peptides from deer milk for pharmaceuticals and furtherresearch should be carried out. Also this work indicates deer milk is a usefulsource of novel bioactive peptides. Future work • Many different peptides have been identified in this study from three immunostimulating FPLC fractions from unfermented and fermented deer milk digestions. It will be important to determine which, if any, of these 126 areimmunostimulating peptides by further purification by appropriate chromatography techniques together with biological assays (lymphocyte proliferation and cytokine production). It will also be important to develop genetic resources for deer either using genomic sequencing or expressed sequence tags as this will allow the identification of unique deer peptides. This would be helpful to identify one or several most active immunostimulating peptides in each active fraction. Then the activity of each peptide should be tested to confirm the immunostimulating property after synthesis and those peptides may have potential commercial value as cow milk derived commercial bioactive products (Ricci-Cabello et al., 2012). • It is also interesting to investigate the cytokine production with different time intervals (6hrs interval) for longer time (72 hr). • Once any particular immunomodulating peptide/ peptides were identified from deer milk protein, in final stages animal trials should be beneficial to identify optimum plasmatic concentration of these substances and identify the therapeutic potential of immunostimulating bioactive peptides. • Some observations in this research led to the interest to study in areas which not directly relevant to present topic, but could be potential use of deer milk. Low growth of LAB strains in deer milk than cow milk (Chapter 4) created a really interesting area to study on antibacterial properties of deer milk. • It is also interesting to investigate other bioactivities in deer milk like opiate-like, mineral binding, antioxidant, antithrombotic, hypocholesterolemic, and antihypertensive actions since many bioactive peptides are multifunctional and can exhibit more than one of the effects (Korhonen, 2009). • Also further studies of the buffering capacity of deer milk is beneficial to confirm the observed higher buffering capacity, find out what cause the high buffering capacity and finally to investigate potential use of deer milk to treat human gastric problems. • LAB fermentation of present work was carried out in aerobic condition without pH control. It is interesting to find behaviour of tested lab strains in different fermentative conditions such as anaerobic and with pH control for both deer and cow milks and test the differences in peptide formation and immunomodulating activity. 127 References Agyei, D., & Danquah, M. K. (2012). Rethinking food-derived bioactive peptides for antimicrobial and immunomodulatory activities. Trends in Food Science & Technology, 23(2), 62-69. Aimutis, W. R. (2004). Bioactive properties of milk proteins with particular focus on anticariogenesis. The Journal of Nutrition, 134(4), 989S-995S. Almaas, H., Cases, A.-L., Devold, T. G., Holm, H., Langsrud, T., Aabakken, L., Aadnoey, T. &Vegarud, G. E. (2006). In vitro digestion of bovine and caprine milk by human gastric and duodenal enzymes. International Dairy Journal, 16(9), 961-968. Al-Nasiry, S., Geusens, N., Hanssens, M., Luyten, C., & Pijnenborg, R. (2007). The use of Alamar Blue assay for quantitative analysis of viability, migration and invasion of choriocarcinoma cells. Human Reproduction, 22(5), 1304-1309. doi:10.1093/humrep/dem011 Alvarez, M. J., & Lombardero, M. (2002). IgE-mediated anaphylaxis to sheep's and goat's milk. Allergy, 57(11), 1091-1092. doi:10.1034/j.1398-9995.2002.23836_13.x Amarowicz, R., & Shahidi, F. (1997). Antioxidant activity of peptide fractions of capelin protein hydrolysates. Food Chemistry, 58(4), 355-359. Ansar Ahmed, S., Gogal Jr, R. M., & Walsh, J. E. (1994). A new rapid and simple nonradioactive assay to monitor and determine the proliferation of lymphocytes: an alternative to [3H]thymidine incorporation assay. Journal of Immunological Methods, 170(2), 211-224. doi:10.1016/0022-1759(94)90396-4 Antal, J., Pál, G., Asbóth, B., Buzás, Z., Patthy, A., & Gráf, L. (2001). Specificity assay of serine proteinases by Reverse-Phase High-Performance Liquid Chromatography analysis of competing oligopeptide substrate library. Analytical Biochemistry, 288(2), 156-167. doi:10.1006/abio.2000.4886 Arman, P., Kay, R. N. B., Goodall, E. D., & Sharman, G. A. M. (1974). The composition and yield of milk from captive red deer (Cervus elaphus L.). Journal of Reprod & Fertility, 37(1), 67-84. doi:10.1530/jrf.0.0370067 128 Barbano, D. M., Lynch, J. M., & Fleming, J. R. (1991). Direct and indirect determination of true protein content of milk by Kjeldahl analysis. Journal of the AOAC, 74, 281–288. Bekhit, A. E.-D. A., Morton, J. D., Dawson, C. O., & Sedcole, R. (2009). Optical properties of raw and processed fish roes from six commercial New Zealand species. Journal of Food Engineering, 91(2), 363-371. Belardelli, F. (1995). Role of interferons and other cytokines in the regulation of the immune response. Acta Pathologica, Microbiologica et Immunologica Scandinavica, 103(1-6), 161179. doi:10.1111/j.1699-0463.1995.tb01092.x Belardelli, F., & Ferrantini, M. (2002). Cytokines as a link between innate and adaptive antitumor immunity. Trends in Immunology, 23(4), 201-208. Berthou, J., Migliore-Samour, D., Lifchitz, A., Delettré, J., Floc'h, F., & Jollès, P. (1987). Immunostimulating properties and three-dimensional structure of two tripeptides from human and cow caseins. FEBS Letters, 218(1), 55-58. Bhat, Z. F., & Bhat, H. (2011). Milk and dairy products as functional foods. Journal of Dairy Science, 6(1), 1-12. doi: 10.3923/ijds.2011.1.12 Biffi, A., Coradini, D., Larsen, R., Riva, L., & Di Fronzo, G. (1997). Antiproliferative effect of fermented milk on the growth of a human breast cancer cell line. Nutrition and Cancer, 28(1), 93-99. Birghila, S., Dobrinas, S., Stanciu, G., & Soceanu, A. (2008). Determination of major and minor elements in milk through ICP-AES. Environmental Engineering and Management Journal, 7(6), 805-808. Blasi, F., Montesano, D., De Angelis, M., Maurizi, A., Ventura, F., Cossignani, L., Simonetti, M. S. & Damiani, P. (2008). Results of stereospecific analysis of triacylglycerol fraction from donkey, cow, ewe, goat and buffalo milk. Journal of Food Composition and Analysis, 21(1), 1-7. Blattman, J. N., Grayson, J. M., Wherry, E. J., Kaech, S. M., Smith, K. A., & Ahmed, R. (2003). Therapeutic use of IL-2 to enhance antiviral T-cell responses in vivo. Nature Medicine, 9, 540-547. 129 Blum, K. S., & Pabst, R. (2007). Lymphocyte numbers and subsets in the human blood: Do they mirror the situation in all organs? Immunology Letters, 108(1), 45-51. Bobe, G., Beitz, D. C., Freeman, A. E., & Lindberg, G. L. (1998). Separation and quantification of bovine milk proteins by reversed-phase high-performance liquid chromatography. Journal of Agricultural and Food Chemistry, 46(2), 458-463. doi:10.1021/jf970499p Boilard, E., & Surette, M. E. (2001). Anti-CD3 and concanavalin A-induced human T cell proliferation is associated with an increased rate of arachidonate-phospholipid remodeling. Journal of Biological Chemistry, 276(20), 17568-17575. doi:10.1074/jbc.M006152200 Bos, C., Mahé, S., Gaudichon, C., Benamouzig, R., Gausserès, N., Luengo, C., Ferrière, F., Rautureau, J. &Tomé, D. (1999). Assessment of net postprandial protein utilization of Nlabelled milk nitrogen in human subjects. British Journal of Nutrition, 81(03), 221-226. Bu, G., Luo, Y., Zhang, Y., & Chen, F. (2010). Effects of fermentation by lactic acid bacteria on the antigenicity of bovine whey proteins. Journal of the Science of Food and Agriculture, 90(12), 2015-2020. doi:10.1002/jsfa.4046 Burrells, C., Clarke, C. J., Colston, A., Kay, J. M., Porter, J., Little, D., & Sharp, J. M. (1999). Interferon-gamma and interleukin-2 release by lymphocytes derived from the blood, mesenteric lymph nodes and intestines of normal sheep and those affected with paratuberculosis (Johne's disease). Veterinary Immunology and Immunopathology, 68(2-4), 139-148. doi:10.1016/s0165-2427(99)00022-7 Ceballos, L. S., Morales, E. R., de la Torre Adarve, G., Castro, J. D., Martínez, L. P., & Sampelayo, M. R. S. (2009). Composition of goat and cow milk produced under similar conditions and analyzed by identical methodology. Journal of Food Composition and Analysis, 22(4), 322-329. Ceyhan, B. B., Enc, F. Y., & Sahin, S. (2004). IL-2 and IL-10 levels in induced sputum and serum samples of asthmatics. Journal of Investigational Allergology and Clinical Immunology, 14(1), 80-85. Chan, S. H., Perussia, B., Gupta, J. W., Kobayashi, M., Pospísil, M., Young, H. A., Wolf, S. F., Young, D., Clark, S. C.& Trinchieri, G. (1991). Induction of interferon gamma production by natural killer cell stimulatory factor: characterization of the responder cells and synergy 130 with other inducers. The Journal of Experimental Medicine, 173(4), 869-879. doi:10.1084/jem.173.4.869 Choi, J., Sabikhi, L., Hassan, A., & Anand, S. (2012). Bioactive peptides in dairy products. International Journal of Dairy Technology, 65(1), 1-12. doi:10.1111/j.14710307.2011.00725.x Chope, G. A., & Terry, L. A. (2009). Use of canonical variate analysis to differentiate onion cultivars by mineral content as measured by ICP-AES. Food Chemistry, 115(3), 1108-1113. Church, F. C., Swaisgood, H. E., Porter, D. H., & Catignani, G. L. (1983). Spectrophotometric assay using o-phthaldialdehyde for determination of proteolysis in milk and isolated milk proteins. Journal of Dairy Science, 66(6), 1219-1227. Clare, D. A., Catignani, G. L., & Swaisgood, H. E. (2003). Biodefense properties of milk: the role of antimicrobial proteins and peptides. Current Pharmaceutical Design, 9(16), 12391255. Clare, D. A., & Swaisgood, H. E. (2000). Bioactive milk peptides: A prospectus. Journal of Dairy Science, 83(6), 1187-1195. Cocco, R. R., Järvinen, K.-M., Sampson, H. A., & Beyer, K. (2003). Mutational analysis of major, sequential IgE-binding epitopes in αs1-casein, a major cow's milk allergen. Journal of Allergy and Clinical Immunology, 112(2), 433-437. Coste, M., Rochet, V., Léonil, J., Mollé, D., Bouhallab, S., & Tomé, D. (1992). Identification of C-terminal peptides of bovine β-casein that enhance proliferation of rat lymphocytes. Immunology Letters, 33(1), 41-46. Coste, M., & Tome, D. (1991). Milk peptides with physiological activities. II. Opioid and immunostimulating peptides derived from milk proteins. Le Lait, 71(2), 241-247. Crittenden, R. G., & Bennett, L. E. (2005). Cow’s Milk Allergy: A Complex Disorder. Journal of the American College of Nutrition, 24(suppl 6), 582S-591S. Cross, M. L., & Gill, H. S. (1999). Modulation of immune function by a modified bovine whey protein concentrate. Immunology and Cell Biology, 77(4), 345-350. Cross, M. L., & Gill, H. S. (2000). Immunomodulatory properties of milk. British Journal of Nutrition, 84(SupplementS1), 81-89. doi:doi:10.1017/S0007114500002294 131 Dangin, M., Boirie, Y., Guillet, C., & Beaufrere, B. (2002). Influence of the protein digestion rate on protein turnover in young and elderly subjects. Journal of Nutrition, 132(10), 3228S3233. Dangin, M., Guillet, C., Garcia-Rodenas, C., Gachon, P., Bouteloup-Demange, C., ReiffersMagnani, K., Fauquant, J., Ballevre, O. & Beaufrère, B. (2003). The rate of protein digestion affects protein gain differently during aging in humans. The Journal of Physiology, 549(2), 635-644. doi:10.1113/jphysiol.2002.036897 Dat, N. M., Hamanaka, D., Tanaka, F., & Uchino, T. (2012). Control of milk pH reduces biofilm formation of Bacillus licheniformis and Lactobacillus paracasei on stainless steel. Food Control, 23(1), 215-220. De Fries, R., & Mitsuhashi, M. (1995). Quantification of mitogen induced human lymphocyte proliferation: Comparison of alamarbluetm assay to 3h-thymidine incorporation assay. Journal of Clinical Laboratory Analysis, 9(2), 89-95. doi:10.1002/jcla.1860090203 der Meer, R. V., Kleibeuker, J. H., & Lapre, J. A. (1991). Calcium phosphate, bile acids and colorectal cancer. European Journal of Cancer Prevention, 1, 55-62. Dunlop, R. J., & Campbell, C. W. (2000). Cytokines and advanced cancer. Journal of Pain and Symptom Management, 20(3), 214-232. Ebaid, H., Badr, G., & Metwalli, A. (2012). Immunoenhancing property of dietary undenatured whey protein derived from three camel breeds in mice. Biologia, 67(2), 425-433. doi:10.2478/s11756-012-0014-0 Ebner, C., Siemann, U., Bohle, B., Willheim, M., Wiedermann, U., Schenk, S., Klotz, F., Ebner, H., Kraft, D. & Scheiner, O. (1997). Immunological changes during specific immunotherapy of grass pollen allergy: reduced lymphoproliferative responses to allergen and shift from TH2 to TH1 in T-cell clones specific for Phi p 1, a major grass pollen allergen. Clinical & Experimental Allergy, 27(9), 1007-1015. doi:10.1111/j.1365-2222.1997.tb01252.x Ei-Zahar, K., Sitohy, M., Choiset, Y., Metro, F., Haertle, T., & Chobert, J. M. (2004). Antibacterial activity of ovine whey protein and their peptic hydrolysates. Milchwissenschaft, 59, 653-656. El-Agamy, E. I. (2007). The challenge of cow milk protein allergy. Small Ruminant Research, 68(1–2), 64-72. 132 El-Agamy, E. I. (2009). Bioactive components in camel milk. In Bioactive Components in Milk and Dairy Products (pp. 159-194): Wiley-Blackwell. Retrieved from http://dx.doi.org/10.1002/9780813821504.ch6. doi:10.1002/9780813821504.ch6 El-Ghaish, S., Ahmadova, A., Hadji-Sfaxi, I., El Mecherfi, K. E., Bazukyan, I., Choiset, Y., Rabesona, H., Sitohy, M., Popov, Y. G., Kuliev, A. A., Mozzi, F., Chobert, J. &Haertlé, T. (2011). Potential use of lactic acid bacteria for reduction of allergenicity and for longer conservation of fermented foods. Trends in Food Science & Technology, 22(9), 509-516. Elitsur, Y., & Luk, G. D. (1991). Beta-casomorphin (BCM) and human colonic lamina propria lymphocyte proliferation. Clinical and Experimental Immunology, 85, 493-497. Emmett, P. M., & Rogers, I. S. (1997). Properties of human milk and their relationship with maternal nutrition. Early Human Development, 49(Supplement 1), S7-S28. End, A., Donia, M. A. A., Abd-Rabou, N. S., Abou-Arab, A. A. K., & El-Senaity, M. H. (2009). Chemical composition of raw milk and heavy metals behavior during processing of milk products. Global Veterinaria, 3(3), 268-275. Erdmann, K., Cheung, B. W. Y., & Schröder, H. (2008). The possible roles of food-derived bioactive peptides in reducing the risk of cardiovascular disease. The Journal of Nutritional Biochemistry, 19(10), 643-654. Eriksen, E. K., Vegarud, G. E., Langsrud, T., Almaas, H., & Lea, T. (2008). Effect of milk proteins and their hydrolysates on in vitro immune responses. Small Ruminant Research, 79(1), 29-37. Fabienne Parker, Migliore-Samour, D., Floch, F., Zerial, A., Werner, G. H., Jolles, J., Casaretto, M., Zahn, H. & Jolles, P. (1984). Immunostimulating hexapeptide from human casein: amino acid sequence, synthesis and biological properties. European Journal of Biochemistry, 145(3), 677-682. Feeley, R. M., Eitenmiller, R. R., Jones, J. B., & Barnhart, H. (1983). Copper, iron, and zinc contents of human milk at early stages of lactation. The American Journal of Clinical Nutrition, 37(3), 443-448. Fiat, A.-M., Migliore-Samour, D., Jolles, P., Drouet, L., Sollier, C. B. D., & Caen, J. (1993). Biologically active peptides from milk proteins with emphasis on two examples concerning antithrombotic and immunomodulating activities. Journal of Dairy Science, 76(1), 301-310. 133 Fira, D., Kojic, M., Banina, A., Spasojevic, I., Strahinic, I., & Topisirovic, L. (2001). Characterization of cell envelope-associated proteinases of thermophilic lactobacilli. Journal of applied microbiology, 90(1), 123-130. doi:10.1046/j.1365-2672.2001.01226.x Florisa, R., Recio, I., Berkhout, B., & Visser, S. (2003). Antibacterial and antiviral effects of milk proteins and derivatives thereof. Current Pharmaceutical Design, 9(16), 1257-1275. Fondahl, G. (1989). Reindeer dairying in the Soviet Union. Polar Records, 25(155), 285-294. Fox, P. F., & Brodkorb, A. (2008). The casein micelle: Historical aspects, current concepts and significance. International Dairy Journal, 18(7), 677-684. Franco, I., Castillo, E., Pérez, M. D., Calvo, M., & Sánchez, L. (2010). Effect of bovine lactoferrin addition to milk in yogurt manufacturing. Journal of Dairy Science, 93(10), 44804489. Friberg, D. (1994). In vivo cytokine production by normal human peripheral blood mononuclear cells as a measure of immunocompetence of the state of activation. Clinical and Diagnostic Laboratory Immunology, 1, 261-268. Frucht, D. M., Fukao, T., Bogdan, C., Schindler, H., O'Shea, J. J., & Koyasu, S. (2001). IFNγ production by antigen-presenting cells: mechanisms emerge. Trends in Immunology, 22(10), 556-560. Fujimoto, Z., Fujii, Y., Kaneko, S., Kobayashi, H., & Mizuno, H. (2004). Crystal structure of aspartic proteinase from irpex lacteus in complex with inhibitor pepstatin. Journal of Molecular Biology, 341(5), 1227-1235. doi:10.1016/j.jmb.2004.06.049 Furushiro, M., Hashimoto, S., Hamura, M., & Yokokura, T. (1993). Mechanism for the antihypertensive effect of a polysaccharide-glycopeptide complex from Lactobacillus casei in spontaneously hypertensive rats (SHR). Bioscience, Biotechnology, and Biochemistry, 57(6), 978-981. Galdeano, C., Nunez, I., de Moreno de LeBlanc, A., Carmuega, E., Weill, R., & Perdigon, G. (2011). Impact of a probiotic fermented milk in the gut ecosystem and in the systemic immunity using a non-severe protein-energy-malnutrition model in mice. BMC Gastroenterology, 11(1), 64-74. 134 Garibay-Escobar, A., Estrada-Garcıá , I., Estrada-Parra, S., & Santos-Argumedo, L. (2003). Integrated measurements by flow cytometry of the cytokines IL-2, IFN-ă, IL-12, TNF-á and functional evaluation of their receptors in human blood. Journal of Immunological Methods, 280(1–2), 73-88. Gauthier, S. F., & Pouliot, Y. (2003). Functional and biological properties of peptides obtained by enzymatic hydrolysis of whey proteins. Journal of Dairy Science, 86(13_suppl), E78-87. Gauthier, S. F., Pouliot, Y., & Saint-Sauveur, D. (2006). Immunomodulatory peptides obtained by the enzymatic hydrolysis of whey proteins. International Dairy Journal, 16(11), 1315-1323. Gessani, S., & Belardelli, F. (1998). IFN-γ expression in macrophages and its possible biological significance. Cytokine & Growth Factor Reviews, 9(2), 117-123. Ghosh, S., & Playford, R. J. (2003). Bioactive natural compounds for the treatment of gastrointestinal disorders. Clinical Science, 104(6), 547-556. doi:10.1042/cs20030067 Gill, H. S., Doull, F., Rutherfurd, K. J., & Cross, M. L. (2000). Immunoregulatory peptides in bovine milk. British Journal of Nutrition, 84(SupplementS1), 111-117. doi:doi:10.1017/S0007114500002336 Gobbetti, M., Ferranti, P., Smacchi, E., Goffredi, F., & Addeo, F. (2000). Production of Angiotensin-I-Converting-Enzyme-Inhibitory peptides in fermented milks started by Lactobacillus delbrueckii subsp. bulgaricus SS1 and Lactococcus lactis subsp. cremoris FT4. Applied &Environmental Microbiology, 66(9), 3898-3904. doi:10.1128/aem.66.9.38983904.2000 Gobbetti, M., Minervini, F., & Rizzello, C. G. (2006). Bioactive peptides in dairy products: John Wiley & Sons, Inc. Retrieved from http://dx.doi.org/10.1002/9780470113554.ch70. doi:10.1002/9780470113554.ch70 Gobbetti, M., Stepaniak, L., De Angelis, M., Corsetti, A., & Di Cagno, R. (2002). Latent bioactive peptides in milk proteins: proteolytic activation and significance in dairy processing. Critical Reviews in Food Science and Nutrition, 42(3), 223-239. doi:10.1080/10408690290825538 135 González-Chávez, S. A., Arévalo-Gallegos, S., & Rascón-Cruz, Q. (2009). Lactoferrin: structure, function and applications. International Journal of Antimicrobial Agents, 33(4), 301.e301-301.e308. Gonzalez-Llano, D., Polo, C., & Ramos, M. (1990). Update on HPLC and FPLC analysis of nitrogen compounds in dairy products. Lait, 70(3), 255-277. Grosvenor, C. E., Picciano, M. F., & Baumrucker, C. R. (1993). Hormones and Growth Factors in Milk. Endocrine Reviews, 14(6), 710-728. doi:10.1210/edrv-14-6-710 Haenlein, G. F. W., & Wendorff, W. L. (2008). Sheep Milk. In Handbook of Milk of NonBovine Mammals (pp. 137-194): Blackwell Publishing Professional. Retrieved from http://dx.doi.org/10.1002/9780470999738.ch7. doi:10.1002/9780470999738.ch7 Hansen, C. L., den Berg, F. v., Rasmussen, M. A., Engelsen, S. B., & Holroyd, S. (2010). Detecting variation in ultrafiltrated milk permeates — Infrared spectroscopy signatures and external factor orthogonalization. Chemometrics and Intelligent Laboratory Systems, 104(2), 243-248. Hayes, M., Ross, R. P., Fitzgerald, G. F., Hill, C., & Stanton, C. (2006). Casein-derived antimicrobial peptides generated by Lactobacillus acidophilus DPC6026. Applied and Environmental Microbiology, 72(3), 2260-2264. Haza, A. I., Morales, P., Martin, R., Garcia, T., Anguita, G., Gonzalez, I., Sanz, B. & Hernandez, P. E. (1995). Immunoreactivity of goat's milk casein fractionated by ionexchange chromatography. Journal of Agricultural and Food Chemistry, 43(8), 2025-2029. doi:doi:10.1021/jf00056a013 Heinzel, F. P., Schoenhaut, D. S., Rerko, R. M., Rosser, L. E., & Gately, M. K. (1993). Recombinant interleukin 12 cures mice infected with Leishmania major. The Journal of Experimental Medicine, 177(5), 1505-1509. doi:10.1084/jem.177.5.1505 Hernández, D., Cardell, E., & Zárate, V. (2005). Antimicrobial activity of lactic acid bacteria isolated from Tenerife cheese: initial characterization of plantaricin TF711, a bacteriocin like substance produced by Lactobacillus plantarum TF711. Journal of Applied Microbiology, 99(1), 77-84. Hernández-Ledesma, B., Ramos, M., & Gómez-Ruiz, J. Á. (2011). Bioactive components of ovine and caprine cheese whey. Small Ruminant Research, 101(1–3), 196-204. 136 Hitchins, A. D., & McDonough, F. E. (1989). Prophylactic and therapeutic aspects of fermented milk. The American Journal of Clinical Nutrition, 49(4), 675-684. Hopkins, S. J. (2003). The pathophysiological role of cytokines. Legal Medicine, 5, Supplement(0), S45-S57. Hou, H., Fan, Y., Li, B., Xue, C., Yu, G., Zhang, Z., & Zhao, X. (2012). Purification and identification of immunomodulating peptides from enzymatic hydrolysates of Alaska pollock frame. Food Chemistry, 134(2), 821-828. Huong, P. L. T., Kolk, A. H. J., Eggelte, T. A., Verstijnen, C. P. H. J., Gilis, H., & Hendriks, J. T. (1991). Measurement of antigen specific lymphocyte proliferation using 5-bromodeoxyuridine incorporation an easy and low cost alternative to radioactive thymidine incorporation. Journal of Immunological Methods, 140(2), 243-248. Hurley, W. L., & Theil, P. K. (2011). Perspectives on immunoglobulins in colostrum and milk. Nutrients, 3(4), 442-474. Inglingstad, R. A. E., Devold, T. G., Eriksen, E. K., Holm, H., Jacobsen, M., Liland, K. H., Rukke, E. O. &Vegarud, G. E. (2010). Comparison of the digestion of caseins and whey proteins in equine, bovine, caprine and human milks by human gastrointestinal enzymes. Dairy Science Technology, 90(5), 549-563. Ismail, A. A., El Deeb, S. A., & El Difrawi, E. A. (1973). The buffering properties of cow and buffalo milks. Zeitschrift für Lebensmitteluntersuchung und -Forschung A, 152(1), 2531. doi:10.1007/bf01810557 Jacquot, A., Gauthier, S. F., Drouin, R., & Boutin, Y. (2010). Proliferative effects of synthetic peptides from β-lactoglobulin and α-lactalbumin on murine splenocytes. International Dairy Journal, 20(8), 514-521. Järvinen, K.-M., Beyer, K., Vila, L., Chatchatee, P., Busse, P. J., & Sampson, H. A. (2002). B-cell epitopes as a screening instrument for persistent cow's milk allergy. Journal of Allergy and Clinical Immunology, 110(2), 293-297. Jolles, P., Parker, F., Floc'h, F., Migliore, D., Alliel, P., Zerial, A., & Werner, G. H. (1981). Immunostimulating substances from human casein. Immunopharmacology and Immunotoxicology, 3(3-4), 363-370. doi:doi:10.3109/08923978109031067 137 Juillard, V., Guillot, A., Le Bars, D., & Gripon, J.-C. (1998). Specificity of milk peptide utilization by Lactococcus lactis. Applied Environmental Microbiology, 64(4), 1230-1236. Juillard, V., Laan, H., Kunji, E. R., Jeronimus-Stratingh, C. M., Bruins, A. P., & Konings, W. N. (1995). The extracellular PI-type proteinase of Lactococcus lactis hydrolyzes beta-casein into more than one hundred different oligopeptides. Journal of Bacteriology, 177(12), 34723478. Jutel, M., Pichler, W. J., Skrbic, D., Urwyler, A., Dahinden, C., & Muller, U. R. (1995). Bee venom immunotherapy results in decrease of IL-4 and IL-5 and increase of IFN-gamma secretion in specific allergen-stimulated T cell cultures. The Journal of Immunology, 154(8), 4187-4194. Kandler, O. (1983). Carbohydrate metabolism in lactic acid bacteria. Antonie van Leeuwenhoek, 49(3), 209-224. doi:10.1007/bf00399499 Kayser, H., & Meisel, H. (1996). Stimulation of human peripheral blood lymphocytes by bioactive peptides derived from bovine milk proteins. FEBS Letters, 383(1-2), 18-20. Khan, I. A., Bhardwaj, G., Malla, N., Wattal, C., & Agarwal, S. C. (1986). Effect of serotonin on T lymphocyte proliferation in vitro in healthy individuals. International Archives of Allergy and Immunology, 81(4), 378-380. Kitts, D. D., & Weiler, K. (2003). Bioactive proteins and peptides from food sources. Applications of bioprocesses used in isolation and recovery. Current Pharmaceutical Design, 9(16), 1309. Kleber, N., Weyrich, U., & Hinrichs, J. (2006). Screening for lactic acid bacteria with potential to reduce antigenic response of β-lactoglobulin in bovine skim milk and sweet whey. Innovative Food Science & Emerging Technologies, 7(3), 233-238. Kopf-Bolanz, K. A., Schwander, F., Gijs, M., Vergeres, G., & Portmann, R. (2012). Validation of an in vitro digestive system for studying macronutrient decomposition in humans. The Journal of Nutrition, 142 (2), 245-250. Korhonen, H. (2009). Milk-derived bioactive peptides: from science to applications. Journal of Functional Foods, 1(2), 177-187. 138 Korhonen, H., Marnila, P., & Gill, H. S. (2000). Milk immunoglobulins and complement factors. British Journal of Nutrition, 84(S1), 75-80. Korhonen, H., & Pihlanto, A. (2003). Food-derived bioactive peptides - opportunities for designing future foods. Current Pharmaceutical Design, 9(16), 1297-1308. Korhonen, H., & Pihlanto, A. (2006). Bioactive peptides: production and functionality. International Dairy Journal, 16(9), 945-960. Korhonen, H., & Pihlanto, A. (2007). Bioactive Peptides from Food Proteins. In Handbook of Food Products Manufacturing (pp. 1-37): John Wiley & Sons, Inc. Retrieved from http://dx.doi.org/10.1002/9780470113554.ch46. doi:10.1002/9780470113554.ch46 Korhonen, H. J. (2006). Technological and health aspects of bioactive components of milk. International Dairy Journal, 16(11), 1227-1228. Kraan van der, M. I. A., Nazmi, K., van ’t Hof, W., Amerongen, A. V. N., Veerman, E. C. I., & Bolscher, J. G. M. (2006). Distinct bactericidal activities of bovine lactoferrin peptides LFampin 268–284 and LFampin 265–284: Asp-Leu-Ile makes a difference. Biochemistry and Cell Biology, 84(3), 358-362. Kurzrock, R., Redman, J., Cabanillas, F., Jones, D., Rothberg, J., & Talpaz, M. (1993). Serum interleukin 6 levels are elevated in lymphoma patients and correlate with survival in advanced hodgkin's disease and with B symptoms. Cancer Research, 53(9), 2118-2122. Laemmli, U. K. (1970). Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature, 227(5259), 680-685. Laffineur, E., Genetet, N., & Leonil, J. (1996). Immunomodulatory activity of {beta}-casein permeate medium fermented by lactic acid bacteria. Journal of Dairy Science, 79(12), 21122120. Landete-Castillejos, T., Garcia, A., Molina, P., Vergara, H., Garde, J., & Gallego, L. (2000). Milk production and composition in captive Iberian red deer (Cervus elaphus hispanicus): effect of birth date. Journal of Animal Science, 78, 2771-2777. Lahov, E., & Regelson, W. (1996). Antibacterial and immunostimulating casein-derived substances from milk: Casecidin, isracidin peptides. Food and Chemical Toxicology, 34(1), 131-145. 139 LeBlanc, J., Fliss, I., & Matar, C. (2004). Induction of a humoral immune response following an Escherichia coli O157:H7 infection with an immunomodulatory peptidic fraction derived from Lactobacillus helveticus-fermented milk. Clinical and Diagnostic Laboratory Immunology, 11(6), 1171-1181. doi:10.1128/cdli.11.6.1171-1181.2004 LeBlanc, J. G., Matar, C., Valdez, J. C., LeBlanc, J., & Perdigon, G. (2002). Immunomodulating Effects of Peptidic Fractions Issued from Milk Fermented with Lactobacillus helveticus. Journal of Dairy Science, 85(11), 2733-2742. Ledur, A., Fitting, C., David, B., Hamberger, C., & Cavaillon, J.-M. (1995). Variable estimates of cytokine levels produced by commercial ELISA kits: results using international cytokine standards. Journal of Immunological Methods, 186(2), 171-179. Lindén, M. V., Wiedmer, S. K., Hakala, R. M. S., & Riekkola, M.-L. (2004). Stabilization of phosphatidylcholine coatings in capillary electrophoresis by increase in membrane rigidity. Journal of Chromatography A, 1051(1–2), 61-68. Liu, X., Song, C., Chen, R., Jiang, X., Jin, Y., & Zou, H. (2010). Identification of angiotensin I-converting enzyme inhibitors in peptides mixture of hydrolyzed red deer plasma with proteomic approach. Chinese Journal of Chemistry, 28(9), 1665-1672. doi:10.1002/cjoc.201090282 McCarthy O.J, & John, W. F. (2002). Milk | Physical and Physico-Chemical Properties of Milk. In Encyclopedia of Dairy Sciences (Second Edition) (pp. 467-477). San Diego: Academic Press. Mackle, T. R., Bryant, A. M., Petch, S. F., Hill, J. P., & Auldist, M. J. (1999). Nutritional influences on the composition of milk from cows of different protein phenotypes in New Zealand. Journal of Dairy Science, 82(1), 172-180. Mahé, S., Benamouzig, R., Gaudichon, C., Huneau, J. F., De Cruz, I., Rautureau, J., & Tomé, D. (1995). Nitrogen movements in the upper jejunum lumen in human fed low amounts of casein or -lactoglobulin. Gastroentérologie clinique et biologique, 19(1), 20-26. Mahe, S., Roos, N., Benamouzig, R., Davin, L., Luengo, C., Gagnon, L., Rautureau, J.&Tome, D. (1996). Gastrojejunal kinetics and the digestion of [15N]beta-lactoglobulin and casein in humans: the influence of the nature and quantity of the protein. The American Journal of Clinical Nutrition, 63(4), 546-552. 140 Mao, X. Y., Yang, H. Y., Song, J. P., Li, Y. H., & Ren, F. Z. (2007). Effect of yak milk casein hydrolysate on Th1/Th2 cytokines production by murine spleen lymphocytes in vitro. Journal of Agricultural and Food Chemistry, 55(3), 638-642. doi:10.1021/jf062452m Marnila, P., Korhonen, H., & John, W. F. (2011). Milk Proteins | Immunoglobulins. In: Encyclopedia of Dairy Sciences (Second Edition) (pp. 807-815). San Diego: Academic Press. Retrieved from http://www.sciencedirect.com/science/article/pii/B9780123744074004362 Matar, C., Amiot, J., Savoie, L., & Goulet, J. (1996). The effect of milk fermentation by Lactobacillus helveticus on the release of peptides during in vitro digestion. Journal of Dairy Science, 79(6), 971-979. Matar, C., Valdez, J. C., Medina, M., Rachid, M., & Perdigon, G. (2001). Immunomodulating effects of milks fermented by Lactobacillus helveticus and its non-proteolytic variant. Journal of Dairy Research, 68, 601-609. Matsuzaki, T. (1998). Immunomodulation by treatment with Lactobacillus casei strain Shirota. International Journal of Food Microbiology, 41, 133-140. McDougall, E. I., & Stewart, J. C. (1975). The whey proteins of the milk of red deer.Biochemistry Journal 153(1), 647-655. McIntosh, G. H., Royle, P. J., Le Leu, R. K., Regester, G. O., Johnson, M. A., Grinsted, R. L., Kenward, R. S.& Smithers, G. W. (1998). Whey proteins as functional food ingredients? International Dairy Journal, 8(5–6), 425-434. Meance, S., Cayuela, C., Raimondi, A., Turchet, P., Lucas, C., & Antoine, J.-m. (2003). Recent advances in the use of functional foods: effects of the commercial fermented milk with Bifidobacterium animalis strain dn-173 010 and yoghurt strains on gut transit time in the elderly. Microbial Ecology in Health and Disease, 15(1), 15-22. doi:doi:10.1080/08910600310015565 Medina, A. L., Colas, B., Le Meste, M., Renaudet, I., & Lorient, D. (1992). Physicochemical and dynamic properties of caseins modified by chemical phosphorylation. Journal of Food Science, 57(3), 617-621. doi:10.1111/j.1365-2621.1992.tb08055.x Meisel, H. (1997). Biochemical properties of bioactive peptides derived from milk proteins: Potential nutraceuticals for food and pharmaceutical applications. Livestock Production Science, 50(1–2), 125-138. 141 Meisel, H. (2001). Bioactive peptides from milk proteins: a perspective for consumer and producers Australian Journal of Dairy Technology, 56, 83-91. Meisel, H., & Bockelmann, W. (1999). Bioactive peptides encrypted in milk proteins: proteolytic activation and thropho-functional properties. Antonie van Leeuwenhoek, 76(1), 207-215. Meixner, A., Karreth, F., Kenner, L., & Wagner, E. F. (2004). JunD regulates lymphocyte proliferation and T helper cell cytokine expression. EMBO Journal, 23(6), 1325-1335. Mercier, A., Gauthier, S. F., & Fliss, I. l. (2004). Immunomodulating effects of whey proteins and their enzymatic digests. International Dairy Journal, 14(3), 175-183. Metcalf, D., & Wiadrowski, M. (1966). Autoradiographic analysis of lymphocyte proliferation in the thymus and in thymic lymphoma tissue. Cancer Research, 26(3 Part 1), 483-491. Migliore-Samour, D., Floc'h, F., & Jollès, P. (1989). Biologically active casein peptides implicated in immunomodulation. Journal of Dairy Research, 56(03), 357-362. doi:doi:10.1017/S0022029900028806 Migliore-Samour, D., & Jollès, P. (1988). Casein, a prohormone with an immunomodulating role for the newborn? Cellular and Molecular Life Sciences, 44(3), 188-193. doi:10.1007/bf01941703 Minervini, F., Algaron, F., Rizzello, C. G., Fox, P. F., Monnet, V., & Gobbetti, M. (2003). Angiotensin I-converting-enzyme-inhibitory and antibacterial peptides from Lactobacillus helveticus PR4 proteinase-hydrolyzed caseins of milk from six species. Applied and Environmental Microbiology, 69(9), 5297-5305. Miyauchi, H., Kaino, A., Shinoda, I., Fukuwatari, Y., & Hayasawa, H. (1997). Immunomodulatory effect of bovine lactoferrin pepsin hydrolysate on murine splenocytes and peyer's patch cells. Journal of Dairy Science, 80(10), 2330-2339. Möller, N., Scholz-Ahrens, K., Roos, N., & Schrezenmeir, J. (2008). Bioactive peptides and proteins from foods: indication for health effects. European Journal of Nutrition, 47(4), 171182. doi:10.1007/s00394-008-0710-2 142 Moller, S. A., Danielsson, L. D., & Borrebaek, C. A. (1986). Concanavalin A-induced B-cell proliferation mediated by allogeneically derived helper factors. Immunobiology, 57(3), 387393. Morgan, D. A., Ruscetti, F. W., & Gallo, R. (1976). Selective in vitro growth of T lymphocytes from normal human bone marrows. Science, 193(4257), 1007-1008. doi:10.1126/science.181845 Muraro, M. A., Giampietro, P. G., & Galli, E. (2002). Soy formulas and nonbovine milk. Annals of Allergy, Asthma & Immunology, 89(6, Supplement), 97-101. Nagpal, R., Behare, P., Rana, R., Kumar, A., Kumar, M., Arora, S., Morotta, F., Jain, S.& Yadav, H. (2011). Bioactive peptides derived from milk proteins and their health beneficial potentials: an update. Food & Function, 2(1), 18-27. Natale, M., Bisson, C., Monti, G., Peltran, A., Perono Garoffo, L., Valentini, S., Morotta, F., Jain, S. &Conti, A. (2004). Cow's milk allergens identification by two-dimensional immunoblotting and mass spectrometry. Molecular Nutrition & Food Research, 48(5), 363369. doi:10.1002/mnfr.200400011 Nielsen, M. S., Martinussen, T., Flambard, B., Sørensen, K. I., & Otte, J. (2009). Peptide profiles and angiotensin-I-converting enzyme inhibitory activity of fermented milk products: effect of bacterial strain, fermentation pH, and storage time. International Dairy Journal, 19(3), 155-165. Nolte, J., &. (2003). ICP emission spectrometry: A practical Guide”: Wiley-VCH Opatha Vithana, N.L., Mason, S. L., Bekhit, A. E. A. & Morton, J. D. (2010) Immunomodulatory bioactives from red deer milk. Abstract from Proceedings of the IDF International Dairy conference. http://www.wds2010.com/delegates/posters/DST-Opatha%20Vithana.Pdf Opatha Vithana, N.L., Mason, S. L., Bekhit, A. E. A. & Morton, J. D. (2011). The release of peptides by in vitro digestion of fermented red deer (Cervus elaphus) and cow (Bos taurus) milk. Proceedings of the Nutrition Society of New Zealand. Volume 35. (In press) 143 Opatha Vithana, N.L., Mason, S. L., Bekhit, A. E. A. & Morton, J. D. (2012). In vitro digestion of red deer (Cervus elaphus) and cow (Bos taurus) milk. International Food Research Journal. 19 (4): 409-416. Osorio, M. T., Zumalacárregui, J. M., Bermejo, B., Lozano, A., Figueira, A. C., & Mateo, J. (2007). Effect of ewe's milk versus milk-replacer rearing on mineral composition of suckling lamb meat and liver. Small Ruminant Research, 68(3), 296-302. Otani, H., & Monnai, M. (1993). Inhibition of proliferative responses of mouse spleen lymphocytes by bovine milk κ‐casein digests. Food and Agricultural Immunology, 5(4), 219- 229. doi:10.1080/09540109309354801 Otani, H., Monnai, M., Kawasaki, Y., Kawakami, H., & Tanimoto, M. (1995). Inhibition of mitogen-induced proliferative responses of lymphocytes by bovine κ-caseinoglycopeptides having different carbohydrate chains. Journal of Dairy Research, 62(02), 349-357. doi:doi:10.1017/S0022029900031046 Otani, H., Monni, M., & Hosono, A. (1992). Bovine kepa-casein as inhibitor of the proliferation of mouse splenocytes induced by lipopolysaccharide stimulation. Milchwissenschaft, 47, 512-515. Pan, D., Luo, Y., & Tanokura, M. (2005). Antihypertensive peptides from skimmed milk hydrolysate digested by cell-free extract of Lactobacillus helveticus JCM1004. Food Chemistry, 91(1), 123-129. Pandya, A. J., & Haenlein, G. F. W. (2009). Bioactive components in buffalo milk. In Bioactive Components in Milk and Dairy Products (pp. 105-157): Wiley-Blackwell. Retrieved from http://dx.doi.org/10.1002/9780813821504.ch5. doi:10.1002/9780813821504.ch5 Papadimitriou, C. G., Vafopoulou-Mastrojiannaki, A., Silva, S. V., Gomes, A.-M., Malcata, F. X., & Alichanidis, E. (2007). Identification of peptides in traditional and probiotic sheep milk yoghurt with angiotensin I-converting enzyme (ACE)-inhibitory activity. Food Chemistry, 105(2), 647-656. 144 Pariza, M. W., Park, Y., & Cook, M. E. (2001). The biologically active isomers of conjugated linoleic acid. Progress in Lipid Research, 40(4), 283-298. Park, Y. W. (1991). Relative buffering capacity of goat milk, cow milk, soy-based infant formulas, and commercial nonprescription antacid drugs. Journal of Dairy Science, 74(10), 3326-3333. doi:10.3168/jds.S0022-0302(91)78520-2 Park, Y. W. (1992). Comparison of buffering components in goat and cow milk. Small Ruminant Research, 8(1-2), 75-81. doi:10.1016/0921-4488(92)90009-s Park, Y. W. (2009). Overview of bioactive components in milk and dairy products. Bioactive components in milk and dairy products: Wiley-Blackwell. (pp. 3-12). Retrieved from http://books.google.co.nz/books?id=VFpG2doYN7IC Park, Y. W., & Haenlein, G. F. W. (Eds.). (2006). Handbook of Milk of Non-Bovine Mammals. Iowa: Blackwell Publishing. Park, Y.W. (2011). Milk | milks of other domesticated mammals (Pigs, Yaks, Reindeer, etc.). In Encyclopedia of Dairy Sciences (Second Edition) (pp. 530-537). San Diego: Academic Press. Retrieved from http://www.sciencedirect.com/science/article/pii/B9780123744074003198 Parker, F., Migliore-Samour, D., Floch, F., Zerial, A., Werner, G. H., JollÈS, J., Casaretto, M., Zahn, H. &Jolles, P. (1984). Immunostimulating hexapeptide from human casein: amino acid sequence, synthesis and biological properties. European Journal of Biochemistry, 145(3), 677-682. doi:10.1111/j.1432-1033.1984.tb08609.x Pedroche, J., Yust, M. a. M., Lqari, H., Girón-Calle, J., Vioque, J., Alaiz, M., & Millán, F. (2004). Production and characterization of casein hydrolysates with a high amino acid Fischer's ratio using immobilized proteases. International Dairy Journal, 14(6), 527-533. Perdigón, G., Alvarez, S., & de Ruiz Holgado, A. P. (1991). Immunoadjuvant activity of oral Lactobacillus casei: influence of dose on the secretory immune response and protective capacity in intestinal infections. Journal of Dairy Research, 58(04), 485-496. doi:doi:10.1017/S0022029900030090 Perelson, A. S., & Oster, G. F. (1979). Theoretical studies of clonal selection: Minimal antibody repertoire size and reliability of self-non-self discrimination. Journal of Theoretical Biology, 81(4), 645-670. 145 Perez Espitia, P. J., de Fátima Ferreira Soares, N., dos Reis Coimbra, J. S., de Andrade, N. J., Souza Cruz, R., & Alves Medeiros, E. A. (2012). Bioactive Peptides: Synthesis, Properties, and Applications in the Packaging and Preservation of Food. Comprehensive Reviews in Food Science and Food Safety, 11(2), 187-204. doi:10.1111/j.1541-4337.2011.00179.x Pescuma, M., Hébert, E. M., Mozzi, F., & Font de Valdez, G. (2008). Whey fermentation by thermophilic lactic acid bacteria: Evolution of carbohydrates and protein content. Food Microbiology, 25(3), 442-451. Phelan, M., Aherne, A., FitzGerald, R. J., & O'Brien, N. M. (2009). Casein-derived bioactive peptides: Biological effects, industrial uses, safety aspects and regulatory status. International Dairy Journal, 19(11), 643-654. Picariello, G., Ferranti, P., Fierro, O., Mamone, G., Caira, S., Di Luccia, A., Monica, S. & Addeo, F. (2010). Peptides surviving the simulated gastrointestinal digestion of milk proteins: Biological and toxicological implications. Journal of Chromatography B, 878(3-4), 295-308. doi:10.1016/j.jchromb.2009.11.033 Pihlanto, A. (2006). Antioxidative peptides derived from milk proteins. International Dairy Journal, 16(11), 1306-1314. Pihlanto, A., & John, W. F. (2011). Milk protein products | bioactive peptides. In Encyclopedia of Dairy Sciences (Second Edition) (pp. 879-886). San Diego: Academic Press. Retrieved from http://www.sciencedirect.com/science/article/pii/B9780123744074003514 Pihlanto-Leppälä, A., Rokka, T., & Korhonen, H. (1998). Angiotensin I converting enzyme inhibitory peptides derived from bovine milk proteins. International Dairy Journal, 8(4), 325-331. Polat, K., Şahan, S., & Güneş, S. (2006). A new method to medical diagnosis: artificial immune recognition system (AIRS) with fuzzy weighted pre-processing and application to ECG arrhythmia. Expert Systems with Applications, 31(2), 264-269. Prioult, G., Pecquet, S., & Fliss, I. (2004). Stimulation of interleukin-10 production by acidic [beta]-lactoglobulin-derived peptides hydrolyzed withLactobacillus paracasei NCC2461 peptidases. Clinical and Diagnostic Laboratory Immunology, 11(2), 266-271. doi:10.1128/cdli.11.2.266-271.2004 146 Prioult, G., Pecquet, S., & Fliss, I. (2005). Allergenicity of acidic peptides from bovine [beta]-lactoglobulin is reduced by hydrolysis with Bifidobacterium lactis NCC362 enzymes. International Dairy Journal, 15(5), 439-448. doi:10.1016/j.idairyj.2004.09.001 Raynal-Ljutovac, K., Lagriffoul, G., Paccard, P., Guillet, I., & Chilliard, Y. (2008). Composition of goat and sheep milk products: An update. Small Ruminant Research, 79(1), 57-72. Ribeiro, A. S., Moretto, A. L., Arruda, M. A. Z., & Cadore, S. (2003). Analysis of powdered coffee and milk by ICP OES after sample treatment with tetramethylammonium hydroxide. Microchimica Acta, 141(3), 149-155. doi:10.1007/s00604-002-0935-3 Ricci-Cabello, I., Olalla Herrera, M., & Artacho, R. (2012). Possible role of milk-derived bioactive peptides in the treatment and prevention of metabolic syndrome. Nutrition Reviews, 70(4), 241-255. doi:10.1111/j.1753-4887.2011.00448.x Richard J Fitzgerald, B. A. M. (2006). Bioactive peptides and lactic fermentations. International Journal of Dairy Technology, 59(2), 118-125. Rincón, F., Moreno, R., Zurera, G., & Amaro, M. (1994). Mineral composition as a characteristic for the identification of animal origin of raw milk. Journal of Dairy Research, 61(01), 151-154. doi:doi:10.1017/S0022029900028144 Rohit, A. C., Sathisha, K., & Aparna, H. S. (2012). A variant peptide of buffalo colostrum βlactoglobulin inhibits angiotensin I-converting enzyme activity. European Journal of Medicinal Chemistry, 53(0), 211-219. Saint-Sauveur, D., Gauthier, S. F., Boutin, Y., & Montoni, A. (2008). Immunomodulating properties of a whey protein isolate, its enzymatic digest and peptide fractions. International Dairy Journal, 18(3), 260-270. Salami, M., Yousefi, R., Ehsani, M. R., Dalgalarrondo, M., Chobert, J.-M., Haertlé, T., Razavi, S. H.,Saboury, A. A., Niasari-Naslaji, A., Ahmad, F. &Moosavi-Movahedi, A. A. (2008). Kinetic characterization of hydrolysis of camel and bovine milk proteins by pancreatic enzymes. International Dairy Journal, 18(12), 1097-1102. doi:10.1016/j.idairyj.2008.06.003 Salami, M., Yousefi, R., Ehsani, M. R., Razavi, S. H., Chobert, J.-M., Haertlé, T., Saboury, A. A., Atri, M. S., Niasari-Naslaji, A., Ahmad, F. &Moosavi-Movahedi, A. A. (2009). 147 Enzymatic digestion and antioxidant activity of the native and molten globule states of camel [alpha]-lactalbumin: Possible significance for use in infant formula. International Dairy Journal, 19(9), 518-523. doi:10.1016/j.idairyj.2009.02.007 Salaün, F., Mietton, B., & Gaucheron, F. (2005). Buffering capacity of dairy products. International Dairy Journal, 15(2), 95-109. Saucier, L., Julien, M., Cheour, F., Letarte, R., & Goulet, J. (1992). Effect of feeding lactic acid bacteria and fermented milk on specific and nonspecific immune responses of mice infected with Klebsiella pneumoniae AD-1. Journal of Food Protection (USA). Savalle, B., Miranda, G., & Pelissier, J. P. (1989). In vitro simulation of gastric digestion of milk proteins. Journal of Agricultural and Food Chemistry, 37(5), 1336-1340. doi:10.1021/jf00089a028 Semo, E., Kesselman, E., Danino, D., & Livney, Y. D. (2007). Casein micelle as a natural nano-capsular vehicle for nutraceuticals. Food Hydrocolloids, 21(5–6), 936-942. Shah, N. P. (2000). Effects of milk-derived bioactives: an overview. British Journal of Nutrition, 84(SupplementS1), 3-10. doi:doi:10.1017/S000711450000218X Silva, S. V., & Malcata, F. X. (2005). Caseins as source of bioactive peptides. International Dairy Journal, 15(1), 1-15. Silva, S. V., Pihlanto, A., & Malcata, F. X. (2006). Bioactive peptides in ovine and caprine cheeselike systems prepared with proteases from Cynara cardunculus. Journal of Dairy Science, 89(9), 3336-3344. Sizemore, R. C., Dienglewicz, R. L., Pecunia, E., & Gottlieb, A. A. (1991). Modulation of concanavalin A-induced, antigen-nonspecific regulatory cell activity by leu-enkephalin and related peptides. Clinical Immunology and Immunopathology, 60(2), 310-318.Smacchi, E., & Gobbetti, M. (2000). Bioactive peptides in dairy products: synthesis and interaction with proteolytic enzymes. Food Microbiology, 17(2), 129-141. Smyth, M. J., Godfrey, D. I., & Trapani, J. A. (2001). A fresh look at tumor immunosurveillance and immunotherapy. NatureImmunology, 2(4), 293-299. Szwajkowska, M., Wolanciuk, A., Barlowska, J., Krol, J., & Litwinczuk, Z. (2011). Bovine milk protein as the source of bioactive peptides influencing the consumer's immune system a review. Animal Science Papers and Reports, 29(4), 269-280. 148 Takeda, K., & Okumura, K. (2007). Effects of a fermented milk drink containing Lactobacillus casei Strain Shirota on the Human NK-Cell Activity. Journal of Nutrition, 137(3), 791S-793. Tanabe, S. (2012). Short peptide modules for enhancing intestinal barrier function. Current Pharmaceutical Design, 18(6), 776-781. Tartour, E., Dorval, T., Mosseri, V., Deneux, L., Mathiot, C., Brailly, H., Montero, F., Joyeux, I., Pouillart, P. & Fridman, W. H. (1994). Serum interleukin 6 and C-reactive protein levels correlate with resistance to IL-2 therapy and poor survival in melanoma patients. British Journal of Cancer, 69(5), 911-913. Tezcucano Molina, A. C., Alli, I., Konishi, Y., & Kermasha, S. (2007). Effect of dephosphorylation on bovine casein. Food Chemistry, 101(3), 1263-1271. doi:10.1016/j.foodchem.2006.03.033 Tharmaraj, N. & Shah, N. P. (2003). Selective Enumeration of Lactobacillus delbrueckii ssp. Bulgaricus, Streptococcus thermophilus, Lactobacillus acidophilus, Bifidobacteria, Lactobacillus casei, Lactobacillus rhamnosus, and Propionibacteria. Journal of Dairy Science, 86, 2288-2296. Turvey, S. E., & Broide, D. H. (2010). Innate immunity. Journal of Allergy and Clinical Immunology, 125(2, Supplement 2), S24-S32. Vergara, H., Landete-Castillejos, T., Garcia, A., Molina, P., & Gallego, L. (2003). Concentration of Ca, Mg, K, Na, P and Zn in milk in two subspecies of red deer: Cervus elaphushispanicus and C. e. scoticus. Small Ruminant Research, 47(1), 77-83. Vincenzetti, S., Polidori, P., Mariani, P., Cammertoni, N., Fantuz, F. & Vita, A. 2008. Donkey’s milk protein fractions characterization. Food Chemistry, 106, 640-649. Vinderola, G., Matar, C., Palacios, J., & Perdigón, G. (2007). Mucosal immunomodulation by the non-bacterial fraction of milk fermented by Lactobacillus helveticus R389. International Journal of Food Microbiology, 115(2), 180-186. Wagner, U., Burkhardt, E., & Failing, K. (1999). Evaluation of canine lymphocyte proliferation: comparison of three different colorimetric methods with the -thymidine incorporation assay. Veterinary Immunology and Immunopathology, 70(3-4), 151-159. doi:10.1016/s0165-2427(99)00041-0 149 Wal, J. M. (1998). Immunochemical and molecular characterization of milk allergens. Allergy, 53, 114-117. doi:10.1111/j.1398-9995.1998.tb04979.x Weichert, H., Blechschmidt, I., Schroder, S., & Ambrosius, H. (1991). The MTT-assay as a rapid test for cell proliferation and cell killing: application to human peripheral blood lymphocytes (PBL). Allergie and Immunologie, 37, 139-144. Werner, G. H., Floc'h, F., Migliore-Samour, D., & Jollès, P. (1986). Immunomodulating peptides. Cellular and Molecular Life Sciences, 42(5), 521-531. Wiking, L., Larsen, T., & Sehested, J. (2008). Transfer of dietary zinc and fat to milk— evaluation of milk fat quality, milk fat precursors, and mastitis indicators.Journal of Dairy Science, 91(4), 1544-1551. Wong, C. W., Seow, H. F., Husband, A. J., Regester, G. O., & Watson, D. L. (1997). Effects of purified bovine whey factors on cellular immune functions in ruminants. Veterinary Immunology and Immunopathology, 56(1–2), 85-96. Wong, C. W., Seow, H. F., Liu, A. H., Husband, A. J., Smithers, G. W., & Watson, D. L. (1996). Modulation of immune responses by bovine [beta]-casein. Immunology & Cell Biology, 74(4), 323-329. Wood, P. J. (2006). The immune system: recognition of infectious agents. Anaesthesia & Intensive Care Medicine, 7(6), 179-180. Xu, X., Yan, H., Chen, J., & Zhang, X. (2011). Bioactive proteins from mushrooms. Biotechnology Advances, 29(6), 667-674. Yang, H., Liu, Y.-h., Ma, L.-z., & Kong, B.-h. (2009). Hydrolyzing condition and immunocompetence of sheep bone protein enzymatic lysates. Agricultural Sciences in China, 8(11), 1332-1338. Yoav D, L. (2010). Milk proteins as vehicles for bioactives. Current Opinion in Colloid & Interface Science, 15(1–2), 73-83. Young, J. Z. (1962). The life of vertebrates. New York: Oxford University Press. Retrieved from /z-wcorg/ database. Yuki, N., Watanabe, K., Mike, A., Tagami, Y., Tanaka, R., Ohwaki, M., & Morotomi, M. (1999). Survival of a probiotic, Lactobacillus casei strain Shirota, in the gastrointestinal tract: 150 Selective isolation from faeces and identification using monoclonal antibodies. International Journal of Food Microbiology, 48(1), 51-57. doi:http://dx.doi.org/10.1016/S01681605(99)00029-X Yun, S.S., Sugita-Konishi, Y., Kumagai, S., & Yamauchi, R. (1996). Isolation of mitogenic glycophosphopeptides from cheese whey protein concentrates. Bioscience, Biotechnology, and Biochemistry, 60, 429-433. Zhang, Q., Zeng, X., Guo, J., & Wang, X. (2002). Oxidant stress mechanism of homocysteine potentiating Con A-induced proliferation in murine splenic T lymphocytes. Cardiovascular Research, 53(4), 1035-1042. doi:10.1016/s0008-6363(01)00541-7 Zhi-Jun, Y., Sriranganathan, N., Vaught, T., Arastu, S. K., & Ansar Ahmed, S. (1997). A dye-based lymphocyte proliferation assay that permits multiple immunological analyses: mRNA, cytogenetic, apoptosis, and immunophenotyping studies. Journal of Immunological Methods, 210(1), 25-39. doi:10.1016/s0022-1759(97)00171-3 Zilman, A., Ganusov, V. V., & Perelson, A. S. (2010). Stochastic models of lymphocyte proliferation and death. PLOS ONE, 5(9), e12775. Zucht, H.-D., Raida, M., Adermann, K., Mägert, H.-J., & Forssmann, W.-G. (1995). Casocidin-I: a casein-[alpha]s2 derived peptide exhibits antibacterial activity. FEBS Letters, 372(2-3), 185-188. 151 Appendix A Appendix A Identification of deer milk proteins compare to cow milk proteins& selection of SDS-PAGE concentration Identification of deer milk proteins compare to cow milk proteins MW: 250 KD 150 100 75 50 37 Ig HC LF SA CN 25 20 15 10 β-lg α-la M C1 C2 D1 C3 C4 D2 D3 Figure 1.SDS- PAGE (4-12%) of skimmed cow and deer milk and milk digested with pepsin and CPP. High molecular weight marker is shown on left-hand side of the gel. The lanes are: M: High molecular marker,C1: Cow milk (10 µl sample),C2: Cow milk (20 µl sample),D1: Deer milk (10 µl sample),C3: Cow milk hydrolysed (10 µl sample),C4: Cow milk hydrolysed (20 µl sample),D2: Deer milk hydrolysed (10 µl sample),D3: Deer milk hydrolysed (20 µl sample). protein.Immunoglobulins heavy chain (IgHC), lactoferrin (LF), serum albumin (SA), casein (CN), β-lactoglobulin (β-lg) and α-lactalbumin (α-la).Each contained had 2 mg/ µl 152 The shown cow protein bands were identified accordance with Almaas et al., 2006 (20% SDS-PAGE) and Inglingstad et al., 2010 (12.5 % and 15 % SDS-PAGE) gel results. Deer protein bands were identified based on similarity to cow milk protein bands. Selection of SDS – PAGE concentration MW: 250 kDa 150 100 75 50 37 25 20 15 10 C C30 C50 C60 D D30 D50 D60 Figure 2.SDS- PAGE (8-16%) of skimmed cow & deer milk, cow & deer milk digested, with pepsin and CPP. The lanes are: High molecular marker (M), Cow milk(C), Digest after30min (C30), 50min (C50), 60min (C60), Deer milk (D), Digest after30min (D30), 50min (D50), 60min (D60). Each contained had 2 mg/ µl MW: 250 kDa 150 100 75 50 37 25 20 15 10 CL DL CS DS Csh Dsh C D 153 Figure 3.SDS-PAGE (8-16%) of fermented cow and deer milks by Lactobacillus delbrueckiisubsp bulgaricus, Streptococcus salivarius subsp thermophilus and Lactobacillus casei strain Shirota at 37°C for 24 hr. The lanes are Lactobacillus delbrueckiisubsp bulgaricus fermented cow (CL) and deer (DL) milk, Streptococcus salivarius subspthermophilusfermented cow (CS) and deer (DS) milk, Lactobacillus casei strain Shirota fermented cow (Csh) and deer (Dsh) milk, unfermented cow (C) and deer (D) milk. Each contained had 2 mg/ µl C C60 D60 D D M Figure 4.SDS-PAGE (20%) of skimmed cow & deer milk, cow & deer milk digested, with pepsin and CPP. The lanes are: High molecular marker (M), Cow milk(C), Cow milk digest after 60min (C60), Deer milk (D), Deer milk digest after 60min (D60). Each contained had 2 mg/ µl As preliminary studies different concentration of gels were tested base on literature. Vinderola et al., 2006 used 12 % SDS – PAGE for LAB fermented cow milk and Matar et al., 1995 used 12.5% seperating gel and 4% stacking gel. Almass et al., 2005 used 20% SDSPAGE for cow and goat milk and their digests. Inglingstad et al., 2010 was used 12.5 % and 15 % gel to analyse cow, goat, horse, human milk and their digest. Milk, milk ferment and milk digests were run with 4-12% precast gel which used in experiment chapters (fig. 3.3, 3.4, 4.7, 6.3), 8-16% gel (Fig 2 and 3) and 20 % gel (fig. 4). As shown in figure 2 and 3 protein bands of milk and digests were not clear in 8-16% gel and protein did not run well in 20 % gel (fig. 4) while 4-14% gel (experiemental chapters) showed cleare band. Since this study aimed to analyse milk protein bands and digested protein bands together 4-12 % gels were selected which gave clear bands in both case. 154 Appendix B Paper accepted forProceedings of the Nutrition Society of New Zealand (2011), Volume 35. The release of peptides by in-vitro digestion of fermented red deer (Cervus elphus) and cow (Bos taurus) milk. N. L. O PATHA V ITHANA1 , S. L. MASON1 , A. E. A. BEKHIT2 , J. D. MORTON1 1 Lincoln University, New Zealand; 2Otago University, New Zealand ABSTRACT Fermentation and digestion release peptides from milk as a source of amino acid and energy, as well as a source of biofunctional peptides that may have health benefits. The aim of this study was to ferment deer and cow milk using three strains of Lactic acid bacteria (LAB) and to compare the release of peptides following in-vitro digestion of the fermented milks. The three strains were Lactobacillus belburueckii subspbulgaricus, Streptococcus salivarius subsp thermophilus and Lactobacillus casei strain Shirota and the fermentations were carried at 37 oC for 24 hours. The in-vitrodigestion was performed in two steps; imitating both the human stomach (Pepsin, pH 2.5) and the duodenum (Corolase PP, pH 7.5). Release of peptides during milk fermentation and subsequent digestion was quantified using OPA (o-phthaldialdehyde) assay. Changes in protein and peptide profiles were evaluated using sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE) and quantified using ImageJ software. After 24 hours of fermentation, the pH of cow milk dropped below 4.6 and precipitated caseins while pH of deer milk remained above pH 4.6 for all three strains. Deer milk fermentations gave higher peptide production than cow milk fermentations. Following in-vitro digestion peptide production was significantly greater in deer milk than cow milk (P≤ 0.05). Lactobacillus casei strain Shirota showed the highest release of peptides. The main milk proteins were degraded during fermentation of both milks. Lactoferrin (LF) in cow milk was more resistant to fermentation than that in deer milk for all 3 strains. After 24 hours of fermentation by Lactobacillus casei strain Shirota, cow LF was still intact while 47% of the deer LF had degraded. Digestibility of β-lactoglobulin, α-lactalbumin of deer milk and immunoglobulin of cow milk was improved by fermentation.This study showed LAB fermentation prior to invitro digestion increased the digestibility and release of peptides from both milks. This effect was greater in deer milk than cow milk. INTRODUCTION Fermented milk products, in addition to providing a source of energy and nutrients, are also a source of peptides with biological functions that may improve health when ingested. The health benefits of fermented milk have been recognized and documented (Gobbetti et al., 2006). Over the last decade a great number of peptide 155 sequences with different bioactivities (eg. immunomodulatory, antihypertensive, antithrombotic, antibacterial, antioxidative and opioid activity) have been identified in various milk proteins (Korhonen, 2009). Many commercial lactic acid bacteria (LAB) based starter cultures are highly proteolytic (Korhonen, 2009). The in vitro study by Pihlanto-Leppala et al. (1998) demonstrated that fermentation of milk with starter cultures or enzymes derived from such cultures prior to treatment with digestive enzymes can enhance the release and alter the profile of bioactive peptides produced. Further, Matar et al. (1996) showed that fermentation of milk by LAB has a major impact on the release of novel low molecular mass peptides during in vitro digestion. It is likely that peptides are also released during digestion in the gastrointestinal tract. Deer milk has 8.8 % protein which is twice as concentrated as cow milk (Opatha Vithana et al., 2010). This could be a good substrate for proteolytic activity of LAB stains and may produce more peptides which might have biological functions beneficial to health. The aim of this study was to compare deer and cow milk during fermentation using three LAB cultures in terms of peptide production before and after in vitro digestion and compare deer and cow milk protein digestibility. This is the first report studying the fermentation of deer milk followed by in vitro digestion and the information from the present work is potentially useful in understanding the release of peptides in animal nutrition and to evaluate the potential use of deer milk products for human use. METHODS Milk Fermentation Skim deer and cow milk were inoculated withLactobacillus delbrueckiisubsp bulgaricus, Streptococcus salivarius subsp thermophilus and Lactobacillus casei strain Shirota with 2% (vol/vol) inoculums separately and incubated at 37°C for 24 hr (Matar et al., 1996). In vitro Digestion In vitro digestion was performed for milk and fermented milk in two steps using Pepsin and Corolase PP (mixture of trypsin, chymotrypsin and several amino and carboxypeptidases) according to Eriksen et al. (2008). The release of peptides during milk fermentation and digestion was quantified using OPA (o-phthaldialdehyde) assay(Church et al., 1983). The changes in protein and peptide profiles were compared by sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE) as per Lammli (1970) and quantified using ImageJ software (rsbweb.nih.gov/ij/). Statistical analysis All experiments were carried out in triplicate and the reported values are mean ± standard deviation. The data were subjected to one way analysis of variance (ANOVA), followed by Tukey’s test to determine the significant difference between means at p˂0.05 level using Minitab (16 version). RESULTS The pH of deer milk was 6.1 prior to fermentation whereas it was 6.5 for cow milk. After 24 hr of fermentation; the pH of cow milk was significantly lower than deer milk ferments for all three stains of LAB;Lactobacillus casei strain Shirota, Lactobacillus delbrueckiisubsp bulgaricus and Streptococcus salivarius subsp thermophilus. The pH fell below 4.6 for cow milk at which pH the casein is precipitated. Deer milk pH did not fall below 4.6 for any of the three LAB fermentations over 24 hr (Fig 1). (b) (c) 7.0 7.0 6.5 6.5 6.5 6.0 6.0 6.0 5.5 pH 7.0 pH pH (a) 5.5 5.5 5.0 5.0 5.0 4.5 4.5 4.5 4.0 4.0 0hr 6hr 12hr 24hr 44hr Fermentation time 72hr 4.0 0hr 6hr 12hr 17hr Fermentation time 24hr 0hr 6hr 12hr 17hr 24hr Fermentation time Figure 1. pH during fermentation of deer ( ◦ ) and cow ( • ) milk at 37°C. (a) Lactobacillus casei strain Shirota (Lcs), (b) Lactobacillus delbrueckiisubsp bulgaricus (Ldb), (c) Streptococcus salivarius subsp thermophilus (Sst). Data are mean of three independent fermentations ± S.D. The proteolytic activities of the studied strains (Fig.2) were significantly higher in deer milk than cow milk (p<0.05). The highest production of peptides was generated by Lactobacillus casei strain Shirota (Fig.2) after 24 hours of fermentation at 37°C. Once ferments were digested, significantly ( p<0.05) higher peptide production was observed in deer milk compared to cow milk for all three strains and the highest production was 156 found in digest of Lactobacillus casei strain Shirota fermented deer milk. Fermented milk digests always have slightly higher peptide concentration than raw milk digest. When comparing the three stains in terms of peptide production there was no significant difference after in vitro digestion of both deer and cow milk ferment. Figure 2. Peptide production following in vitro digest of raw milk and milk ferment for 24 hr as well as undigested ferment. Cow( ) and deer ( ) milk fermented with (a) Lactobacillus casei strain Shirota (b) Lactobacillus delbrueckiisubspbulgaricus (c) Streptococcus salivarius subsp thermophilus. Data are means± SD (n = 3). The degradation of milk proteins was visualized using SDS gel electrophoresis. The main milk proteins started to degrade during fermentation of both milks (Fig 3). After in vitrodigestion, most of the milk protein bands completely disappeared and appearance of new lower molecular mass bands on the gel could be seen. Quantification of protein bands using ImageJ software is shown in Table 1. (i) (ii) (iii) IgHC LF SA CN βLG αLA M C Cf Cfd D Df Dfd C Cf Cfd D Df Dfd C Cf Cfd D Df Dfd Figure 3. SDS-PAGE (4-12%) of deer and cow milk, ferment and digested ferment using(i) Lactobacillus casei strain Shirota, (ii) Lactobacillus delbrueckiisubsp bulgaricus and (iii) Streptococcus salivarius subsp thermophilus. The wells contains (C) cow milk, (Cf) cow milk ferment, (Cfd) cow milk ferment digest, (D) deer milk, (Df) deer milk ferment, (Dfd) deer milk ferment digest, (M) molecular weight marker. Each contained had 2 mg/ µl protein. Table 1. Remaining protein content (%) in digest of milk, Lactobacillus casei strain Shirota, Lactobacillus delbrueckiisubspbulgaricus and Streptococcus salivarius subsp thermophilusfermented (24 hr at37°C) milk before and after in vitro digested (30min simulated stomach + 30min simulated duodenum). Values are obtained by ImageJ. Lactobacillus delburueckii Streptococcus salivarius subs Lactobacillus casei strain Shirota subsp bulgaricus thermophilus Ferment Ferment Ferment Milk Digest Ferment Digest Ferment Digest Ferments Digest Deer Cow Deer Cow Deer Cow Deer Cow Deer Cow Deer Cow Deer Cow IgHC LF 1± 2 0±1 21±5 1±1 62±1 47±3 64±2 101±1 0±0 1±1 0±0 2±1 71±4 42±5 74±3 63±4 0±0 0±0 8±1 2±1 73±3 48±2 77±3 69±5 0±0 0±0 0±0 0±0 SA 0±0 1±1 77±1 68±1 0±1 1±0 62±7 63±6 0±0 1±1 70±1 67±6 0±0 0±0 157 CN β-lg 0±0 54±5 1±1 55±8 83±2 87±1 85±1 86±1 0±0 52±1 0±1 57±1 76±8 85±2 82±4 91±7 1±0 51±1 1±1 57±4 85±2 83±4 84±1 78±2 2±0 51±1 2±0 68±1 α-la 11±2 27±5 92±2 90±1 8±4 17±1 87±2 90±3 1±1 13±4 85±3 91±2 15±3 23±4 Data are mean ± S.D. (n=3) Lactoferrin (LF) of cow milk is more resistant to degradation during fermentation by all three LAB strains than deer milk (Table 1). After 24 hours of fermentation by Lactobacillus casei strain Shirota, LF was still intact (100%) in cow milk while 47% LF remained intact after deer milk fermentation. Digestibility of α –lactalbumin (α –la) of deer milk was significantly (p< 0.05) improved by Lactobacillus delbrueckiisubsp bulgaricusfermentation. About 11% intact α –la was found after in vitro digestion of raw deer milk whileLactobacillus delbrueckiisubsp bulgaricus ferment digest only contained 1% intact α –la (Table 1). The digestibility of β lactoglobulin in Streptococcus salivarius subsp thermophilus fermened deer milk was also significantly (p< 0.05) greater than β-lactoglobulin in cow milk ferment by the same culture. Deer milk fermented by the other two stains and digested showed slightly higher digestibility than cow ferment digest for β-lactoglobulin (β-lg). There was a significant difference observed in immunoglobulin (IG) of cow milk. Intact protein level was 21% after in vitro digestion of raw milk and this decreased to 0 (no intact protein) after in vitro digestion of milk fermented by all three strains. These differences in digestibility of milk protein may lead to formation of novel peptides. DISCUSSION Deer milk was slightly more acidic than cow milk. Differences in pH and buffering capacity of fresh milk reflect compositional variation (McCarthy, 2002). After 24 hour of fermentation, the deer milk ferment showed significantly higher pH (p<0.05) than cow milk which went below the casein iso electric point resulting in precipitation of casein for all three strains (Fig.1). The smaller pH drop of deer milk may be due to several factors such as low bacterial growth resulting in low lactic acid formation or a higher buffering capacity of deer milk than cow milk.The ultimate pH of cheese results from the lactic acid produced (from starter culture lactose metabolism) and moderated by the buffering capacity of the milk (Pendey et al., 2003). Principal buffer components in milk are soluble phosphate, colloidal calcium phosphate, citrate, bicarbonate, casein, salt and a number of minor constituents (McCarthy, 2002). Goat milk has high buffering capacity due to its high content of major buffering components such as minerals and protein (Park, 1992). The mineral and casein content of red deer milk is about twice that of cow milk (Opatha Vithana et al., 2010). This high casein and minerals can lead to high buffering capacity of deer milk and could reduce the pH drop during fermentation when compared to cow milk. Further studies should be done to confirm the nature and the components contributing to the buffering capacity of deer milk. Lactobacillus delbrueckiisubsp bulgaricus and Lactobacillus casei strain Shirota fermentation of deer milk produced significantly (p<0.05) higher peptide concentration than the fermentation of cow milk (Fig 2). When all three strains ferments were digested, deer milk ferment produced significantly higher peptide concentration than cow milk ferment. Gobbetti et al. (2000) showed that during milk fermentation, probiotic strains may produce several oligopeptides which generate bioactive peptides only after subsequent digestion by pepsin and trypsin. Peptide bonds that are protected within the native protein structure might be exposed by the action of LAB enzymes, thereby allowing the release of new peptides. According to Korhonen and Pilanto (2006), the use of both fermentation and digestion has been more effectiv in generating biofunctional peptides than fermentation or digestion alone. Mata et al. (1996) reported that proteolysis during fermentation enhanced the release of peptides and may lead to the formation of novel peptides during gastrointestinal digestion. Overall deer milk digest produce more peptides than cow milk and this was further increased by fermentation prior to digestion. The ability to produce extracellular proteinases is a very important feature of LAB. They catalyse proteolysis of milk proteins, providing the amino acids essential for growth of LAB (Fira et al., 2001). LAB fermentation in yogurt is a desirable process improving milk digestibility and enhancing nutritional quality by protein degradation and hence, changes the texture, the taste and the aroma of fermented products (El-Ghaish et al., 2011). In this study LAB fermentation improved the digestibility of β-lg of deer milk more than for cow milk (Table 1). β-lg is the main cause of 80% of milk allergies in children and infants. β-lg is the major whey protein in milk and in dairy products and it is of particular interest since it is the only whey protein of cow milk absent in human milk (El-Ghaish et al., 2011). Kleber et al., 2006 studied the ability of some LAB strains to reduce the antigenicity of β-lg using skim milk and sweet whey by indirect competitive ELISA, using polyclonal antibodies. They observed the reduction of antigenicity of skim milk by 90% and sweet whey by 70% compared to the initial value. Our results suggest that less β-lg remained in the ferment digest of deer milk compared to cow ferment digest which may leads to less allergenicity of LAB fermented digest in deer milk than cow milk. α-Lactalbumin is another whey protein which is less allergenic than to β-lg (Wal, 1998). 11% intact α –la of deer milk was reduced to 1% by digestion with Lactobacillus delbrueckiisubsp bulgaricus and to 8% by 158 digestion with Lactobacillus casei strain Shirota ferments (Table 1). There was significantly lower concentration of intact α –la in digest of deer ferment than cow ferment for all three strains. Bu et al. (2010) found that LAB fermentation reduced the antigenicity of cow α –la and β-lg by hydrolysis. Since our results showed less α –la and β-lg in deer ferment digest than cow ferment digest, fermented deer milk digest may be less allergen than fermented cow milk digest. Digestibility of cow IG was significantly improved after fermentation by all tested LAB strains (Table 3). Cow milk IGs are relatively resistant to proteolytic digestive enzymes in the gastrointestinal tract, but can be sensitive to microbial enzymes (Marnila and Korhone, 2011). In this study lactoferrrin (LF) in cow milk was significantly more resistant (P<0.05) to fermentation than that in deer milk for all three strains. Lactoferrin is an 80 kDa iron-binding glycoprotein of the transferrin family that is expressed in most biological fluids and is a major component of the mammalian innate immune system (Gonzalez-Chavez et al., 2009). In characterising the various peptides generated by LF hydrolysis, it was found that minimal variations in the amino acid sequence change the antimicrobial activity of the peptide. For example, LFampin 268–284 and LFampin 265–284, chemically synthesised fragments from the N-terminal sequence of bLF, differ in only three amino acids (265Asp-Leu-267Ile) but exhibit different antibacterial activities (Kraan van der et al., 2006). Therefore different levels of hydrolysis in deer and cow milk during fermentation may form different peptides which may have different strength of biological activity. Similar to our cow milk fermentation results, results of Franco et al. (2010) indicate that LF structure does not seem to be altered much by the activity of commercial LAB bacteria (yogurt). In contrast digestibility of deer milk is higher than cow milk and was further improved by LAB fermentation prior to digestion. CONCLUSION Fermentation prior to digestion increased the production of peptides from and the digestibility of major milk proteins from both deer and cow. Deer ferment digest produced more peptides than cow ferment digest. There was no significant difference in terms of peptide level produced after digestion among three LAB stains used in this experiment. Digestibility of major milk proteins was higher in deer ferment than cow ferment. This study is a novel approach which might have a great impact in diversifying income stream for deer farmers and generate new information which will help in understanding fawn nutrition. In future work deer and cow milk peptides will be fractionated using FPLC and immunomodulatory activity will be studied using human peripheral blood mononuclear cells (PBMC). REFERENCES Bu, G., Luo, Y., Zhang, Y., & Chen, F. (2010). Effects of fermentation by lactic acid bacteria on the antigenicity of bovine whey proteins. Journal of the Science of Food and Agriculture, 90(12), 2015-2020. Church, F. C., Swaisgood, H. E., Porter, D. H., & Catignani, G. L. (1983). Spectrophotometric assay using oPhthaldialdehyde for determination of proteolysis in milk and isolated milk proteins. Journal of Dairy Science, 66(6), 1219-1227. El-Ghaish, S., Ahmadova, A., Hadji-Sfaxi, I., El Mecherfi, K. E., Bazukyan, I., Choiset, Y. (2011). Potential use of lactic acid bacteria for reduction of allergenicity and for longer conservation of fermented foods. Trends in Food Science &Technology, 22(9), 509-516. Eriksen, E. K., Vegarud, G. E., Langsrud, T., Almaas, H., & Lea, T. (2008). Effect of milk proteins and their hydrolysates on in vitro immune responses. Small Ruminant Research, 79(1), 29-37. Fira, D., Kojic, M., Banina, A., Spasojevic, I., Strahinic, I., & Topisirovic, L. (2001). Characterization of cell envelope-associated proteinases of thermophilic lactobacilli. Journal of Applied Microbiology, 90(1), 123-130. Franco, I., Castillo, E., Pérez, M. D., Calvo, M., & Sánchez, L. (2010). Effect of bovine lactoferrin addition to milk in yogurt manufacturing. Journal of Dairy Science, 93(10), 4480-4489. Gobbetti, M., Ferranti, P., Smacchi, E., Goffredi, F., & Addeo, F. (2000). Production of angiotensin-Iconverting-enzyme-inhibitory peptides in fermented milks started by Lactobacillus delbrueckii subsp. bulgaricus SS1 and Lactococcus lactis subsp. cremoris FT4. Applied & Environmental Microbiology, 66(9), 3898-3904. Gobbetti, M., Minervini, F., & Rizzello, C. G. (2006). Bioactive Peptides in Dairy Products. John Wiley & Sons, Inc. González-Chávez, S. A., Arévalo-Gallegos, S., & Rascón-Cruz, Q. (2009). Lactoferrin: structure, function and applications. International Journal of Antimicrobial Agents, 33(4), 301.e301-301.e308. Kleber, N., Weyrich, U., & Hinrichs, J. (2006). Screening for lactic acid bacteria with potential to reduce antigenic response of β-lactoglobulin in bovine skim milk and sweet whey. Innovative Food Science & Emerging Technologies, 7(3), 233-238. Korhonen, H. (2009). Milk-derived bioactive peptides: From science to applications. Journal of Functional Foods, 1(2), 177-187. Korhonen, H., & Pihlanto, A.(2006).Bioactive peptides:Production and functionality. International Dairy Journal, 16(9), 945-960. 159 Kraan van der, M. I. A., Nazmi, K., van ’t Hof, W., Amerongen, A. V. N., Veerman, E. C. I., & Bolscher, J. G. M. (2006). Distinct bactericidal activities of bovine lactoferrin peptides LFampin 268–284 and LFampin 265–284: Asp-Leu-Ile makes a difference. Biochemistry and Cell Biology, 84(3), 358-362. Laemmli, U. K. (1970). Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4. Nature, 227(5259), 680-685. McCarthy, O.J., (2002). Milk | Physical and Physico-Chemical Properties of Milk. In Encyclopedia of Dairy Sciences (Second Edition),John, W. F. (pp. 467-477). San Diego: Academic Press. Marnila, P., and Korhonen, H., (2011). Milk proteins immunoglobulins. In Encyclopedia of Dairy Sciences (Second Edition),John, W. F. (pp. 807-815). San Diego: Academic Press. Matar, C., Amiot, J., Savoie, L., & Goulet, J. (1996). The effect of milk fermentation by Lactobacillus helveticus on the release of peptides during in vitro digestion. Journal of Dairy Science, 79(6), 971979. Opatha Vithana, N. L., Mason, S. L., Bekhit, A. E. A., Morton, J. D., (2010). Bioactive peptides from red deer (Cervus elaphus) milk. IDF World Dairy Summit (pp22). http://wwwwds.2010.com/poster/AllPosterAbstract.pdf Pandey, P. K., Ramaswamy, H. S., & St-Gelais, D. (2003). Evaluation of pH change kinetics during various stages of Cheddar cheese-making from raw, pasteurized, micro-filtered and high-pressure-treated milk. LWT - Food Science and Technology, 36(5), 497-506. Pihlanto-Leppälä, A., Rokka, T., & Korhonen, H. (1998). Angiotensin I Converting Enzyme inhibitory peptides derived from bovine milk proteins. International Dairy Journal, 8(4), 325-331. Wal, J. M. (1998). Immunochemical and molecular characterization of milk allergens. Allergy, 53, 114-117. 160 Appendix C IL-2 production by human peripheral blood mononuclear cells (PBMC) stimulated by Con A with FPLC fraction 13 and 36 of unfermented and fermented deer and cow milk in vitro digests Fraction 36 50 50 40 40 IL2 production (pg/ml) IL2 Production (pg/ml) Fraction 13 30 20 10 30 20 10 0 0 Control Milk digest Ldb digests Sst digests LcS digests Control Protein o.125 mg/ml control D C Milk digest Ldb digests Sst digests LcS digests Protein 0.125 mg/ml control deer cow Figure 1. IL-2 production by human peripheral blood mononuclear cells (PBMC) stimulated by Con A with FPLC fraction 13 and 36 of unfermented and fermented deer ( ) and cow ( ) milk in vitrodigests (0.125mg/ml protein). Fractions from deer and cow milk digests and digests of Lactobacillus delburueckii subsp bulgaricus (Ldb), Streptococcus salivarius subs thermophilus (Sst) and Lactobacillus casi strain Shirota (Lcs) ferment. Control ( ) cells were stimulated by Con A without the addition of proteins. Data are mean ± S.D. (n = 3). Samples measured in triplicates. 161 Appendix D Deer and cow milk digests FPLC fractions absorbance at 280 nm Figure 1.Absorbance at 280 nm of RP-FPLC chromatograms of the deer milk digests Figure 2. Absorbance at 280 nm of RP-FPLC chromatograms of the cow milk digests 162